BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349:2241-2252. [PMID: 14657432 DOI: 10.1056/nejmra035010] [Cited by in Crossref: 1936] [Cited by in F6Publishing: 943] [Article Influence: 101.9] [Reference Citation Analysis]
Number Citing Articles
1 Zhai R, Chen F, Liu G, Su L, Kulke MH, Asomaning K, Lin X, Heist RS, Nishioka NS, Sheu CC, Wain JC, Christiani DC. Interactions among genetic variants in apoptosis pathway genes, reflux symptoms, body mass index, and smoking indicate two distinct etiologic patterns of esophageal adenocarcinoma. J Clin Oncol 2010;28:2445-51. [PMID: 20385987 DOI: 10.1200/JCO.2009.26.2790] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
2 Liu SG, Qin XG, Zhao BS, Qi B, Yao WJ, Wang TY, Li HC, Wu XN. Differential expression of miRNAs in esophageal cancer tissue. Oncol Lett 2013;5:1639-42. [PMID: 23761828 DOI: 10.3892/ol.2013.1251] [Cited by in Crossref: 91] [Cited by in F6Publishing: 98] [Article Influence: 10.1] [Reference Citation Analysis]
3 Rawat S, Kumar G, Kakria A, Sharma MK, Chauhan D. Chemoradiotherapy in the management of locally advanced squamous cell carcinoma esophagus: is surgical resection required? J Gastrointest Cancer 2013;44:277-84. [PMID: 23389866 DOI: 10.1007/s12029-013-9477-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
4 Zhou L, Deng ZZ, Li HY, Jiang N, Wei ZS, Hong MF, Wang JH, Zhang MX, Shi YH, Lu ZQ, Huang XM. Overexpression of PRR11 promotes tumorigenic capability and is associated with progression in esophageal squamous cell carcinoma. Onco Targets Ther 2019;12:2677-93. [PMID: 31040705 DOI: 10.2147/OTT.S180255] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Liu SY, Chen W, Chughtai EA, Qiao Z, Jiang JT, Li SM, Zhang W, Zhang J. PIK3CA gene mutations in Northwest Chinese esophageal squamous cell carcinoma. World J Gastroenterol 2017; 23(14): 2585-2591 [PMID: 28465643 DOI: 10.3748/wjg.v23.i14.2585] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
6 Blank S, Nienhüser H, Dreikhausen L, Sisic L, Heger U, Ott K, Schmidt T. Inflammatory cytokines are associated with response and prognosis in patients with esophageal cancer. Oncotarget 2017;8:47518-32. [PMID: 28537901 DOI: 10.18632/oncotarget.17671] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
7 Shi Z, Tang Y, Li K, Fan Q. TKTL1 expression and its downregulation is implicated in cell proliferation inhibition and cell cycle arrest in esophageal squamous cell carcinoma. Tumour Biol 2015;36:8519-29. [PMID: 26032094 DOI: 10.1007/s13277-015-3608-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
8 Bradbury PA, Kulke MH, Heist RS, Zhou W, Ma C, Xu W, Marshall AL, Zhai R, Hooshmand SM, Asomaning K. Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes. Pharmacogenet Genomics. 2009;19:613-625. [PMID: 19620936 DOI: 10.1097/FPC.0b013e32832f3010] [Cited by in Crossref: 51] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
9 Liu S, Wang N, Yang J, Yang JY, Shi ZH. Use of tunnel endoscopy for diagnosis of obscure submucosal esophageal adenocarcinoma: A case report and review of the literature with emphasis on causes of esophageal stenosis. World J Clin Cases 2019; 7(5): 668-675 [PMID: 30863768 DOI: 10.12998/wjcc.v7.i5.668] [Reference Citation Analysis]
10 Zhang P, Xi M, Zhao L, Shen JX, Li QQ, He LR, Liu SL, Liu MZ. Is there a benefit in receiving concurrent chemoradiotherapy for elderly patients with inoperable thoracic esophageal squamous cell carcinoma? PLoS One 2014;9:e105270. [PMID: 25133495 DOI: 10.1371/journal.pone.0105270] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
11 Huang Q, Luo K, Yang H, Wen J, Zhang S, Li J, Ela Bella A, Liu Q, Yang F, Zheng Y, Hu R, Chen J, Fu J. Impact of alcohol consumption on survival in patients with esophageal carcinoma: a large cohort with long-term follow-up. Cancer Sci 2014;105:1638-46. [PMID: 25287715 DOI: 10.1111/cas.12552] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
12 Saito S, Morishima K, Ui T, Hoshino H, Matsubara D, Ishikawa S, Aburatani H, Fukayama M, Hosoya Y, Sata N, Lefor AK, Yasuda Y, Niki T. The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma. BMC Cancer 2015;15:82. [PMID: 25884729 DOI: 10.1186/s12885-015-1065-8] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
13 Luo J, Xie K, Gao X, Yao Y, Wang G, Shao C, Li X, Xu Y, Ren B, Hu L, Shen Y. Long Noncoding RNA Nuclear Paraspeckle Assembly Transcript 1 Promotes Progression and Angiogenesis of Esophageal Squamous Cell Carcinoma Through miR-590-3p/MDM2 Axis. Front Oncol 2020;10:618930. [PMID: 33680941 DOI: 10.3389/fonc.2020.618930] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Yu J, Wu X, Huang K, Zhu M, Zhang X, Zhang Y, Chen S, Xu X, Zhang Q. Bioinformatics identification of lncRNA biomarkers associated with the progression of esophageal squamous cell carcinoma. Mol Med Rep. 2019;19:5309-5320. [PMID: 31059058 DOI: 10.3892/mmr.2019.10213] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
15 Lee JM, Chen SC, Yang SM, Tseng YF, Yang PW, Huang PM. Comparison of single- and multi-incision minimally invasive esophagectomy (MIE) for treating esophageal cancer: a propensity-matched study. Surg Endosc 2017;31:2925-31. [PMID: 27826778 DOI: 10.1007/s00464-016-5308-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Xie F, Liu H, Zhu YH, Qin YR, Dai Y, Zeng T, Chen L, Nie C, Tang H, Li Y, Fu L, Guan XY. Overexpression of GPR39 contributes to malignant development of human esophageal squamous cell carcinoma. BMC Cancer 2011;11:86. [PMID: 21352519 DOI: 10.1186/1471-2407-11-86] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
17 Jayaprakash N, O'Kelly F, Lim KT, Reynolds JV. Management of synchronous adenocarcinoma of the esophago-gastric junction and ampulla of Vater: Case report of a surgically challenging condition. Patient Saf Surg. 2009;3:23. [PMID: 19785744 DOI: 10.1186/1754-9493-3-23] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
18 Carns J, Keahey P, Quang T, Anandasabapathy S, Richards-Kortum R. Optical molecular imaging in the gastrointestinal tract. Gastrointest Endosc Clin N Am. 2013;23:707-723. [PMID: 23735112 DOI: 10.1016/j.giec.2013.03.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
19 Zhao M, Cui H, Zhao B, Li M, Man H. Long intergenic non‑coding RNA LINC01232 contributes to esophageal squamous cell carcinoma progression by sequestering microRNA‑654‑3p and consequently promoting hepatoma‑derived growth factor expression. Int J Mol Med 2020;46:2007-18. [PMID: 33125097 DOI: 10.3892/ijmm.2020.4750] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
20 Wang LX, Shi YL, Zhang LJ, Wang KR, Xiang LP, Cai ZY, Lu JL, Ye JH, Liang YR, Zheng XQ. Inhibitory Effects of (-)-Epigallocatechin-3-gallate on Esophageal Cancer. Molecules. 2019;24:pii: E954. [PMID: 30857144 DOI: 10.3390/molecules24050954] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
21 Hu F, Tao Z, Shen Z, Wang X, Hua F. Down-regulation of EphB4 phosphorylation is necessary for esophageal squamous cell carcinoma tumorigenecity. Tumour Biol 2014;35:7225-32. [PMID: 24771266 DOI: 10.1007/s13277-014-1955-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
22 Halmos B, Jia Y, Bokar JA, Fu P, Adelstein DJ, Juergens R, Rodal MB, Dowlati A. A Phase I study of the combination of oxaliplatin/docetaxel and vandetanib for the treatment of advanced gastroesophageal cancer. Invest New Drugs 2013;31:1244-50. [PMID: 23553066 DOI: 10.1007/s10637-013-9945-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
23 Tetreault MP, Yang Y, Travis J, Yu QC, Klein-Szanto A, Tobias JW, Katz JP. Esophageal squamous cell dysplasia and delayed differentiation with deletion of krüppel-like factor 4 in murine esophagus. Gastroenterology. 2010;139:171-81.e9. [PMID: 20347813 DOI: 10.1053/j.gastro.2010.03.048] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 4.2] [Reference Citation Analysis]
24 Basu S, Alavi A. Should FDG-PET imaging be considered on a routine basis in clinical trials for carcinoma of esophagus to assure uniformity of protocols among sites? Eur J Nucl Med Mol Imaging 2007;34:604-5. [PMID: 17206414 DOI: 10.1007/s00259-006-0315-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
25 Lee TS, Song IH, Shin JI, Park YS, Kim JY, Kim KI, Lee YJ, Kang JH. PET Imaging Biomarkers of Anti-EGFR Immunotherapy in Esophageal Squamous Cell Carcinoma Models. Cells 2018;7:E187. [PMID: 30373221 DOI: 10.3390/cells7110187] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Wu X, Wanders A, Wardega P, Tinge B, Gedda L, Bergstrom S, Sooman L, Gullbo J, Bergqvist M, Hesselius P. Hsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycin. Br J Cancer. 2009;100:334-343. [PMID: 19142186 DOI: 10.1038/sj.bjc.6604855] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]
27 Teng H, Xue M, Liang J, Wang X, Wang L, Wei W, Li C, Zhang Z, Li Q, Ran X, Shi X, Cai W, Wang W, Gao H, Sun Z. Inter- and intratumor DNA methylation heterogeneity associated with lymph node metastasis and prognosis of esophageal squamous cell carcinoma. Theranostics 2020;10:3035-48. [PMID: 32194853 DOI: 10.7150/thno.42559] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
28 Tsuchikawa T, Ikeda H, Cho Y, Miyamoto M, Shichinohe T, Hirano S, Kondo S. Association of CD8+ T cell infiltration in oesophageal carcinoma lesions with human leucocyte antigen (HLA) class I antigen expression and survival. Clin Exp Immunol. 2011;164:50-56. [PMID: 21352198 DOI: 10.1111/j.1365-2249.2010.04311.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
29 Zang W, Wang Y, Du Y, Xuan X, Wang T, Li M, Ma Y, Li P, Chen X, Dong Z. Differential expression profiling of microRNAs and their potential involvement in esophageal squamous cell carcinoma. Tumor Biol. 2014;35:3295-3304. [PMID: 24272087 DOI: 10.1007/s13277-013-1432-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
30 Njei B, McCarty TR, Birk JW. Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis. J Gastroenterol Hepatol. 2016;31:1141-1146. [PMID: 26749521 DOI: 10.1111/jgh.13289] [Cited by in Crossref: 125] [Cited by in F6Publishing: 114] [Article Influence: 25.0] [Reference Citation Analysis]
31 Tan C, Qian X, Guan Z, Yang B, Ge Y, Wang F, Cai J. Potential biomarkers for esophageal cancer. Springerplus. 2016;5:467. [PMID: 27119071 DOI: 10.1186/s40064-016-2119-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 5.7] [Reference Citation Analysis]
32 Rees JR, Lao-Sirieix P, Wong A, Fitzgerald RC: Treatment for Barrett’s oesophagus Cochrane Database Syst Rev. 2010;CD004060. [PMID: 20091557 DOI: 10.1002/14651858.cd004060.pub2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
33 Antonowicz SS, Lorenzi B, Parker M, Tang CB, Harvey M, Kadirkamanathan SS. Annual computed tomography scans do not improve outcomes following esophagectomy for cancer: a 10-year UK experience. Dis Esophagus 2015;28:365-70. [PMID: 24649807 DOI: 10.1111/dote.12209] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
34 Baba Y, Iyama KI, Hirashima K, Nagai Y, Yoshida N, Hayashi N, Miyanari N, Baba H. Laminin-332 promotes the invasion of oesophageal squamous cell carcinoma via PI3K activation. Br J Cancer 2008;98:974-80. [PMID: 18283320 DOI: 10.1038/sj.bjc.6604252] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
35 Hao JJ, Lin DC, Dinh HQ, Mayakonda A, Jiang YY, Chang C, Jiang Y, Lu CC, Shi ZZ, Xu X, Zhang Y, Cai Y, Wang JW, Zhan QM, Wei WQ, Berman BP, Wang MR, Koeffler HP. Spatial intratumoral heterogeneity and temporal clonal evolution in esophageal squamous cell carcinoma. Nat Genet 2016;48:1500-7. [PMID: 27749841 DOI: 10.1038/ng.3683] [Cited by in Crossref: 120] [Cited by in F6Publishing: 115] [Article Influence: 20.0] [Reference Citation Analysis]
36 Yoon HH, Shi Q, Sukov WR, Lewis MA, Sattler CA, Wiktor AE, Wu TT, Diasio RB, Jenkins RB, Sinicrope FA. Adverse prognostic impact of intratumor heterogeneous HER2 gene amplification in patients with esophageal adenocarcinoma. J Clin Oncol 2012;30:3932-8. [PMID: 22987085 DOI: 10.1200/JCO.2012.43.1890] [Cited by in Crossref: 66] [Cited by in F6Publishing: 30] [Article Influence: 6.6] [Reference Citation Analysis]
37 Athanasopoulos PG, Kyriazi M, Arkadopoulos N, Dellaportas D, Manta A, Theodosopoulos T, Tympa A, Vassileiou I, Smyrniotis V. Parathyroid autotransplantation in extensive head and neck resections: case series report. World J Surg Oncol 2011;9:149. [PMID: 22085420 DOI: 10.1186/1477-7819-9-149] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
38 Zhou M, Li Y, Lin S, Chen Y, Qian Y, Zhao Z, Fan H. H3K9me3, H3K36me3, and H4K20me3 Expression Correlates with Patient Outcome in Esophageal Squamous Cell Carcinoma as Epigenetic Markers. Dig Dis Sci 2019;64:2147-57. [PMID: 30788686 DOI: 10.1007/s10620-019-05529-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
39 Zhou P, Dong H, He S, Fang L, Jiang N, Sun Q. miR612 is associated with esophageal squamous cell carcinoma development and metastasis, mediated through TP53. Mol Med Rep 2017;16:1855-63. [PMID: 28656264 DOI: 10.3892/mmr.2017.6808] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
40 Huang SD, Yuan Y, Zhuang CW, Li BL, Gong DJ, Wang SG, Zeng ZY, Cheng HZ. MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma. Mol Cancer. 2012;11:51. [PMID: 22867052 DOI: 10.1186/1476-4598-11-51] [Cited by in Crossref: 78] [Cited by in F6Publishing: 78] [Article Influence: 7.8] [Reference Citation Analysis]
41 Shiroma S, Yoshio T, Kato Y, Horie Y, Namikawa K, Tokai Y, Yoshimizu S, Yoshizawa N, Horiuchi Y, Ishiyama A, Hirasawa T, Tsuchida T, Akazawa N, Akiyama J, Tada T, Fujisaki J. Ability of artificial intelligence to detect T1 esophageal squamous cell carcinoma from endoscopic videos and the effects of real-time assistance. Sci Rep 2021;11:7759. [PMID: 33833355 DOI: 10.1038/s41598-021-87405-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Seki N, Toh U, Sayers TJ, Fujii T, Miyagi M, Akagi Y, Kusukawa J, Kage M, Shirouzu K, Yamana H. Bortezomib sensitizes human esophageal squamous cell carcinoma cells to TRAIL-mediated apoptosis via activation of both extrinsic and intrinsic apoptosis pathways. Mol Cancer Ther. 2010;9:1842-1851. [PMID: 20515944 DOI: 10.1158/1535-7163.mct-09-0918] [Cited by in Crossref: 33] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
43 Qiao YM, Zhang Y. Immunotherapy for esophageal cancer: Current studies and future perspectives. Shijie Huaren Xiaohua Zazhi 2016; 24(36): 4739-4751 [DOI: 10.11569/wcjd.v24.i36.4739] [Reference Citation Analysis]
44 Luo J, Zhou X, Ge X, Liu P, Cao J, Lu X, Ling Y, Zhang S. Upregulation of Ying Yang 1 (YY1) suppresses esophageal squamous cell carcinoma development through heme oxygenase-1. Cancer Sci 2013;104:1544-51. [PMID: 23919806 DOI: 10.1111/cas.12248] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
45 Wolin KY, Carson K, Colditz GA. Obesity and cancer. Oncologist. 2010;15:556-565. [PMID: 20507889 DOI: 10.1634/theoncologist.2009-0285] [Cited by in Crossref: 412] [Cited by in F6Publishing: 350] [Article Influence: 34.3] [Reference Citation Analysis]
46 Islamian JP, Mohammadi M, Baradaran B. Inhibition of human esophageal squamous cell carcinomas by targeted silencing of tumor enhancer genes: an overview. Cancer Biol Med 2014;11:78-85. [PMID: 25009749 DOI: 10.7497/j.issn.2095-3941.2014.02.002] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
47 Sharma P, Gautam SD, Rajendra S. Importance of investigating high-risk human papillomavirus in lymph node metastasis of esophageal adenocarcinoma. World J Gastroenterol 2020; 26(21): 2729-2739 [PMID: 32550750 DOI: 10.3748/wjg.v26.i21.2729] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Nicolau-Neto P, Da Costa NM, de Souza Santos PT, Gonzaga IM, Ferreira MA, Guaraldi S, Moreira MA, Seuánez HN, Brewer L, Bergmann A, Boroni M, Mencalha AL, Kruel CDP, Lima SCS, Esposito D, Simão TA, Pinto LFR. Esophageal squamous cell carcinoma transcriptome reveals the effect of FOXM1 on patient outcome through novel PIK3R3 mediated activation of PI3K signaling pathway. Oncotarget 2018;9:16634-47. [PMID: 29682174 DOI: 10.18632/oncotarget.24621] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
49 Yin J, Tang W, Long T, Pan H, Liu J, Lv L, Liu C, Shi Y, Zhu J, Sun Y, Shao A, Zhou Q, Ren Z, Ding G, Chen S, Liu Y, Yao J, Ding H, Yan Y, Gu H, Qian C, Wang L, Wang Q, Tan L. Association of ALDH3B2 gene polymorphism and risk factors with susceptibility of esophageal squamous cell carcinoma in a Chinese population: a case-control study involving 2,358 subjects. Oncotarget 2017;8:110153-65. [PMID: 29299137 DOI: 10.18632/oncotarget.22656] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
50 Zang W, Wang T, Wang Y, Chen X, Du Y, Sun Q, Li M, Dong Z, Zhao G. Knockdown of long non-coding RNA TP73-AS1 inhibits cell proliferation and induces apoptosis in esophageal squamous cell carcinoma. Oncotarget. 2016;7:19960-19974. [PMID: 26799587 DOI: 10.18632/oncotarget.6963] [Cited by in Crossref: 56] [Cited by in F6Publishing: 63] [Article Influence: 14.0] [Reference Citation Analysis]
51 Taghavi N, Biramijamal F, Sotoudeh M, Khademi H, Malekzadeh R, Moaven O, Memar B, A'rabi A, Abbaszadegan MR. p16INK4a hypermethylation and p53, p16 and MDM2 protein expression in esophageal squamous cell carcinoma. BMC Cancer 2010;10:138. [PMID: 20388212 DOI: 10.1186/1471-2407-10-138] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 3.7] [Reference Citation Analysis]
52 Maeng CH, Lee J, van Hummelen P, Park SH, Palescandolo E, Jang J, Park HY, Kang SY, MacConaill L, Kim KM. High-throughput genotyping in metastatic esophageal squamous cell carcinoma identifies phosphoinositide-3-kinase and BRAF mutations. PLoS One. 2012;7:e41655. [PMID: 22870241 DOI: 10.1371/journal.pone.0041655] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
53 Meng RY, Jin H, Nguyen TV, Chai OH, Park BH, Kim SM. Ursolic Acid Accelerates Paclitaxel-Induced Cell Death in Esophageal Cancer Cells by Suppressing Akt/FOXM1 Signaling Cascade. Int J Mol Sci 2021;22:11486. [PMID: 34768915 DOI: 10.3390/ijms222111486] [Reference Citation Analysis]
54 Pham Van B, Nguyen Thi Thanh H, Le Thi H, Nguyen Le Tuan A, Dang Thi Thu H, Dang Viet D. Nutritional Status and Feeding Regimen of Patients with Esophagus Cancer-A Study from Vietnam. Healthcare (Basel) 2021;9:289. [PMID: 33800823 DOI: 10.3390/healthcare9030289] [Reference Citation Analysis]
55 Tianxing G, Xiaojie P, Lihuan Z, Yangyun H. Combination of preoperative fibrinogen and neutrophil to lymphocyte ratio is a predictive prognostic factor in ESCC and AEG systematic review. Biosci Rep 2019;39:BSR20190480. [PMID: 31511434 DOI: 10.1042/BSR20190480] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
56 So H, Ahn JY, Han S, Jung K, Na HK, Lee JH, Jeong KW, Kim DH, Choi KD, Song HJ, Lee GH, Jung HY. Efficacy and Safety of Fully Covered Self-Expanding Metal Stents for Malignant Esophageal Obstruction. Dig Dis Sci 2018;63:234-41. [PMID: 29147877 DOI: 10.1007/s10620-017-4839-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
57 Biere SS, Maas KW, Bonavina L, Garcia JR, van Berge Henegouwen MI, Rosman C, Sosef MN, de Lange ES, Bonjer HJ, Cuesta MA. Traditional invasive vs. minimally invasive esophagectomy: a multi-center, randomized trial (TIME-trial). BMC Surg. 2011;11:2. [PMID: 21226918 DOI: 10.1186/1471-2482-11-2] [Cited by in Crossref: 78] [Cited by in F6Publishing: 59] [Article Influence: 7.1] [Reference Citation Analysis]
58 Wu IC, Wu CC, Lu CY, Hsu WH, Wu MC, Lee JY, Chou SH, Lee JM, Chou YP, Wu DC, Wu MT. Substance use (alcohol, areca nut and cigarette) is associated with poor prognosis of esophageal squamous cell carcinoma. PLoS One 2013;8:e55834. [PMID: 23409056 DOI: 10.1371/journal.pone.0055834] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
59 Gallerani G, Fabbri F. Circulating Tumor Cells in the Adenocarcinoma of the Esophagus. Int J Mol Sci 2016;17:E1266. [PMID: 27527155 DOI: 10.3390/ijms17081266] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
60 Suzuki I, Cho YM, Hirata T, Toyoda T, Akagi JI, Nakamura Y, Park EY, Sasaki A, Nakamura T, Okamoto S, Shirota K, Suetome N, Nishikawa A, Ogawa K. 4-Methylthio-3-butenyl isothiocyanate (raphasatin) exerts chemopreventive effects against esophageal carcinogenesis in rats. J Toxicol Pathol 2016;29:237-46. [PMID: 27821908 DOI: 10.1293/tox.2016-0037] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
61 Sarbia M, Stahl M, von Weyhern C, Weirich G, Pühringer-Oppermann F. The prognostic significance of genetic polymorphisms (Methylenetetrahydrofolate Reductase C677T, Methionine Synthase A2756G, Thymidilate Synthase tandem repeat polymorphism) in multimodally treated oesophageal squamous cell carcinoma. Br J Cancer 2006;94:203-7. [PMID: 16333305 DOI: 10.1038/sj.bjc.6602900] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.2] [Reference Citation Analysis]
62 Yue Y, Song M, Qiao Y, Li P, Yuan Y, Lian J, Wang S, Zhang Y. Gene function analysis and underlying mechanism of esophagus cancer based on microarray gene expression profiling. Oncotarget 2017;8:105222-37. [PMID: 29285246 DOI: 10.18632/oncotarget.22160] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
63 Zhang H, Lin W, Kannan K, Luo L, Li J, Chao PW, Wang Y, Chen YP, Gu J, Yen L. Aberrant chimeric RNA GOLM1-MAK10 encoding a secreted fusion protein as a molecular signature for human esophageal squamous cell carcinoma. Oncotarget 2013;4:2135-43. [PMID: 24243830 DOI: 10.18632/oncotarget.1465] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
64 Nagata H, Kozaki KI, Muramatsu T, Hiramoto H, Tanimoto K, Fujiwara N, Imoto S, Ichikawa D, Otsuji E, Miyano S, Kawano T, Inazawa J. Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma. Oncotarget 2017;8:37740-50. [PMID: 28465481 DOI: 10.18632/oncotarget.17147] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
65 Luketich JD, Pennathur A, Awais O, Levy RM, Keeley S, Shende M, Christie NA, Weksler B, Landreneau RJ, Abbas G, Schuchert MJ, Nason KS. Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg. 2012;256:95-103. [PMID: 22668811 DOI: 10.1097/sla.0b013e3182590603] [Cited by in Crossref: 469] [Cited by in F6Publishing: 186] [Article Influence: 46.9] [Reference Citation Analysis]
66 Zhou Z, Ran YL, Hu H, Pan J, Li ZF, Chen LZ, Sun LC, Peng L, Zhao XL, Yu L. TM4SF3 promotes esophageal carcinoma metastasis via upregulating ADAM12m expression. Clin Exp Metastasis. 2008;25:537-548. [PMID: 18365756 DOI: 10.1007/s10585-008-9168-0] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 3.2] [Reference Citation Analysis]
67 Abnet CC, Freedman ND, Hollenbeck AR, Fraumeni JF Jr, Leitzmann M, Schatzkin A. A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma. Eur J Cancer 2008;44:465-71. [PMID: 18221867 DOI: 10.1016/j.ejca.2007.12.009] [Cited by in Crossref: 112] [Cited by in F6Publishing: 93] [Article Influence: 8.0] [Reference Citation Analysis]
68 Song PI, Liang H, Fan JH, Wei WQ, Wang GQ, Qiao YL. Long-term survival after esophagectomy for early esophageal squamous cell carcinoma in Linxian, China. J Surg Oncol 2011;104:176-80. [PMID: 21538356 DOI: 10.1002/jso.21953] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
69 Pritchett NR, Burgert SL, Murphy GA, Brockman JD, White RE, Lando J, Chepkwony R, Topazian MD, Abnet CC, Dawsey SM, Mwachiro MM. Cross sectional study of serum selenium concentration and esophageal squamous dysplasia in western Kenya. BMC Cancer 2017;17:835. [PMID: 29216866 DOI: 10.1186/s12885-017-3837-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
70 Wang YS, Tian J, Han Y, Han SM, Shi SB. Gemcitabine Plus Vinorelbine as Second-Line Therapy in Patients With Metastatic Esophageal Cancer Previously Treated With Platinum-Based Chemotherapy. Oncol Res 2016;24:129-35. [PMID: 27296953 DOI: 10.3727/096504016X14618564639213] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
71 Chao YK. Extracapsular lymph node involvement in patients with esophageal cancer treated with neoadjuvant chemoradiation therapy followed by surgery: the closer you look, the less you see. J Thorac Dis 2017;9:4270-2. [PMID: 29268488 DOI: 10.21037/jtd.2017.10.53] [Reference Citation Analysis]
72 Wang HB, Jiang ZB, Li M. Research on the typical miRNA and target genes in squamous cell carcinoma and adenocarcinoma of esophagus cancer with DNA microarray. Pathol Oncol Res 2014;20:245-52. [PMID: 24519530 DOI: 10.1007/s12253-013-9688-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
73 Tuynman JB, Buskens CJ, Kemper K, ten Kate FJ, Offerhaus GJ, Richel DJ, van Lanschot JJ. Neoadj-uvant selective COX-2 inhibition down-regulates important oncogenic pathways in patients with esophageal adenocarcinoma. Ann Surg. 2005;242:840-849. [PMID: 16327494 DOI: 10.1097/01.sla.0000189546.77520.ef] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
74 Guo W, Jiang YG. Current gene expression studies in esophageal carcinoma. Curr Genomics 2009;10:534-9. [PMID: 20514215 DOI: 10.2174/138920209789503888] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
75 Yun JK, Lee IS, Gong CS, Kim BS, Kim HR, Kim DK, Park SI, Kim YH. Clinical utility of robot-assisted transthoracic esophagectomy in advanced esophageal cancer after neoadjuvant chemoradiation therapy. J Thorac Dis 2019;11:2913-23. [PMID: 31463120 DOI: 10.21037/jtd.2019.07.53] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
76 Pultrum BB, Bosch DJ, Nijsten MW, Rodgers MG, Groen H, Slaets JP, Plukker JT. Extended esophagectomy in elderly patients with esophageal cancer: minor effect of age alone in determining the postoperative course and survival. Ann Surg Oncol. 2010;17:1572-1580. [PMID: 20180031 DOI: 10.1245/s10434-010-0966-7] [Cited by in Crossref: 71] [Cited by in F6Publishing: 67] [Article Influence: 5.9] [Reference Citation Analysis]
77 Tarapore RS, Yang Y, Katz JP. Restoring KLF5 in esophageal squamous cell cancer cells activates the JNK pathway leading to apoptosis and reduced cell survival. Neoplasia 2013;15:472-80. [PMID: 23633919 DOI: 10.1593/neo.122126] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
78 Nagami Y, Shiba M, Ominami M, Sakai T, Minamino H, Fukunaga S, Sugimori S, Tanaka F, Kamata N, Tanigawa T, Yamagami H, Watanabe T, Tominaga K, Fujiwara Y, Arakawa T. Single Locoregional Triamcinolone Injection Immediately After Esophageal Endoscopic Submucosal Dissection Prevents Stricture Formation. Clin Transl Gastroenterol 2017;8:e75. [PMID: 28230852 DOI: 10.1038/ctg.2017.5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
79 Jin Z, Wang L, Zhang Y, Cheng Y, Gao Y, Feng X, Dong M, Cao Z, Chen S, Yu H, Zhao Z, Zhang X, Liu J, Mori Y, Fan X, Meltzer SJ. MAL hypermethylation is a tissue-specific event that correlates with MAL mRNA expression in esophageal carcinoma. Sci Rep 2013;3:2838. [PMID: 24088706 DOI: 10.1038/srep02838] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
80 Golder WA. [The Will Rogers phenomenon and its impact on imaging diagnostics]. Radiologe 2009;49:348-54. [PMID: 18709345 DOI: 10.1007/s00117-008-1733-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
81 Yao W, Jia X, Xu L, Li S, Wei L. MicroRNA-2053 involves in the progression of esophageal cancer by targeting KIF3C. Cell Cycle 2021;20:1163-72. [PMID: 34057012 DOI: 10.1080/15384101.2021.1929675] [Reference Citation Analysis]
82 Kuo IY, Chang JM, Jiang SS, Chen CH, Chang IS, Sheu BS, Lu PJ, Chang WL, Lai WW, Wang YC. Prognostic CpG methylation biomarkers identified by methylation array in esophageal squamous cell carcinoma patients. Int J Med Sci 2014;11:779-87. [PMID: 24936140 DOI: 10.7150/ijms.7405] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
83 Li J, Qiu G, Fang B, Dai X, Cai J. Deficiency of IL-18 Aggravates Esophageal Carcinoma Through Inhibiting IFN-γ Production by CD8+T Cells and NK Cells. Inflammation 2018;41:667-76. [PMID: 29264744 DOI: 10.1007/s10753-017-0721-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
84 Soheili M, Keyvani H, Soheili M, Nasseri S. Human papilloma virus: A review study of epidemiology, carcinogenesis, diagnostic methods, and treatment of all HPV-related cancers. Med J Islam Repub Iran 2021;35:65. [PMID: 34277502 DOI: 10.47176/mjiri.35.65] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Chen X, Zhou Z, Zhao Y. ELLPMDA: Ensemble learning and link prediction for miRNA-disease association prediction. RNA Biol 2018;15:807-18. [PMID: 29619882 DOI: 10.1080/15476286.2018.1460016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
86 Zhang ZM, He XY, Shi RH. Clinicopathologic significance of miR-133b expression in esophageal squamous cell carcinoma. Shijie Huaren Xiaohua Zazhi 2015; 23(26): 4242-4246 [DOI: 10.11569/wcjd.v23.i26.4242] [Reference Citation Analysis]
87 Qing T, Zhu S, Suo C, Zhang L, Zheng Y, Shi L. Somatic mutations in ZFHX4 gene are associated with poor overall survival of Chinese esophageal squamous cell carcinoma patients. Sci Rep 2017;7:4951. [PMID: 28694483 DOI: 10.1038/s41598-017-04221-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
88 Belkhiri A, El-Rifai W. Advances in targeted therapies and new promising targets in esophageal cancer. Oncotarget 2015;6:1348-58. [PMID: 25593196 DOI: 10.18632/oncotarget.2752] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
89 Ajani JA, Winter K, Komaki R, Kelsen DP, Minsky BD, Liao Z, Bradley J, Fromm M, Hornback D, Willett CG. Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113. J Clin Oncol. 2008;26:4551-4556. [PMID: 18574157 DOI: 10.1200/jco.2008.16.6918] [Cited by in Crossref: 87] [Cited by in F6Publishing: 36] [Article Influence: 6.2] [Reference Citation Analysis]
90 Ziauddin MF, Yeow WS, Maxhimer JB, Baras A, Chua A, Reddy RM, Tsai W, Cole GW Jr, Schrump DS, Nguyen DM. Valproic acid, an antiepileptic drug with histone deacetylase inhibitory activity, potentiates the cytotoxic effect of Apo2L/TRAIL on cultured thoracic cancer cells through mitochondria-dependent caspase activation. Neoplasia 2006;8:446-57. [PMID: 16820090 DOI: 10.1593/neo.05823] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
91 Zhang Y, Yang X, Geng D, Duan Y, Fu J. The change of health-related quality of life after minimally invasive esophagectomy for esophageal cancer: a meta-analysis. World J Surg Oncol 2018;16:97. [PMID: 29793487 DOI: 10.1186/s12957-018-1330-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
92 Song G, Liu K, Yang X, Mu B, Yang J, He L, Hu X, Li Q, Zhao Y, Cai X, Feng G. SATB1 plays an oncogenic role in esophageal cancer by up-regulation of FN1 and PDGFRB. Oncotarget 2017;8:17771-84. [PMID: 28147311 DOI: 10.18632/oncotarget.14849] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
93 Zhao P, Yan W, Fu H, Lin Y, Chen KN. Efficacy of postoperative adjuvant chemotherapy for esophageal squamous cell carcinoma: A meta-analysis. Thorac Cancer 2018;9:1048-55. [PMID: 29927075 DOI: 10.1111/1759-7714.12787] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
94 Liu N, Li C, Huang Y, Yi Y, Bo W, Li C, Li Y, Hu Y, Li K, Wang H, Zhuang L, Fan H, Wang D. A functional module-based exploration between inflammation and cancer in esophagus. Sci Rep 2015;5:15340. [PMID: 26489668 DOI: 10.1038/srep15340] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
95 Hu Z, Zhang M, Wang Z, Song J, Jiang W, Li L, Hu X. An observational study on the clinical features of esophageal cancer followed by multiple primary cancers. Future Oncol 2019;15:601-10. [PMID: 30477336 DOI: 10.2217/fon-2018-0621] [Reference Citation Analysis]
96 Wang C, Zhao K, Huang Y, Ma L, Song Y, Li M. Baseline FDG Uptake And Peripheral Lymphocyte-Monocyte Ratio For Predicting Chemoradiotherapy Response In Patients With Esophageal Squamous Cell Carcinoma. Cancer Manag Res 2019;11:9085-93. [PMID: 31749632 DOI: 10.2147/CMAR.S227342] [Reference Citation Analysis]
97 Gao Y, Guo W, Cai S, Zhang F, Shao F, Zhang G, Liu T, Tan F, Li N, Xue Q, Gao S, He J. Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinoma. J Cancer 2019;10:3188-96. [PMID: 31289589 DOI: 10.7150/jca.30281] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
98 He X, Xu H, Zhao M, Wang S. Serum response factor is overexpressed in esophageal squamous cell carcinoma and promotes Eca-109 cell proliferation and invasion. Oncol Lett 2013;5:819-24. [PMID: 23426188 DOI: 10.3892/ol.2013.1120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
99 O'Callaghan C, Fanning LJ, Houston A, Barry OP. Loss of p38δ mitogen-activated protein kinase expression promotes oesophageal squamous cell carcinoma proliferation, migration and anchorage-independent growth. Int J Oncol 2013;43:405-15. [PMID: 23722928 DOI: 10.3892/ijo.2013.1968] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
100 Ota T, Ishikawa T, Endo Y, Matsumura S, Yoshida J, Yasuda T, Okayama T, Inoue K, Dohi O, Yoshida N, Sakamoto N, Kamada K, Uchiyama K, Takagi T, Konishi H, Konishi H, Shiozaki A, Fujiwara H, Kishimoto M, Naito Y, Itoh Y. Skeletal muscle mass as a predictor of the response to neo-adjuvant chemotherapy in locally advanced esophageal cancer. Med Oncol 2019;36:15. [PMID: 30600347 DOI: 10.1007/s12032-018-1242-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
101 Chan CM, Lai KKY, Ng EKO, Kiang MN, Kwok TWH, Wang HK, Chan KW, Law TT, Tong DK, Chan KT, Lee NP, Law S. Serum microRNA-193b as a promising biomarker for prediction of chemoradiation sensitivity in esophageal squamous cell carcinoma patients. Oncol Lett 2018;15:3273-80. [PMID: 29435069 DOI: 10.3892/ol.2017.7698] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
102 D’Journo XB, Thomas PA. Current management of esophageal cancer. J Thorac Dis. 2014;6 Suppl 2:S253-S264. [PMID: 24868443 DOI: 10.3978/j.issn.2072-1439.2014.04.16] [Cited by in F6Publishing: 52] [Reference Citation Analysis]
103 Zhao Z, Yan L, Li S, Sun H, Zhou Y, Li X. Increased MMP-21 expression in esophageal squamous cell carcinoma is associated with progression and prognosis. Med Oncol 2014;31:91. [PMID: 25015395 DOI: 10.1007/s12032-014-0091-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
104 Li Z, Cheng J, Zhang Y, Wen S, Lv H, Xu Y, Zhu Y, Zhang Z, Mu D, Tian Z. Comparison of Up-Front Minimally Invasive Esophagectomy versus Open Esophagectomy on Quality of Life for Esophageal Squamous Cell Cancer. Curr Oncol 2021;28:693-701. [PMID: 33503901 DOI: 10.3390/curroncol28010068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Hong J, Belkhiri A. AXL mediates TRAIL resistance in esophageal adenocarcinoma. Neoplasia 2013;15:296-304. [PMID: 23479507 DOI: 10.1593/neo.122044] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
106 Wang C, Pu W, Zhao D, Zhou Y, Lu T, Chen S, He Z, Feng X, Wang Y, Li C, Li S, Jin L, Guo S, Wang J, Wang M. Identification of Hyper-Methylated Tumor Suppressor Genes-Based Diagnostic Panel for Esophageal Squamous Cell Carcinoma (ESCC) in a Chinese Han Population. Front Genet 2018;9:356. [PMID: 30233644 DOI: 10.3389/fgene.2018.00356] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
107 Shaverdashvili K, Padlo J, Weinblatt D, Jia Y, Jiang W, Rao D, Laczkó D, Whelan KA, Lynch JP, Muir AB, Katz JP. KLF4 activates NFκB signaling and esophageal epithelial inflammation via the Rho-related GTP-binding protein RHOF. PLoS One 2019;14:e0215746. [PMID: 30998758 DOI: 10.1371/journal.pone.0215746] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
108 Gao Y, Hu N, Han XY, Ding T, Giffen C, Goldstein AM, Taylor PR. Risk factors for esophageal and gastric cancers in Shanxi Province, China: a case-control study. Cancer Epidemiol. 2011;35:e91-e99. [PMID: 21846596 DOI: 10.1016/j.canep.2011.06.006] [Cited by in Crossref: 82] [Cited by in F6Publishing: 80] [Article Influence: 7.5] [Reference Citation Analysis]
109 Scarpa M, Valente S, Alfieri R, Cagol M, Diamantis G, Ancona E, Castoro C. Systematic review of health-related quality of life after esophagectomy for esophageal cancer. World J Gastroenterol 2011; 17(42): 4660-4674 [PMID: 22180708 DOI: 10.3748/wjg.v17.i42.4660] [Cited by in CrossRef: 98] [Cited by in F6Publishing: 86] [Article Influence: 8.9] [Reference Citation Analysis]
110 Jonsson L, Hedner C, Gaber A, Korkocic D, Nodin B, Uhlén M, Eberhard J, Jirström K. High expression of RNA-binding motif protein 3 in esophageal and gastric adenocarcinoma correlates with intestinal metaplasia-associated tumours and independently predicts a reduced risk of recurrence and death. Biomark Res 2014;2:11. [PMID: 24963396 DOI: 10.1186/2050-7771-2-11] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
111 Ding T, Liu C, Huang B, Chu L, Wei L, Lin Y, Luo Y, Zhang B, Hong C, Xu Y, Peng Y. A Survival Prediction Nomogram for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery. Cancer Manag Res 2021;13:7771-82. [PMID: 34675672 DOI: 10.2147/CMAR.S329687] [Reference Citation Analysis]
112 Zhou SL, Wang LD. Circulating microRNAs: Novel biomarkers for esophageal cancer. World J Gastroenterol 2010; 16(19): 2348-2354 [PMID: 20480519 DOI: 10.3748/wjg.v16.i19.2348] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
113 Guo W, Li Z, Jiang Y, Fan S. Postoperative thoracic empyema might improve the survival of patients with esophageal cancer. Med Hypotheses 2008;70:893. [PMID: 17964740 DOI: 10.1016/j.mehy.2007.09.003] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
114 Liang H, Fan JH, Qiao YL. Epidemiology, etiology, and prevention of esophageal squamous cell carcinoma in China. Cancer Biol Med. 2017;14:33-41. [PMID: 28443201 DOI: 10.20892/j.issn.2095-3941.2016.0093] [Cited by in Crossref: 85] [Cited by in F6Publishing: 100] [Article Influence: 17.0] [Reference Citation Analysis]
115 Kang Y. A Review of Self-Expanding Esophageal Stents for the Palliation Therapy of Inoperable Esophageal Malignancies. Biomed Res Int 2019;2019:9265017. [PMID: 31080835 DOI: 10.1155/2019/9265017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
116 Jiao WJ, Xu J, Pan H, Tian-You, Shen Y. Effect of endothelin-1 in esophageal squamous cell carcinoma invasion and its correlation with cathepsin B. World J Gastroenterol 2007; 13(29): 4002-4005 [PMID: 17663518 DOI: 10.3748/wjg.v13.i29.4002] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
117 Zhao Y, Zhou W, Xue L, Zhang W, Zhan Q. Nicotine activates YAP1 through nAChRs mediated signaling in esophageal squamous cell cancer (ESCC). PLoS One 2014;9:e90836. [PMID: 24621512 DOI: 10.1371/journal.pone.0090836] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
118 Okawa T, Michaylira CZ, Kalabis J, Stairs DB, Nakagawa H, Andl CD, Johnstone CN, Klein-Szanto AJ, El-Deiry WS, Cukierman E. The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation. Genes Dev. 2007;21:2788-2803. [PMID: 17974918 DOI: 10.1101/gad.1544507] [Cited by in Crossref: 126] [Cited by in F6Publishing: 123] [Article Influence: 9.0] [Reference Citation Analysis]
119 Gottlieb J, Wedemeyer J. [Endoscopic palliation of esophageal and bronchial carcinomas]. Internist (Berl) 2010;51 Suppl 1:237-45. [PMID: 20135086 DOI: 10.1007/s00108-009-2502-z] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
120 Yanling H, Yuhong Z, Wenwu H, Lei X, Mingwu C. NQO1 C609T polymorphism and esophageal cancer risk: a HuGE review and meta-analysis. BMC Med Genet 2013;14:31. [PMID: 23497461 DOI: 10.1186/1471-2350-14-31] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
121 Chen X, Yan CC, Zhang X, You ZH, Huang YA, Yan GY. HGIMDA: Heterogeneous graph inference for miRNA-disease association prediction. Oncotarget 2016;7:65257-69. [PMID: 27533456 DOI: 10.18632/oncotarget.11251] [Cited by in Crossref: 156] [Cited by in F6Publishing: 136] [Article Influence: 39.0] [Reference Citation Analysis]
122 Ishibashi Y, Tsujimoto H, Hiraki S, Kouzu K, Tsuchiya S, Itazaki Y, Yaguchi Y, Horiguchi H, Nomura S, Ito N, Shinto E, Kishi Y, Ueno H. Predictive value of immuno-inflammatory and nutritional measures modulated by neoadjuvant chemotherapy on the response of neoadjuvant chemotherapy and long-term outcomes in patients with esophageal cancer. Oncol Lett 2020;19:487-97. [PMID: 31897162 DOI: 10.3892/ol.2019.11122] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
123 Manner H, Pech O, Heldmann Y, May A, Pauthner M, Lorenz D, Fisseler-Eckhoff A, Stolte M, Vieth M, Ell C. The frequency of lymph node metastasis in early-stage adenocarcinoma of the esophagus with incipient submucosal invasion (pT1b sm1) depending on histological risk patterns. Surg Endosc. 2015;29:1888-1896. [PMID: 25294553 DOI: 10.1007/s00464-014-3881-3] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 6.8] [Reference Citation Analysis]
124 Okuno T, Wakabayashi M, Kato K, Shinoda M, Katayama H, Igaki H, Tsubosa Y, Kojima T, Okabe H, Kimura Y, Kawano T, Kosugi S, Toh Y, Kato H, Nakamura K, Fukuda H, Ishikura S, Ando N, Kitagawa Y; Japan Esophageal Oncology Group/Japan Clinical Oncology Group. Esophageal stenosis and the Glasgow Prognostic Score as independent factors of poor prognosis for patients with locally advanced unresectable esophageal cancer treated with chemoradiotherapy (exploratory analysis of JCOG0303). Int J Clin Oncol 2017;22:1042-9. [PMID: 28717855 DOI: 10.1007/s10147-017-1154-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
125 Lu C, Xie H, Wang F, Shen H, Wang J. Diet folate, DNA methylation and genetic polymorphisms of MTHFR C677T in association with the prognosis of esophageal squamous cell carcinoma. BMC Cancer. 2011;11:91. [PMID: 21375764 DOI: 10.1186/1471-2407-11-91] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
126 Ueda H, Takeda M, Ueda S, Kawakami H, Okuno T, Takegawa N, Hayashi H, Tsurutani J, Tamura T, Ishikawa K, Nishimura Y, Nakagawa K. Clinical evaluation of palliative chemoradiotherapy for metastatic esophageal cancer. Oncotarget 2017;8:80286-94. [PMID: 29113302 DOI: 10.18632/oncotarget.17925] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
127 Zhang J, Jiao Q, Kong L, Yu J, Fang A, Li M, Yu J. Nrf2 and Keap1 abnormalities in esophageal squamous cell carcinoma and association with the effect of chemoradiotherapy. Thorac Cancer 2018;9:726-35. [PMID: 29675925 DOI: 10.1111/1759-7714.12640] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
128 Amorim CA, De Souza LP, Moreira JP, Luiz RR, De V Carneiro AJ, De Souza HSP. Geographic distribution and time trends of esophageal cancer in Brazil from 2005 to 2015. Mol Clin Oncol 2019;10:631-8. [PMID: 31086670 DOI: 10.3892/mco.2019.1842] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
129 Pennathur A, Awais O, Luketich JD. Minimally invasive esophagectomy for Barrett's with high-grade dysplasia and early adenocarcinoma of the esophagus. J Gastrointest Surg 2010;14:948-50. [PMID: 20358407 DOI: 10.1007/s11605-009-1152-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
130 Hirajima S, Komatsu S, Ichikawa D, Takeshita H, Konishi H, Shiozaki A, Morimura R, Tsujiura M, Nagata H, Kawaguchi T. Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma. Br J Cancer. 2013;108:1822-1829. [PMID: 23579215 DOI: 10.1038/bjc.2013.148] [Cited by in Crossref: 68] [Cited by in F6Publishing: 67] [Article Influence: 7.6] [Reference Citation Analysis]
131 Schauer DP, Feigelson HS, Koebnick C, Caan B, Weinmann S, Leonard AC, Powers JD, Yenumula PR, Arterburn DE. Association Between Weight Loss and the Risk of Cancer after Bariatric Surgery. Obesity (Silver Spring). 2017;25 Suppl 2:S52-S57. [PMID: 29086527 DOI: 10.1002/oby.22002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
132 Gu J, Ajani JA, Hawk ET, Ye Y, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Wang KK, Wu X. Genome-wide catalogue of chromosomal aberrations in barrett’s esophagus and esophageal adenocarcinoma: a high-density single nucleotide polymorphism array analysis. Cancer Prev Res (Phila). 2010;3:1176-1186. [PMID: 20651033 DOI: 10.1158/1940-6207.capr-09-0265] [Cited by in Crossref: 59] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
133 Lin MW, Yang PW, Lee JM. Translational research in thoracic surgery-the National Taiwan University Hospital experience. J Thorac Dis 2016;8:S642-7. [PMID: 27651941 DOI: 10.21037/jtd.2016.07.95] [Reference Citation Analysis]
134 Jiang YY, Shang L, Shi ZZ, Zhang TT, Ma S, Lu CC, Zhang Y, Hao JJ, Shi C, Shi F, Xu X, Cai Y, Jia XM, Zhan QM, Wang MR. Microtubule-associated protein 4 is an important regulator of cell invasion/migration and a potential therapeutic target in esophageal squamous cell carcinoma. Oncogene 2016;35:4846-56. [PMID: 26876215 DOI: 10.1038/onc.2016.17] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
135 Lin JL. T1 esophageal cancer, request an endoscopic mucosal resection (EMR) for in-depth review. J Thorac Dis. 2013;5:353-356. [PMID: 23825773 DOI: 10.3978/j.issn.2072-1439.2013.06.03] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
136 Li H, Juan L, Xia L, Wang Y, Bao Y, Sun G. Thioridazine Sensitizes Esophageal Carcinoma Cell Lines to Radiotherapy-Induced Apoptosis In Vitro and In Vivo. Med Sci Monit 2016;22:2624-34. [PMID: 27453171 DOI: 10.12659/msm.899950] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
137 Movahed S, Norouzy A, Ghanbari-Motlagh A, Eslami S, Khadem-Rezaiyan M, Emadzadeh M, Nematy M, Ghayour-Mobarhan M, Varshoee Tabrizi F, Bozzetti F, Seilanian Toussi M. Nutritional Status in Patients with Esophageal Cancer Receiving Chemoradiation and Assessing the Efficacy of Usual Care for Nutritional Managements. Asian Pac J Cancer Prev 2020;21:2315-23. [PMID: 32856860 DOI: 10.31557/APJCP.2020.21.8.2315] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
138 Zhai R, Wei Y, Su L, Liu G, Kulke MH, Wain JC, Christiani DC. Whole-miRNome profiling identifies prognostic serum miRNAs in esophageal adenocarcinoma: the influence of Helicobacter pylori infection status. Carcinogenesis 2015;36:87-93. [PMID: 25381453 DOI: 10.1093/carcin/bgu228] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
139 Li W, Zang W, Liu P, Wang Y, Du Y, Chen X, Deng M, Sun W, Wang L, Zhao G, Zhai B. MicroRNA-124 inhibits cellular proliferation and invasion by targeting Ets-1 in breast cancer. Tumour Biol 2014;35:10897-904. [PMID: 25085587 DOI: 10.1007/s13277-014-2402-2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
140 Fassan M, Pizzi M, Battaglia G, Giacomelli L, Parente P, Bocus P, Ancona E, Rugge M. Programmed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis. J Clin Pathol. 2010;63:692-696. [PMID: 20702469 DOI: 10.1136/jcp.2010.078253] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
141 Freedman ND, Murray LJ, Kamangar F, Abnet CC, Cook MB, Nyrén O, Ye W, Wu AH, Bernstein L, Brown LM. Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium. Gut. 2011;60:1029-1037. [PMID: 21406386 DOI: 10.1136/gut.2010.233866] [Cited by in Crossref: 75] [Cited by in F6Publishing: 66] [Article Influence: 6.8] [Reference Citation Analysis]
142 Sarbia M, Ott N, Pühringer-Oppermann F, Brücher BL. The predictive value of molecular markers (p53, EGFR, ATM, CHK2) in multimodally treated squamous cell carcinoma of the oesophagus. Br J Cancer. 2007;97:1404-1408. [PMID: 17940507 DOI: 10.1038/sj.bjc.6604037] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
143 Yi Y, Lu X, Chen J, Jiao C, Zhong J, Song Z, Yu X, Lin B. Downregulated miR-486-5p acts as a tumor suppressor in esophageal squamous cell carcinoma. Exp Ther Med. 2016;12:3411-3416. [PMID: 27882172 DOI: 10.3892/etm.2016.3783] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 4.2] [Reference Citation Analysis]
144 Liu CT, Zhu ST, Li P, Wang YJ, Zhang H, Zhang ST. SULF1 inhibits proliferation and invasion of esophageal squamous cell carcinoma cells by decreasing heparin-binding growth factor signaling. Dig Dis Sci 2013;58:1256-63. [PMID: 23053899 DOI: 10.1007/s10620-012-2429-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
145 Wu C, Wang C, Guan X, Liu Y, Li D, Zhou X, Zhang Y, Chen X, Wang J, Zen K, Zhang CY, Zhang C. Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma. PLoS One. 2014;9:e92292. [PMID: 24651474 DOI: 10.1371/journal.pone.0092292] [Cited by in Crossref: 74] [Cited by in F6Publishing: 72] [Article Influence: 9.3] [Reference Citation Analysis]
146 Wu G, Chen G, Zhou J, Zhu H, Chu J, Zhang F. Liriodenine enhances radiosensitivity in esophageal cancer ECA-109 cells by inducing apoptosis and G2/M arrest. Oncol Lett 2018;16:5020-6. [PMID: 30250568 DOI: 10.3892/ol.2018.9253] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
147 Liu Z, Luo C, Yang W, Wang K, Hu C, Zou J, Zhu H, Fu L, Nie J, Cheng C. Increased Numb protein expression predicts poor clinical outcomes in esophageal squamous cell carcinoma patients. Cancer Biol Ther 2018;19:34-41. [PMID: 28095111 DOI: 10.1080/15384047.2016.1276131] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
148 Bird-lieberman EL, Neves AA, Lao-sirieix P, O'donovan M, Novelli M, Lovat LB, Eng WS, Mahal LK, Brindle KM, Fitzgerald RC. Molecular imaging using fluorescent lectins permits rapid endoscopic identification of dysplasia in Barrett's esophagus. Nat Med 2012;18:315-21. [DOI: 10.1038/nm.2616] [Cited by in Crossref: 178] [Cited by in F6Publishing: 154] [Article Influence: 17.8] [Reference Citation Analysis]
149 Yazbeck R, Jaenisch SE, Watson DI. From blood to breath: New horizons for esophageal cancer biomarkers. World J Gastroenterol 2016; 22(46): 10077-10083 [PMID: 28028355 DOI: 10.3748/wjg.v22.i46.10077] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
150 Liu T, Wu HJ, Liang Y, Liang XJ, Huang HC, Zhao YZ, Liao QC, Chen YQ, Leng AM, Yuan WJ, Zhang GY, Peng J, Chen YH. Tumor-specific expression of shVEGF and suicide gene as a novel strategy for esophageal cancer therapy. World J Gastroenterol 2016; 22(23): 5342-5352 [PMID: 27340350 DOI: 10.3748/wjg.v22.i23.5342] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
151 Tang Y, Yang P, Zhu Y, Su Y. LncRNA TUG1 contributes to ESCC progression via regulating miR-148a-3p/MCL-1/Wnt/β-catenin axis in vitro. Thorac Cancer 2020;11:82-94. [PMID: 31742924 DOI: 10.1111/1759-7714.13236] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
152 Bashash M, Shah A, Hislop G, Treml M, Bretherick K, Janoo-Gilani R, Leach S, Le N, Bajdik C, Brooks-Wilson A. Genetic polymorphisms at TIMP3 are associated with survival of adenocarcinoma of the gastroesophageal junction. PLoS One. 2013;8:e59157. [PMID: 23527119 DOI: 10.1371/journal.pone.0059157] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
153 Mu HW, Chen CH, Yang KW, Pan CS, Lin CL, Hung DZ. The prevalence of esophageal cancer after caustic and pesticide ingestion: A nationwide cohort study. PLoS One 2020;15:e0243922. [PMID: 33373373 DOI: 10.1371/journal.pone.0243922] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
154 Ma Z, Fan C, Yang Y, Di S, Hu W, Li T, Zhu Y, Han J, Xin Z, Wu G, Zhao J, Li X, Yan X. Thapsigargin sensitizes human esophageal cancer to TRAIL-induced apoptosis via AMPK activation. Sci Rep 2016;6:35196. [PMID: 27731378 DOI: 10.1038/srep35196] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
155 Palazzo F, Evans NR 3rd, Rosato EL. Minimally invasive esophagectomy with extracorporeal gastric conduit creation--how I do it. J Gastrointest Surg 2013;17:1683-8. [PMID: 23835730 DOI: 10.1007/s11605-013-2272-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
156 Qiu ML, Lin JB, Li X, Luo RG, Liu B, Lin JW. Current state of esophageal cancer surgery in China: a national database analysis. BMC Cancer 2019;19:1064. [PMID: 31703631 DOI: 10.1186/s12885-019-6191-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
157 Shimamura Y, Ikeya T, Marcon N, Mosko JD. Endoscopic diagnosis and treatment of early esophageal squamous neoplasia. World J Gastrointest Endosc 2017; 9(9): 438-447 [PMID: 28979708 DOI: 10.4253/wjge.v9.i9.438] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
158 Damelin LH, Jivan R, Veale RB, Rousseau AL, Mavri-Damelin D. Metformin induces an intracellular reductive state that protects oesophageal squamous cell carcinoma cells against cisplatin but not copper-bis(thiosemicarbazones). BMC Cancer 2014;14:314. [PMID: 24886082 DOI: 10.1186/1471-2407-14-314] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
159 Kosumi K, Baba Y, Ishimoto T, Harada K, Nakamura K, Ohuchi M, Kiyozumi Y, Izumi D, Tokunaga R, Taki K, Higashi T, Miyata T, Kurashige J, Hiyoshi Y, Iwagami S, Sakamoto Y, Miyamoto Y, Yoshida N, Watanabe M, Baba H. Neutrophil/lymphocyte ratio predicts the prognosis in esophageal squamous cell carcinoma patients. Surg Today 2016;46:405-13. [PMID: 26036223 DOI: 10.1007/s00595-015-1197-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
160 Zhang H, Xia J, Wang K, Zhang J. Serum autoantibodies in the early detection of esophageal cancer: a systematic review. Tumour Biol. 2015;36:95-109. [PMID: 25433500 DOI: 10.1007/s13277-014-2878-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
161 Roeder F, Nicolay NH, Nguyen T, Saleh-Ebrahimi L, Askoxylakis V, Bostel T, Zwicker F, Debus J, Timke C, Huber PE. Intensity modulated radiotherapy (IMRT) with concurrent chemotherapy as definitive treatment of locally advanced esophageal cancer. Radiat Oncol 2014;9:191. [PMID: 25175056 DOI: 10.1186/1748-717X-9-191] [Cited by in Crossref: 41] [Cited by in F6Publishing: 25] [Article Influence: 5.1] [Reference Citation Analysis]
162 Shao M, Li W, Wang S, Liu Z. Identification of key genes and pathways associated with esophageal squamous cell carcinoma development based on weighted gene correlation network analysis. J Cancer 2020;11:1393-402. [PMID: 32047546 DOI: 10.7150/jca.30699] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
163 Pleskow DK, Zhang L, Turzhitsky V, Coughlan MF, Khan U, Zhang X, Sheil CJ, Glyavina M, Chen L, Shinagare S, Zakharov YN, Vitkin E, Itzkan I, Perelman LT, Qiu L. Coherent confocal light scattering spectroscopic microscopy evaluates cancer progression and aggressiveness in live cells and tissue. ACS Photonics 2021;8:2050-9. [PMID: 34485615 DOI: 10.1021/acsphotonics.1c00217] [Reference Citation Analysis]
164 Bu L, Wang R, Liu P, Da J. Aberrantly upregulated FAM83H-AS1 facilitates malignant progression of esophageal squamous cell carcinoma. Oncol Lett 2020;20:368. [PMID: 33154766 DOI: 10.3892/ol.2020.12231] [Reference Citation Analysis]
165 Wang J, Luo FF, Huang TJ, Mei Y, Peng LX, Qian CN, Huang BJ. The upregulated expression of RFC4 and GMPS mediated by DNA copy number alteration is associated with the early diagnosis and immune escape of ESCC based on a bioinformatic analysis. Aging (Albany NY) 2021;13:21758-77. [PMID: 34520390 DOI: 10.18632/aging.203520] [Reference Citation Analysis]
166 Yokobori T, Suzuki S, Tanaka N, Inose T, Sohda M, Sano A, Sakai M, Nakajima M, Miyazaki T, Kato H, Kuwano H. MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1. Cancer Sci. 2013;104:48-54. [PMID: 23013135 DOI: 10.1111/cas.12030] [Cited by in Crossref: 93] [Cited by in F6Publishing: 93] [Article Influence: 9.3] [Reference Citation Analysis]
167 Oguma J, Ozawa S, Sakakibara T, Kajiwara H, Nakamura N, Makuuchi H. Prognostic impact of LY6K and CDCA1 expression for patients with esophageal squamous cell carcinoma. Ann Gastroenterol Surg 2021;5:194-203. [PMID: 33860139 DOI: 10.1002/ags3.12415] [Reference Citation Analysis]
168 Qu J, Zhang H, Wang Z, Zhang F, Liu H, Ding Z, Li Y, Ma J, Zhang Z, Zhang S, Dong Y, Jiang L, Zhang W, Grimm R, Kiefer B, Kamel IR, Qin J, Li H. Comparison between free-breathing radial VIBE on 3-T MRI and endoscopic ultrasound for preoperative T staging of resectable oesophageal cancer, with histopathological correlation. Eur Radiol 2018;28:780-7. [PMID: 28799124 DOI: 10.1007/s00330-017-4963-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
169 Boers JE, Meeuwissen H, Methorst N. HER2 status in gastro-oesophageal adenocarcinomas assessed by two rabbit monoclonal antibodies (SP3 and 4B5) and two in situ hybridization methods (FISH and SISH). Histopathology. 2011;58:383-394. [PMID: 21323962 DOI: 10.1111/j.1365-2559.2011.03760.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 5.1] [Reference Citation Analysis]
170 Adelstein DJ, Rodriguez CP, Rybicki LA, Ives DI, Rice TW. A phase II trial of gefitinib for recurrent or metastatic cancer of the esophagus or gastroesophageal junction. Invest New Drugs. 2012;30:1684-1689. [PMID: 21863238 DOI: 10.1007/s10637-011-9736-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
171 Zhang E, Han L, Yin D, He X, Hong L, Si X, Qiu M, Xu T, De W, Xu L, Shu Y, Chen J. H3K27 acetylation activated-long non-coding RNA CCAT1 affects cell proliferation and migration by regulating SPRY4 and HOXB13 expression in esophageal squamous cell carcinoma. Nucleic Acids Res 2017;45:3086-101. [PMID: 27956498 DOI: 10.1093/nar/gkw1247] [Cited by in Crossref: 151] [Cited by in F6Publishing: 160] [Article Influence: 30.2] [Reference Citation Analysis]
172 van Zoonen M, van Oijen MG, van Leeuwen MS, van Hillegersberg R, Siersema PD, Vleggaar FP. Low impact of staging EUS for determining surgical resectability in esophageal cancer. Surg Endosc. 2012;26:2828-2834. [PMID: 22692460 DOI: 10.1007/s00464-012-2254-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
173 Yang C, Wang Y, Zhang F, Sun G, Li C, Jing S, Liu Q, Cheng Y. Inhibiting UHRF1 expression enhances radiosensitivity in human esophageal squamous cell carcinoma. Mol Biol Rep. 2013;40:5225-5235. [PMID: 23943380 DOI: 10.1007/s11033-013-2559-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
174 Chu JN, Choi J, Tramontano A, Morse C, Forcione D, Nishioka NS, Abrams JA, Rubenstein JH, Kong CY, Inadomi JM, Hur C. Surgical vs Endoscopic Management of T1 Esophageal Adenocarcinoma: A Modeling Decision Analysis. Clin Gastroenterol Hepatol 2018; 16: 392-400. e7. [PMID: 29079222 DOI: 10.1016/j.cgh.2017.10.024] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
175 Fu W, Pang L, Chen Y, Yang L, Zhu J, Wei Y. The microRNAs as prognostic biomarkers for survival in esophageal cancer: a meta-analysis. ScientificWorldJournal. 2014;2014:523979. [PMID: 25097879 DOI: 10.1155/2014/523979] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
176 Guan NN, Wang CC, Zhang L, Huang L, Li JQ, Piao X. In silico prediction of potential miRNA-disease association using an integrative bioinformatics approach based on kernel fusion. J Cell Mol Med 2020;24:573-87. [PMID: 31747722 DOI: 10.1111/jcmm.14765] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
177 Song X, You W, Zhu J, Cui X, Hu J, Chen Y, Liu W, Wang L, Li S, Wei Y, Yang L, Li F. A Genetic Variant in miRNA-219-1 Is Associated with Risk of Esophageal Squamous Cell Carcinoma in Chinese Kazakhs. Dis Markers 2015;2015:541531. [PMID: 26379361 DOI: 10.1155/2015/541531] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
178 Nagami Y, Tominaga K, Machida H, Nakatani M, Kameda N, Sugimori S, Okazaki H, Tanigawa T, Yamagami H, Kubo N, Shiba M, Watanabe K, Watanabe T, Iguchi H, Fujiwara Y, Ohira M, Hirakawa K, Arakawa T. Usefulness of non-magnifying narrow-band imaging in screening of early esophageal squamous cell carcinoma: a prospective comparative study using propensity score matching. Am J Gastroenterol. 2014;109:845-854. [PMID: 24751580 DOI: 10.1038/ajg.2014.94] [Cited by in Crossref: 67] [Cited by in F6Publishing: 66] [Article Influence: 8.4] [Reference Citation Analysis]
179 Andl CD, McCowan KM, Allison GL, Rustgi AK. Cathepsin B is the driving force of esophageal cell invasion in a fibroblast-dependent manner. Neoplasia 2010;12:485-98. [PMID: 20563251 DOI: 10.1593/neo.10216] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
180 Wei J, Jin M, Shao Y, Ning Z, Huang J. High preoperative serum prealbumin predicts long-term survival in resected esophageal squamous cell cancer. Cancer Manag Res 2019;11:7997-8003. [PMID: 31692569 DOI: 10.2147/CMAR.S214037] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
181 Hung AC, Wang YY, Lee KT, Chiang HH, Chen YK, Du JK, Chen CM, Chen MY, Chen KJ, Hu SC, Yuan SF. Reduced tissue and serum resistin expression as a clinical marker for esophageal squamous cell carcinoma. Oncol Lett 2021;22:774. [PMID: 34589153 DOI: 10.3892/ol.2021.13035] [Reference Citation Analysis]
182 Tan Y, Lu X, Cheng Z, Pan G, Liu S, Apiziaji P, Wang H, Zhang J, Abulimiti Y. miR-148a Regulates the Stem Cell-Like Side Populations Distribution by Affecting the Expression of ACVR1 in Esophageal Squamous Cell Carcinoma. Onco Targets Ther 2020;13:8079-94. [PMID: 32904700 DOI: 10.2147/OTT.S248925] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
183 Zheng D, Williams C, Vold JA, Nguyen JH, Harnois DM, Bagaria SP, McLaughlin SA, Li Z. Regulation of sex hormone receptors in sexual dimorphism of human cancers. Cancer Lett 2018;438:24-31. [PMID: 30223066 DOI: 10.1016/j.canlet.2018.09.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
184 Dong LM, Kristal AR, Peters U, Schenk JM, Sanchez CA, Rabinovitch PS, Blount PL, Odze RD, Ayub K, Reid BJ. Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective study. Nutr Cancer. 2008;60:39-48. [PMID: 18444134 DOI: 10.1080/01635580701586762] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
185 Qiao GL, Qi WX, Jiang WH, Chen Y, Ma LJ. Prognostic significance of circulating tumor cells in esophageal carcinoma: a meta-analysis. Onco Targets Ther. 2016;9:1889-1897. [PMID: 27099520 DOI: 10.2147/ott.s100005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
186 Li WF, Zhang L, Li HY, Zheng SS, Zhao L. WISP-1 contributes to fractionated irradiation-induced radioresistance in esophageal carcinoma cell lines and mice. PLoS One 2014;9:e94751. [PMID: 24728101 DOI: 10.1371/journal.pone.0094751] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
187 Yamashita H, Seto Y, Takenaka R, Okuma K, Kiritooshi T, Mori K, Yamada K, Fukuda T, Kaminishi M, Abe O, Nakagawa K. Survival comparison between radical surgery and definitive chemoradiation in 267 esophageal squamous cell carcinomas in a single institution: A propensity-matched study. PLoS One 2017;12:e0177133. [PMID: 28486551 DOI: 10.1371/journal.pone.0177133] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
188 Fujihara S, Morishita A, Ogawa K, Tadokoro T, Chiyo T, Kato K, Kobara H, Mori H, Iwama H, Masaki T. The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKα/mTOR pathway in vitro and in vivo. Oncotarget 2017;8:8536-49. [PMID: 28052030 DOI: 10.18632/oncotarget.14345] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
189 Levine EA, Farmer MR, Clark P, Mishra G, Ho C, Geisinger KR, Melin SA, Lovato J, Oaks T, Blackstock AW. Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer. Ann Surg. 2006;243:472-478. [PMID: 16552197 DOI: 10.1097/01.sla.0000208430.07050.61] [Cited by in Crossref: 124] [Cited by in F6Publishing: 110] [Article Influence: 7.8] [Reference Citation Analysis]
190 Yang B, Chen Q, Wan C, Sun S, Zhu L, Zhao Z, Zhong W, Wang B. Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial-Mesenchymal Transition. Front Oncol 2021;11:709486. [PMID: 34552870 DOI: 10.3389/fonc.2021.709486] [Reference Citation Analysis]
191 Zhang JL, Wang HY, Yang Q, Lin SY, Luo GY, Zhang R, Xu GL. Methyl-methanesulfonate sensitivity 19 expression is associated with metastasis and chemoradiotherapy response in esophageal cancer. World J Gastroenterol 2015; 21(14): 4240-4247 [PMID: 25892874 DOI: 10.3748/wjg.v21.i14.4240] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
192 Bird-lieberman E, Ford H, Fitzgerald R. Barrett’s oesophagus and oesophageal adenocarcinoma. Medicine 2011;39:142-8. [DOI: 10.1016/j.mpmed.2010.12.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
193 Zhao Q, Shen JH, Shen ZY, Wu ZY, Xu XE, Xie JJ, Wu JY, Huang Q, Lu XF, Li EM, Xu LY. Phosphorylation of fascin decreases the risk of poor survival in patients with esophageal squamous cell carcinoma. J Histochem Cytochem 2010;58:979-88. [PMID: 20713986 DOI: 10.1369/jhc.2010.955765] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
194 Wang P, Yang S, Dai S, Ni Q, Liu H, Yu L, Lu K, Han G, Huang J. Expression and Clinical Value of LncRNA GAPLINC in Esophageal Squamous Cell Carcinoma. Onco Targets Ther 2021;14:4039-45. [PMID: 34262290 DOI: 10.2147/OTT.S299394] [Reference Citation Analysis]
195 Liu CT, Hong CQ, Huang XC, Li EM, Xu YW, Peng YH. Blood-based Markers in the Prognostic Prediction of Esophagogastric Junction Cancer. J Cancer 2020;11:4332-42. [PMID: 32489452 DOI: 10.7150/jca.44545] [Reference Citation Analysis]
196 Bi S, Wei Q, Zhao Z, Chen L, Wang C, Xie S. Wee1 Inhibitor AZD1775 Effectively Inhibits the Malignant Phenotypes of Esophageal Squamous Cell Carcinoma In Vitro and In Vivo. Front Pharmacol 2019;10:864. [PMID: 31427973 DOI: 10.3389/fphar.2019.00864] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
197 Abdolahi S, Ghazvinian Z, Muhammadnejad S, Ahmadvand M, Aghdaei HA, Ebrahimi-Barough S, Ai J, Zali MR, Verdi J, Baghaei K. Adaptive NK Cell Therapy Modulated by Anti-PD-1 Antibody in Gastric Cancer Model. Front Pharmacol 2021;12:733075. [PMID: 34588986 DOI: 10.3389/fphar.2021.733075] [Reference Citation Analysis]
198 Prasad GA, Wu TT, Wigle DA, Buttar NS, Wongkeesong LM, Dunagan KT, Lutzke LS, Borkenhagen LS, Wang KK. Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus. Gastroenterology. 2009;137:815-823. [PMID: 19524578 DOI: 10.1053/j.gastro.2009.05.059] [Cited by in Crossref: 235] [Cited by in F6Publishing: 190] [Article Influence: 18.1] [Reference Citation Analysis]
199 Geng TT, Xun XJ, Li S, Feng T, Wang LP, Jin TB, Hou P. Association of colorectal cancer susceptibility variants with esophageal cancer in a Chinese population. World J Gastroenterol 2015; 21(22): 6898-6904 [PMID: 26078566 DOI: 10.3748/wjg.v21.i22.6898] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
200 Revels SL, Morris AM, Reddy RM, Akateh C, Wong SL. Racial disparities in esophageal cancer outcomes. Ann Surg Oncol. 2013;20:1136-1141. [PMID: 23263780 DOI: 10.1245/s10434-012-2807-3] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 4.1] [Reference Citation Analysis]
201 Gong T, Zheng S, Huang S, Fu S, Zhang X, Pan S, Yang T, Sun Y, Wang Y, Hui B, Guo J, Zhang X. PTENP1 inhibits the growth of esophageal squamous cell carcinoma by regulating SOCS6 expression and correlates with disease prognosis. Mol Carcinog 2017;56:2610-9. [PMID: 28731203 DOI: 10.1002/mc.22705] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
202 Sun G, Hu W, Lu Y, Wang Y. A meta-analysis of HIF-1α and esophageal squamous cell carcinoma (ESCC) risk. Pathol Oncol Res 2013;19:685-93. [PMID: 23658132 DOI: 10.1007/s12253-013-9631-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
203 Lanuti M, Liu G, Goodwin JM, Zhai R, Fuchs BC, Asomaning K, Su L, Nishioka NS, Tanabe KK, Christiani DC. A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome. Clin Cancer Res. 2008;14:3216-3222. [PMID: 18483390 DOI: 10.1158/1078-0432.ccr-07-4932] [Cited by in Crossref: 65] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
204 Vitz S, Göbel H, Leibl B, Aigner T, Grabenbauer GG. Adenocarcinoma of the oesophagus: neoadjuvant chemoradiation and radical surgery : Long-term results. Strahlenther Onkol 2018;194:1007-16. [PMID: 29872880 DOI: 10.1007/s00066-018-1320-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
205 Wakefield CJ, Hamati F, Karush JM, Arndt AT, Geissen N, Liptay MJ, Borgia JA, Basu S, Seder CW. Sarcopenia after induction therapy is associated with reduced survival in patients undergoing esophagectomy for locally-advanced esophageal cancer. J Thorac Dis 2021;13:861-9. [PMID: 33717559 DOI: 10.21037/jtd-20-2608] [Reference Citation Analysis]
206 Kambhampati S, Banerjee S, Dhar K, Mehta S, Haque I, Dhar G, Majumder M, Ray G, Vanveldhuizen PJ, Banerjee SK. 2-methoxyestradiol inhibits Barrett's esophageal adenocarcinoma growth and differentiation through differential regulation of the beta-catenin-E-cadherin axis. Mol Cancer Ther 2010;9:523-34. [PMID: 20197389 DOI: 10.1158/1535-7163.MCT-09-0845] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
207 Kim ST, Park KH, Oh SC, Seo JH, Shin SW, Kim JS, Kim YH. Selection of a patient subgroup with advanced esophageal squamous carcinoma who could benefit from second-line chemotherapy. Oncology 2010;79:363-9. [PMID: 21430405 DOI: 10.1159/000322498] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
208 Wang Y, Peng J, Li Y, Luo H, Huang G, Luo S, Yin X, Song J. Association between tooth loss and risk of oesophageal cancer: a dose-response meta-analysis. Springerplus 2016;5:1020. [PMID: 27441139 DOI: 10.1186/s40064-016-2711-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
209 Hoshino I, Takahashi M, Akutsu Y, Murakami K, Matsumoto Y, Suito H, Sekino N, Komatsu A, Iida K, Suzuki T, Inoue I, Ishige F, Iwatate Y, Matsubara H. Genome-wide ChIP-seq data with a transcriptome analysis reveals the groups of genes regulated by histone demethylase LSD1 inhibition in esophageal squamous cell carcinoma cells. Oncol Lett 2019;18:872-81. [PMID: 31289565 DOI: 10.3892/ol.2019.10350] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
210 Ji HH, Hong-Luo, Huang GL, Yin HX, Xu P, Luo SY, Song JK. Association between microRNA-196a2 rs11614913, microRNA-146a rs2910164, and microRNA-423 rs6505162 polymorphisms and esophageal cancer risk: A meta-analysis. Meta Gene 2015;3:14-25. [PMID: 26925372 DOI: 10.1016/j.mgene.2014.12.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
211 Amedei A, Benagiano M, della Bella C, Niccolai E, D'Elios MM. Novel immunotherapeutic strategies of gastric cancer treatment. J Biomed Biotechnol 2011;2011:437348. [PMID: 22253528 DOI: 10.1155/2011/437348] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
212 Chen X, Han H, Li Y, Zhang Q, Mo K, Chen S. Upregulation of long noncoding RNA HOTTIP promotes metastasis of esophageal squamous cell carcinoma via induction of EMT. Oncotarget 2016;7:84480-5. [PMID: 27806322 DOI: 10.18632/oncotarget.12995] [Cited by in Crossref: 42] [Cited by in F6Publishing: 51] [Article Influence: 10.5] [Reference Citation Analysis]
213 Mukaisho K, Nakayama T, Hagiwara T, Hattori T, Sugihara H. Two distinct etiologies of gastric cardia adenocarcinoma: interactions among pH, Helicobacter pylori, and bile acids. Front Microbiol 2015;6:412. [PMID: 26029176 DOI: 10.3389/fmicb.2015.00412] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
214 Zhao CL, Yu S, Wang SH, Li SG, Wang ZJ, Han SN. Characterization of cluster of differentiation 47 expression and its potential as a therapeutic target in esophageal squamous cell cancer. Oncol Lett. 2018;15:2017-2023. [PMID: 29399202 DOI: 10.3892/ol.2017.7447] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
215 Deng J, Weng X, Ye J, Zhou D, Liu Y, Zhao K. Identification of the Germline Mutation Profile in Esophageal Squamous Cell Carcinoma by Whole Exome Sequencing. Front Genet 2019;10:47. [PMID: 30833958 DOI: 10.3389/fgene.2019.00047] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
216 De Pergola G, Silvestris F. Obesity as a major risk factor for cancer. J Obes 2013;2013:291546. [PMID: 24073332 DOI: 10.1155/2013/291546] [Cited by in Crossref: 388] [Cited by in F6Publishing: 377] [Article Influence: 43.1] [Reference Citation Analysis]
217 Ansari MH, Irani S, Edalat H, Amin R, Mohammadi Roushandeh A. Deregulation of miR-93 and miR-143 in human esophageal cancer. Tumour Biol. 2016;37:3097-3103. [PMID: 26427659 DOI: 10.1007/s13277-015-3987-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
218 Li H, Zhang S, Guo J, Zhang L. Hepatic Metastasis in Newly Diagnosed Esophageal Cancer: A Population-Based Study. Front Oncol 2021;11:644860. [PMID: 34041021 DOI: 10.3389/fonc.2021.644860] [Reference Citation Analysis]
219 Pennathur A, Godfrey TE, Luketich JD. The Molecular Biologic Basis of Esophageal and Gastric Cancers. Surg Clin North Am 2019;99:403-18. [PMID: 31047032 DOI: 10.1016/j.suc.2019.02.010] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
220 Luo Q, Wu X, Chang W, Zhao P, Nan Y, Zhu X, Katz JP, Su D, Liu Z. ARID1A prevents squamous cell carcinoma initiation and chemoresistance by antagonizing pRb/E2F1/c-Myc-mediated cancer stemness. Cell Death Differ 2020;27:1981-97. [PMID: 31831874 DOI: 10.1038/s41418-019-0475-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
221 Fristedt R, Gaber A, Hedner C, Nodin B, Uhlén M, Eberhard J, Jirström K. Expression and prognostic significance of the polymeric immunoglobulin receptor in esophageal and gastric adenocarcinoma. J Transl Med 2014;12:83. [PMID: 24694107 DOI: 10.1186/1479-5876-12-83] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
222 Osako Y, Seki N, Kita Y, Yonemori K, Koshizuka K, Kurozumi A, Omoto I, Sasaki K, Uchikado Y, Kurahara H, Maemura K, Natsugoe S. Regulation of MMP13 by antitumor microRNA-375 markedly inhibits cancer cell migration and invasion in esophageal squamous cell carcinoma. Int J Oncol. 2016;49:2255-2264. [PMID: 27779648 DOI: 10.3892/ijo.2016.3745] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 6.8] [Reference Citation Analysis]
223 Wu Y, Yan M, Li J, Li J, Chen Z, Chen P, Li B, Chen F, Jin T, Chen C. Genetic polymorphisms in TERT are associated with increased risk of esophageal cancer. Oncotarget. 2017;8:10523-10530. [PMID: 28060765 DOI: 10.18632/oncotarget.14451] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
224 Umar M, Upadhyay R, Kumar S, Ghoshal UC, Mittal B. Role of novel and GWAS originated PLCE1 genetic variants in susceptibility and prognosis of esophageal cancer patients in northern Indian population. Tumour Biol 2014;35:11667-76. [PMID: 25139097 DOI: 10.1007/s13277-014-2458-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
225 Jacobson BC, Shami VM, Faigel DO, Larghi A, Kahaleh M, Dye C, Pedrosa M, Waxman I. Through-the-scope balloon dilation for endoscopic ultrasound staging of stenosing esophageal cancer. Dig Dis Sci. 2007;52:817-822. [PMID: 17253140 DOI: 10.1007/s10620-006-9488-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
226 Zhang S, Jia M, Cai X, Yang W, Liao S, Liu Z, Wen J, Luo K, Cheng C. Prognostic Role of ABO Blood Type in Operable Esophageal Cancer: Analysis of 2179 Southern Chinese Patients. Front Oncol 2020;10:586084. [PMID: 33392080 DOI: 10.3389/fonc.2020.586084] [Reference Citation Analysis]
227 Yang PW, Chiang TH, Hsieh CY, Huang YC, Wong LF, Hung MC, Tsai JC, Lee JM. The effect of ephrin-A1 on resistance to Photofrin-mediated photodynamic therapy in esophageal squamous cell carcinoma cells. Lasers Med Sci 2015;30:2353-61. [PMID: 26450615 DOI: 10.1007/s10103-015-1812-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
228 Liu H, Yang J, Yuan Y, Xia Z, Chen M, Xie L, Ma X, Wang J, Ouyang S, Wu Q, Yu F, Zhou X, Yang Y, Cao Y, Hu J, Yin B. Regulation of Mcl-1 by constitutive activation of NF-κB contributes to cell viability in human esophageal squamous cell carcinoma cells. BMC Cancer 2014;14:98. [PMID: 24529193 DOI: 10.1186/1471-2407-14-98] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
229 Poneros JM, Faye AS, Barr Fritcher EG, Sen A, Anandasabapathy S, Bresalier RS, Marcon N, Turgeon DK, Appelman H, Normolle D, Morrison LE, Brenner DE, Halling KC. A Multicenter Study of a Fluorescence In Situ Hybridization Probe Set for Diagnosing High-Grade Dysplasia and Adenocarcinoma in Barrett's Esophagus. Dig Dis Sci 2017;62:1216-22. [PMID: 28265829 DOI: 10.1007/s10620-017-4517-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
230 Malik V, Keogan M, Gilham C, Duffy G, Ravi N, Reynolds JV. FDG-PET scanning in the management of cancer of the oesophagus and oesophagogastric junction: early experience with 100 consecutive cases. Ir J Med Sci 2006;175:48-54. [PMID: 17312829 DOI: 10.1007/BF03167967] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
231 Zeng FM, He JZ, Wang SH, Liu DK, Xu XE, Wu JY, Li EM, Xu LY. A Novel Three-Gene Model Predicts Prognosis and Therapeutic Sensitivity in Esophageal Squamous Cell Carcinoma. Biomed Res Int 2019;2019:9828637. [PMID: 31886273 DOI: 10.1155/2019/9828637] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
232 Guo JC, Xie YM, Ran LQ, Cao HH, Sun C, Wu JY, Wu ZY, Liao LD, Zhao WJ, Fang WK, Li EM, Xu LY, Schachner M, Xie JJ. L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription. J Mol Med (Berl) 2017;95:1355-68. [PMID: 28939985 DOI: 10.1007/s00109-017-1595-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
233 Song Q, Liu H, Wang J, Jia Y, Liu Y, Wang N, Tan B, Guan S, An D, Cheng Y. Dinner-to-bed time and post-dinner walk: new potential independent factors in esophageal cancer development. J Cancer Res Clin Oncol 2014;140:817-21. [PMID: 24531974 DOI: 10.1007/s00432-014-1613-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
234 Jackson C, Starling N, Chua YJ, Cunningham D. Pharmacotherapy for oesophagogastric cancer. Drugs 2007;67:2539-56. [PMID: 18034590 DOI: 10.2165/00003495-200767170-00006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
235 Londono R, Badylak SF. Regenerative Medicine Strategies for Esophageal Repair. Tissue Eng Part B Rev 2015;21:393-410. [PMID: 25813694 DOI: 10.1089/ten.TEB.2015.0014] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
236 O'Farrell NJ, Feighery R, Picardo SL, Lynam-Lennon N, Biniecka M, McGarrigle SA, Phelan JJ, MacCarthy F, O'Toole D, Fox EJ, Ravi N, Reynolds JV, O'Sullivan J. Changes in mitochondrial stability during the progression of the Barrett's esophagus disease sequence. BMC Cancer 2016;16:497. [PMID: 27431913 DOI: 10.1186/s12885-016-2544-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
237 Montel RA, Munoz-Zuluaga C, Stiles KM, Crystal RG. Can gene therapy be used to prevent cancer? Gene therapy for aldehyde dehydrogenase 2 deficiency. Cancer Gene Ther 2021. [PMID: 34799722 DOI: 10.1038/s41417-021-00399-1] [Reference Citation Analysis]
238 Hsu PK, Wang BY, Huang CS, Wu YC, Hsu WH. Prognostic factors for post-recurrence survival in esophageal squamous cell carcinoma patients with recurrence after resection. J Gastrointest Surg. 2011;15:558-565. [PMID: 21327531 DOI: 10.1007/s11605-011-1458-1] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 5.3] [Reference Citation Analysis]
239 Fang Y, Fang D, Hu J. MicroRNA and its roles in esophageal cancer. Med Sci Monit. 2012;18:RA22-RA30. [PMID: 22367141 DOI: 10.12659/msm.882509] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
240 Stroh C, Ludwig K, Lippert H, Manger T. Letter to the editor and comments on the article "gastric histopathologies in patients undergoing laparoscopic sleeve gastrectomies" by Salam Al Sabah et al. Obes Surg 2013;23:577-9. [PMID: 23355294 DOI: 10.1007/s11695-013-0869-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
241 Wang C, Zhao K, Hu S, Huang Y, Ma L, Li M, Song Y. The PET-Derived Tumor-to-Liver Standard Uptake Ratio (SUV TLR ) Is Superior to Tumor SUVmax in Predicting Tumor Response and Survival After Chemoradiotherapy in Patients With Locally Advanced Esophageal Cancer. Front Oncol 2020;10:1630. [PMID: 33014819 DOI: 10.3389/fonc.2020.01630] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
242 Hao J, Chen C, Wan F, Zhu Y, Jin H, Zhou J, Chen N, Yang J, Pu Q. Prognostic Value of Pre-Treatment Prognostic Nutritional Index in Esophageal Cancer: A Systematic Review and Meta-Analysis. Front Oncol 2020;10:797. [PMID: 32626652 DOI: 10.3389/fonc.2020.00797] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
243 Yang AJ, Choi SH, Byun HK, Kim HJ, Choi J, Lee YC, Lee SK, Park KR, Lee CG. Management of Clinical T1N0M0 Esophageal Cancer. Gut Liver. 2019;13:315-324. [PMID: 30600672 DOI: 10.5009/gnl18254] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
244 Hao XW, Zhu ST, He YL, Li P, Wang YJ, Zhang ST. Epigenetic inactivation of secreted frizzled-related protein 2 in esophageal squamous cell carcinoma. World J Gastroenterol 2012; 18(6): 532-540 [PMID: 22363119 DOI: 10.3748/wjg.v18.i6.532] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
245 Fiore FD, Lecleire S, Rigal O, Galais MP, Soussan EB, David I, Paillot B, Jacob JH, Michel P. Predictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinoma. World J Gastroenterol 2006; 12(26): 4185-4190 [PMID: 16830371 DOI: 10.3748/wjg.v12.i26.4185] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 48] [Article Influence: 3.1] [Reference Citation Analysis]
246 Wu SG, Xie WH, Zhang ZQ, Sun JY, Li FY, Lin HX, Yong Bao, He ZY. Surgery Combined with Radiotherapy Improved Survival in Metastatic Esophageal Cancer in a Surveillance Epidemiology and End Results Population-based Study. Sci Rep 2016;6:28280. [PMID: 27323696 DOI: 10.1038/srep28280] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
247 Shen C, Liu Z, Wang Z, Guo J, Zhang H, Wang Y, Qin J, Li H, Fang M, Tang Z, Li Y, Qu J, Tian J. Building CT Radiomics Based Nomogram for Preoperative Esophageal Cancer Patients Lymph Node Metastasis Prediction. Transl Oncol 2018;11:815-24. [PMID: 29727831 DOI: 10.1016/j.tranon.2018.04.005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 8.0] [Reference Citation Analysis]
248 Tsai ST, Wang PJ, Liou NJ, Lin PS, Chen CH, Chang WC. ICAM1 Is a Potential Cancer Stem Cell Marker of Esophageal Squamous Cell Carcinoma. PLoS One 2015;10:e0142834. [PMID: 26571024 DOI: 10.1371/journal.pone.0142834] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
249 Goda K, Dobashi A, Yoshimura N, Kato M, Aihara H, Sumiyama K, Toyoizumi H, Kato T, Ikegami M, Tajiri H. Narrow-Band Imaging Magnifying Endoscopy versus Lugol Chromoendoscopy with Pink-Color Sign Assessment in the Diagnosis of Superficial Esophageal Squamous Neoplasms: A Randomised Noninferiority Trial. Gastroenterol Res Pract. 2015;2015:639462. [PMID: 26229530 DOI: 10.1155/2015/639462] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 5.1] [Reference Citation Analysis]
250 Xu WY, Yang XB, Wang WQ, Bai Y, Long JY, Lin JZ, Xiong JP, Zheng YC, He XD, Zhao HT, Sang XT. Prognostic impact of the red cell distribution width in esophageal cancer patients: A systematic review and meta-analysis. World J Gastroenterol 2018; 24(19): 2120-2129 [PMID: 29785080 DOI: 10.3748/wjg.v24.i19.2120] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
251 Lin YS, Kuo TT, Lo CC, Cheng WC, Chang WC, Tseng GC, Bai ST, Huang YK, Hsieh CY, Hsu HS, Jiang YF, Lin CY, Lai LC, Li XG, Sher YP. ADAM9 functions as a transcriptional regulator to drive angiogenesis in esophageal squamous cell carcinoma. Int J Biol Sci 2021;17:3898-910. [PMID: 34671207 DOI: 10.7150/ijbs.65488] [Reference Citation Analysis]
252 Chen S, Dong H, Yang S, Guo H. Cathepsins in digestive cancers. Oncotarget 2017;8:41690-700. [PMID: 28402938 DOI: 10.18632/oncotarget.16677] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
253 Twarock S, Röck K, Sarbia M, Weber AA, Jänicke RU, Fischer JW. Synthesis of hyaluronan in oesophageal cancer cells is uncoupled from the prostaglandin-cAMP pathway. Br J Pharmacol 2009;157:234-43. [PMID: 19338584 DOI: 10.1111/j.1476-5381.2009.00138.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
254 Zhang HF, Alshareef A, Wu C, Li S, Jiao JW, Cao HH, Lai R, Xu LY, Li EM. Loss of miR-200b promotes invasion via activating the Kindlin-2/integrin β1/AKT pathway in esophageal squamous cell carcinoma: An E-cadherin-independent mechanism. Oncotarget 2015;6:28949-60. [PMID: 26334393 DOI: 10.18632/oncotarget.5027] [Cited by in Crossref: 22] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
255 Qin JM, Yang L, Chen B, Wang XM, Li F, Liao PH, He L. Interaction of methylenetetrahydrofolate reductase C677T, cytochrome P4502E1 polymorphism and environment factors in esophageal cancer in Kazakh population. World J Gastroenterol 2008; 14(45): 6986-6992 [PMID: 19058336 DOI: 10.3748/wjg.14.6986] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
256 Enzinger PC, Kulke MH, Clark JW, Ryan DP, Kim H, Earle CC, Vincitore MM, Michelini AL, Mayer RJ, Fuchs CS. A phase II trial of irinotecan in patients with previously untreated advanced esophageal and gastric adenocarcinoma. Dig Dis Sci. 2005;50:2218-2223. [PMID: 16416165 DOI: 10.1007/s10620-005-3038-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
257 Fu S, Jin L, Gong T, Pan S, Zheng S, Zhang X, Yang T, Sun Y, Wang Y, Guo J, Hui B, Zhang X. Effect of sinomenine hydrochloride on radiosensitivity of esophageal squamous cell carcinoma cells. Oncol Rep 2018;39:1601-8. [PMID: 29393484 DOI: 10.3892/or.2018.6228] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
258 Huang X, Hong C, Peng Y, Yang S, Huang L, Liu C, Chen L, Chu L, Xu L, Xu Y. The Diagnostic Value of Serum IGFBP7 in Patients with Esophageal Squamous Cell Carcinoma. J Cancer 2019;10:2687-93. [PMID: 31258777 DOI: 10.7150/jca.32393] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
259 Hammad H, Kaltenbach T, Soetikno R. Endoscopic submucosal dissection for malignant esophageal lesions. Curr Gastroenterol Rep. 2014;16:386. [PMID: 24659252 DOI: 10.1007/s11894-014-0386-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
260 Ahmad T, Jan S, Rashid S, Langoo SA. Omentoplasty, an important technique to prevent complications following esophagectomy: a comparative study. Indian J Thorac Cardiovasc Surg 2016;32:239-43. [DOI: 10.1007/s12055-016-0464-z] [Reference Citation Analysis]
261 Ortiz CM, Ito T, Hashimoto Y, Nagayama S, Iwai A, Tsunoda S, Sato F, Martorell M, Garcia JA, Perez A, Shimada Y. Effects of small interfering RNAs targeting fascin on human esophageal squamous cell carcinoma cell lines. Diagn Pathol 2010;5:41. [PMID: 20565981 DOI: 10.1186/1746-1596-5-41] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
262 Shridhar R, Abbott AM, Doepker M, Hoffe SE, Almhanna K, Meredith KL. Perioperative outcomes associated with robotic Ivor Lewis esophagectomy in patient's undergoing neoadjuvant chemoradiotherapy. J Gastrointest Oncol 2016;7:206-12. [PMID: 27034787 DOI: 10.3978/j.issn.2078-6891.2015.104] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
263 Komatsu S, Ichikawa D, Hirajima S, Takeshita H, Shiozaki A, Fujiwara H, Kawaguchi T, Miyamae M, Konishi H, Kubota T, Okamoto K, Yagi N, Otsuji E. Clinical impact of predicting CCND1 amplification using plasma DNA in superficial esophageal squamous cell carcinoma. Dig Dis Sci. 2014;59:1152-1159. [PMID: 24458211 DOI: 10.1007/s10620-013-3005-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
264 Wang XP, Li XH, Zhang L, Lin JH, Huang H, Kang T, Mao MJ, Chen H, Zheng X. High level of serum apolipoprotein A-I is a favorable prognostic factor for overall survival in esophageal squamous cell carcinoma. BMC Cancer 2016;16:516. [PMID: 27444612 DOI: 10.1186/s12885-016-2502-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
265 van den Boorn HG, Abu-Hanna A, Ter Veer E, van Kleef JJ, Lordick F, Stahl M, Ajani JA, Guimbaud R, Park SH, Dutton SJ, Bang YJ, Boku N, Mohammad NH, Sprangers MAG, Verhoeven RHA, Zwinderman AH, van Oijen MGH, van Laarhoven HWM. SOURCE: A Registry-Based Prediction Model for Overall Survival in Patients with Metastatic Oesophageal or Gastric Cancer. Cancers (Basel) 2019;11:E187. [PMID: 30764578 DOI: 10.3390/cancers11020187] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
266 Jung M. [Mucosectomy as sufficient therapy for early squamous cell]. Chirurg 2005;76:1018-24. [PMID: 16237563 DOI: 10.1007/s00104-005-1106-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
267 Zhu Y, Ma Y, Peng H, Gong L, Xiao M, Xiang L, He D, Cao K. MiR-130b promotes the progression of oesophageal squamous cell carcinoma by targeting SASH1. J Cell Mol Med 2019;23:93-103. [PMID: 30443973 DOI: 10.1111/jcmm.13887] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
268 Wang H, Yang X, Sun G, Yang Q, Cui C, Wang X, Ye H, Dai L, Shi J, Zhang J, Wang P. Identification and Evaluation of Autoantibody to a Novel Tumor-Associated Antigen GNA11 as a Biomarker in Esophageal Squamous Cell Carcinoma. Front Oncol 2021;11:661043. [PMID: 34568004 DOI: 10.3389/fonc.2021.661043] [Reference Citation Analysis]
269 Vay C, Hosch SB, Stoecklein NH, Klein CA, Vallböhmer D, Link BC, Yekebas EF, Izbicki JR, Knoefel WT, Scheunemann P. Integrin expression in esophageal squamous cell carcinoma: loss of the physiological integrin expression pattern correlates with disease progression. PLoS One 2014;9:e109026. [PMID: 25398092 DOI: 10.1371/journal.pone.0109026] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
270 Li X, Wu Z, Mei Q, Li X, Guo M, Fu X, Han W. Long non-coding RNA HOTAIR, a driver of malignancy, predicts negative prognosis and exhibits oncogenic activity in oesophageal squamous cell carcinoma. Br J Cancer 2013;109:2266-78. [PMID: 24022190 DOI: 10.1038/bjc.2013.548] [Cited by in Crossref: 113] [Cited by in F6Publishing: 121] [Article Influence: 12.6] [Reference Citation Analysis]
271 Zhu ZJ, Pang Y, Jin G, Zhang HY, Wang WH, Liu JW, Tuo GX, Wu P, Yang Y, Wang ZQ, Wang K. Hypoxia induces chemoresistance of esophageal cancer cells to cisplatin through regulating the lncRNA-EMS/miR-758-3p/WTAP axis. Aging (Albany NY) 2021;13:17155-76. [PMID: 34081626 DOI: 10.18632/aging.203062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
272 Barreto JC, Posner MC. Transhiatal versus transthoracic esophagectomy for esophageal cancer. World J Gastroenterol 2010; 16(30): 3804-3810 [PMID: 20698043 DOI: 10.3748/wjg.v16.i30.3804] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
273 Tao H, Qian P, Lu J, Guo Y, Zhu H, Wang F. Autophagy inhibition enhances radiosensitivity of Eca‑109 cells via the mitochondrial apoptosis pathway. Int J Oncol 2018;52:1853-62. [PMID: 29620258 DOI: 10.3892/ijo.2018.4349] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
274 Hamai Y, Hihara J, Emi M, Aoki Y, Okada M. Esophageal reconstruction using the terminal ileum and right colon in esophageal cancer surgery. Surg Today. 2012;42:342-350. [PMID: 22200754 DOI: 10.1007/s00595-011-0103-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
275 Tukanova K, Chidambaram S, Guidozzi N, Hanna GB, McGregor AH, Markar SR. ASO Author Reflections: The Role of Physiotherapy Regimens in Esophagectomy and Gastrectomy for Cancer. Ann Surg Oncol 2021. [PMID: 34897586 DOI: 10.1245/s10434-021-11163-y] [Reference Citation Analysis]
276 Lee HK, Kwon MJ, Ra YJ, Lee HS, Kim HS, Nam ES, Cho SJ, Park HR, Min SK, Seo J, Choe JY, Min KW, Kang SY. Significance of druggable targets (PD-L1, KRAS, BRAF, PIK3CA, MSI, and HPV) on curatively resected esophageal squamous cell carcinoma. Diagn Pathol 2020;15:126. [PMID: 33054840 DOI: 10.1186/s13000-020-01045-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
277 Xu X, Guan X, Tao H, Yang K, Bai Y. An association study on genetic polymorphisms of Rab37 gene with the risk of esophageal squamous cell carcinoma in a Chinese Han population. Int J Med Sci 2013;10:235-42. [PMID: 23372429 DOI: 10.7150/ijms.5524] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
278 Natsuizaka M, Naganuma S, Kagawa S, Ohashi S, Ahmadi A, Subramanian H, Chang S, Nakagawa KJ, Ji X, Liebhaber SA. Hypoxia induces IGFBP3 in esophageal squamous cancer cells through HIF-1α-mediated mRNA transcription and continuous protein synthesis. FASEB J. 2012;26:2620-2630. [PMID: 22415309 DOI: 10.1096/fj.11-198598] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
279 Ju MR, Paul S, Polanco P, Augustine M, Mansour J, Wang S, Porembka MR. Underutilization of Palliative Care in Metastatic Foregut Cancer Patients Is Associated with Socioeconomic Disparities. J Gastrointest Surg 2021;25:1404-11. [PMID: 32671798 DOI: 10.1007/s11605-020-04742-z] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
280 Mannath J, Ragunath K. Role of endoscopy in early oesophageal cancer. Nat Rev Gastroenterol Hepatol. 2016;13:720-730. [PMID: 27807370 DOI: 10.1038/nrgastro.2016.148] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
281 Murphy CF, le Roux CW. The Neurobiological Impact of Ghrelin Suppression after Oesophagectomy. Int J Mol Sci 2016;18:E35. [PMID: 28035969 DOI: 10.3390/ijms18010035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
282 Kosugi SI, Kanda T, Nishimaki T, Nakagawa S, Yajima K, Ohashi M, Hatakeyama K. Successful treatment for esophageal carcinoma with lung metastasis by induction chemotherapy followed by salvage esophagectomy: Report of a case. World J Gastroenterol 2006; 12(25): 4101-4103 [PMID: 16810771 DOI: 10.3748/wjg.v12.i25.4101] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
283 Ahrens TD, Timme S, Hoeppner J, Ostendorp J, Hembach S, Follo M, Hopt UT, Werner M, Busch H, Boerries M. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine. Epigenetics. 2015;10:431-445. [PMID: 25923331 DOI: 10.1080/15592294.2015.1039216] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 6.8] [Reference Citation Analysis]
284 Yang H, Wang K, Wang T, Li M, Li B, Li S, Yuan L. The Combination Options and Predictive Biomarkers of PD-1/PD-L1 Inhibitors in Esophageal Cancer. Front Oncol 2020;10:300. [PMID: 32195194 DOI: 10.3389/fonc.2020.00300] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
285 Lin DC, Koeffler HP. Genomic lesions drive the metastasis of esophageal squamous cell carcinoma. J Thorac Dis 2017;9:3523-4. [PMID: 29268331 DOI: 10.21037/jtd.2017.09.58] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
286 Subramanian S, Sridharan N, Balasundaram V, Chaudhari S. Effectiveness and tolerability of nimotuzumab in unresectable, locally advanced/metastatic esophageal cancer: Indian hospital-based retrospective evidence. South Asian J Cancer 2019;8:112-5. [PMID: 31069192 DOI: 10.4103/sajc.sajc_89_18] [Reference Citation Analysis]
287 Lin QH, Que FC, Gu CP, Zhong DS, Zhou D, Kong Y, Yu L, Liu SW. ABT-263 induces G1/G0-phase arrest, apoptosis and autophagy in human esophageal cancer cells in vitro. Acta Pharmacol Sin 2017;38:1632-41. [PMID: 28713162 DOI: 10.1038/aps.2017.78] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
288 Da CL, Tan Y, Zhan YY, Li YW, Liu K, Wang RZ. Radiation-induced expression of HOTAIR, Snail and E-cadherin in esophageal squamous cell carcinoma cells. Shijie Huaren Xiaohua Zazhi 2016; 24(8): 1227-1232 [DOI: 10.11569/wcjd.v24.i8.1227] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
289 Long L, Pang XX, Zeng FM, Zhan XH, Xie YH, Pan F, Wang W, Liao LD, Xu XE, Li B, Wang LD, Chang ZJ, Li EM, Xu LY. Promotion of rs3746804 (p. L267P) polymorphism to intracellular SLC52A3a trafficking and riboflavin transportation in esophageal cancer cells. Amino Acids 2021;53:1197-209. [PMID: 34223992 DOI: 10.1007/s00726-021-03025-4] [Reference Citation Analysis]
290 Prueksapanich P, Pittayanon R, Rerknimitr R, Wisedopas N, Kullavanijaya P. Value of probe-based confocal laser endomicroscopy (pCLE) and dual focus narrow-band imaging (dNBI) in diagnosing early squamous cell neoplasms in esophageal Lugol's voiding lesions. Endosc Int Open. 2015;3:E281-E288. [PMID: 26356321 DOI: 10.1055/s-0034-1391903] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
291 Fan J, Liu Z, Mao X, Tong X, Zhang T, Suo C, Chen X. Global trends in the incidence and mortality of esophageal cancer from 1990 to 2017. Cancer Med 2020;9:6875-87. [PMID: 32750217 DOI: 10.1002/cam4.3338] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
292 Lin C, Song L, Liu A, Gong H, Lin X, Wu J, Li M, Li J. Overexpression of AKIP1 promotes angiogenesis and lymphangiogenesis in human esophageal squamous cell carcinoma. Oncogene 2015;34:384-93. [PMID: 24413079 DOI: 10.1038/onc.2013.559] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
293 MacGuill MJ, Barrett C, Ravi N, MacDonald G, Reynolds JV. Isolated tumour cells in pathological node-negative lymph nodes adversely affect prognosis in cancer of the oesophagus or oesophagogastric junction. J Clin Pathol 2007;60:1108-11. [PMID: 17220206 DOI: 10.1136/jcp.2006.044149] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
294 Spitzner M, Ebner R, Wolff HA, Ghadimi BM, Wienands J, Grade M. STAT3: A Novel Molecular Mediator of Resistance to Chemoradiotherapy. Cancers (Basel) 2014;6:1986-2011. [PMID: 25268165 DOI: 10.3390/cancers6041986] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 7.6] [Reference Citation Analysis]
295 Ren C, Cai XY, Qiu MZ, Wang DS, Wang FH, Luo HY, Xu RH. Impact of body mass index on survival of esophageal squamous carcinoma patients in southern China. J Thorac Dis 2015;7:337-45. [PMID: 25922711 DOI: 10.3978/j.issn.2072-1439.2014.10.12] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
296 Wang S, Xi J, Lin Z, Hao J, Yao C, Zhan C, Jiang W, Shi Y, Wang Q. Clinical values of Ku80 upregulation in superficial esophageal squamous cell carcinoma. Cancer Med 2018;7:1006-18. [PMID: 29532618 DOI: 10.1002/cam4.1314] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
297 Shin WS, Kwon J, Lee HW, Kang MC, Na HW, Lee ST, Park JH. Oncogenic role of protein tyrosine kinase 7 in esophageal squamous cell carcinoma. Cancer Sci. 2013;104:1120-1126. [PMID: 23663482 DOI: 10.1111/cas.12194] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
298 Wang Y, Wang Q, Zhang N, Ma H, Gu Y, Tang H, Xu Z, Gao Y. Identification of microRNAs as novel biomarkers for detecting esophageal squamous cell carcinoma in Asians: a meta-analysis. Tumour Biol. 2014;35:11595-11604. [PMID: 25135426 DOI: 10.1007/s13277-014-2350-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
299 Choi S, Cui C, Luo Y, Kim SH, Ko JK, Huo X, Ma J, Fu LW, Souza RF, Korichneva I, Pan Z. Selective inhibitory effects of zinc on cell proliferation in esophageal squamous cell carcinoma through Orai1. FASEB J. 2018;32:404-416. [PMID: 28928244 DOI: 10.1096/fj.201700227rrr] [Cited by in Crossref: 32] [Cited by in F6Publishing: 17] [Article Influence: 6.4] [Reference Citation Analysis]
300 Akiyama S, Saeki H, Nakashima Y, Iimori M, Kitao H, Oki E, Oda Y, Nakabeppu Y, Kakeji Y, Maehara Y. Prognostic impact of MutT homolog-1 expression on esophageal squamous cell carcinoma. Cancer Med 2017;6:258-66. [PMID: 27917618 DOI: 10.1002/cam4.979] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
301 Parfitt JR, Miladinovic Z, Driman DK. Increasing incidence of adenocarcinoma of the gastroesophageal junction and distal stomach in Canada -- an epidemiological study from 1964-2002. Can J Gastroenterol 2006;20:271-6. [PMID: 16609756 DOI: 10.1155/2006/175751] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
302 Bashash M, Shah A, Hislop G, Brooks-Wilson A, Le N, Bajdik C. Incidence and survival for gastric and esophageal cancer diagnosed in British Columbia, 1990 to 1999. Can J Gastroenterol 2008;22:143-8. [PMID: 18299732 DOI: 10.1155/2008/645107] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
303 Goense L, Meziani J, van Rossum PSN, Wessels FJ, Lam MGEH, van Hillegersberg R, Ruurda JP. Cervical ultrasonography has no additional value over negative 18F-FDG PET/CT scans for diagnosing cervical lymph node metastases in patients with oesophageal cancer. Eur Radiol 2018;28:2031-7. [PMID: 29218619 DOI: 10.1007/s00330-017-5136-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
304 Bhat YM, Furth EE, Brensinger CM, Ginsberg GG. Endoscopic Resection with Ligation Using a Multi-Band Mucosectomy System in Barrett's Esophagus with High-Grade Dysplasia and Intramucosal Carcinoma. Therap Adv Gastroenterol 2009;2:323-30. [PMID: 21180580 DOI: 10.1177/1756283X09346794] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
305 Zhou Z, Bandla S, Ye J, Xia Y, Que J, Luketich JD, Pennathur A, Peters JH, Tan D, Godfrey TE. Cyclin E involved in early stage carcinogenesis of esophageal adenocarcinoma by SNP DNA microarray and immunohistochemical studies. BMC Gastroenterol 2014;14:78. [PMID: 24742107 DOI: 10.1186/1471-230X-14-78] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
306 Chen MF, Lu MS, Chen PT, Chen WC, Lin PY, Lee KD. Role of interleukin 1 beta in esophageal squamous cell carcinoma. J Mol Med (Berl) 2012;90:89-100. [PMID: 21912958 DOI: 10.1007/s00109-011-0809-4] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
307 Giugliano DN, Berger AC, Rosato EL, Palazzo F. Total minimally invasive esophagectomy for esophageal cancer: approaches and outcomes. Langenbecks Arch Surg. 2016;401:747-756. [PMID: 27401326 DOI: 10.1007/s00423-016-1469-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
308 Koterazawa Y, Nakamura T, Oshikiri T, Kanaji S, Tanaka S, Ishida T, Yamashita K, Matsuda T, Morita Y, Suzuki S, Kakeji Y. A comparison of the clinical outcomes of esophagectomy and chemoradiotherapy after noncurative endoscopic submucosal dissection for esophageal squamous cell carcinoma. Surg Today 2018;48:783-9. [PMID: 29532261 DOI: 10.1007/s00595-018-1650-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
309 Shi GZ, Yuan Y, Jiang GJ, Ge ZJ, Zhou J, Gong DJ, Tao J, Tan YF, Huang SD. PRAF3 induces apoptosis and inhibits migration and invasion in human esophageal squamous cell carcinoma. BMC Cancer 2012;12:97. [PMID: 22433565 DOI: 10.1186/1471-2407-12-97] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
310 Guo W, Ma Z, Zhao YP, Jiang YG. Controllable metastasis: the trap for the esophageal cancer cells? Med Hypotheses 2010;74:1000-1. [PMID: 20129740 DOI: 10.1016/j.mehy.2010.01.017] [Reference Citation Analysis]
311 Hamao N, Ito I, Konishi S, Tanabe N, Shirata M, Oi I, Tsukino M, Matsumoto H, Yasutomo Y, Kadowaki S, Hirai T. Comparison of ceftriaxone plus macrolide and ampicillin/sulbactam plus macrolide in treatment for patients with community-acquired pneumonia without risk factors for aspiration: an open-label, quasi-randomized, controlled trial. BMC Pulm Med 2020;20:160. [PMID: 32503515 DOI: 10.1186/s12890-020-01198-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
312 Jain RV, Mills PK, Parikh-Patel A. Cancer incidence in the south Asian population of California, 1988-2000. J Carcinog 2005;4:21. [PMID: 16283945 DOI: 10.1186/1477-3163-4-21] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 1.8] [Reference Citation Analysis]
313 Rasmussen SR, Nielsen RV, Fenger AS, Siemsen M, Ravn HB. Postoperative complications and survival after surgical resection of esophageal squamous cell carcinoma. J Thorac Dis 2018;10:4052-60. [PMID: 30174848 DOI: 10.21037/jtd.2018.07.04] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
314 Zhang H, Luo H, Hu Z, Peng J, Jiang Z, Song T, Wu B, Yue J, Zhou R, Xie R, Chen T, Wu S. Targeting WISP1 to sensitize esophageal squamous cell carcinoma to irradiation. Oncotarget 2015;6:6218-34. [PMID: 25749038 DOI: 10.18632/oncotarget.3358] [Cited by in Crossref: 33] [Cited by in F6Publishing: 40] [Article Influence: 5.5] [Reference Citation Analysis]
315 Speicher PJ, Englum BR, Ganapathi AM, Wang X, Hartwig MG, D'Amico TA, Berry MF. Traveling to a High-volume Center is Associated With Improved Survival for Patients With Esophageal Cancer. Ann Surg. 2017;265:743-749. [PMID: 28266965 DOI: 10.1097/sla.0000000000001702] [Cited by in Crossref: 48] [Cited by in F6Publishing: 19] [Article Influence: 9.6] [Reference Citation Analysis]
316 Taniguchi D, Saeki H, Nakashima Y, Kudou K, Nakanishi R, Kubo N, Ando K, Oki E, Oda Y, Maehara Y. CD44v9 is associated with epithelial-mesenchymal transition and poor outcomes in esophageal squamous cell carcinoma. Cancer Med 2018;7:6258-68. [PMID: 30474922 DOI: 10.1002/cam4.1874] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
317 Qiu G, Zhang H, Wang F, Zheng Y, Wang Z, Wang Y. Metastasis Patterns and Prognosis of Elderly Patients With Esophageal Adenocarcinoma in Stage IVB: A Population-Based Study. Front Oncol 2021;11:625720. [PMID: 34123784 DOI: 10.3389/fonc.2021.625720] [Reference Citation Analysis]
318 Liang H, Peng H, Chen L. Prognostic Value of Sarcopenia and Systemic Inflammation Markers in Patients Undergoing Definitive Radiotherapy for Esophageal Cancer. Cancer Manag Res 2021;13:181-92. [PMID: 33469362 DOI: 10.2147/CMAR.S288522] [Reference Citation Analysis]
319 Shibamoto M, Hirata H, Eguchi H, Sawada G, Sakai N, Kajiyama Y, Mimori K. The loss of CASP4 expression is associated with poor prognosis in esophageal squamous cell carcinoma. Oncol Lett 2017;13:1761-6. [PMID: 28454321 DOI: 10.3892/ol.2017.5646] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
320 Lin Y, Su X, Su H, Lin P, Long H, Zhang L, Fu J, Rong T, Tan Z, Meng Y, Ma G. Prediagnostic smoking and postoperative survival in lymph node-negative esophagus squamous cell carcinoma patients. Cancer Sci 2012;103:1985-8. [PMID: 22913634 DOI: 10.1111/cas.12000] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
321 Kgomo M, Mokoena TR, Ker JA. Non-acid gastro-oesophageal reflux is associated with squamous cell carcinoma of the oesophagus. BMJ Open Gastroenterol. 2017;4:e000180. [PMID: 29177066 DOI: 10.1136/bmjgast-2017-000180] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
322 Huang CY, Lee CH, Tu CC, Wu CH, Huang MT, Wei PL, Chang YJ. Glucose-regulated protein 94 mediates progression and metastasis of esophageal squamous cell carcinoma via mitochondrial function and the NF-kB/COX-2/VEGF axis. Oncotarget 2018;9:9425-41. [PMID: 29507700 DOI: 10.18632/oncotarget.24114] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
323 Chen Y, Liao LD, Wu ZY, Yang Q, Guo JC, He JZ, Wang SH, Xu XE, Wu JY, Pan F, Lin DC, Xu LY, Li EM. Identification of key genes by integrating DNA methylation and next-generation transcriptome sequencing for esophageal squamous cell carcinoma. Aging (Albany NY) 2020;12:1332-65. [PMID: 31962291 DOI: 10.18632/aging.102686] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
324 Wong GS, Habibollahi P, Heidari P, Lee JS, Klein-Szanto AJ, Waldron TJ, Gimotty P, Nakagawa H, Taylor PR, Wang TC, Mahmood U, Rustgi AK. Optical imaging of periostin enables early endoscopic detection and characterization of esophageal cancer in mice. Gastroenterology 2013;144:294-7. [PMID: 23085486 DOI: 10.1053/j.gastro.2012.10.030] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
325 Dong X, Chen X, Lu D, Diao D, Liu X, Mai S, Feng S, Xiong G. LncRNA miR205HG hinders HNRNPA0 translation: anti-oncogenic effects in esophageal carcinoma. Mol Oncol 2021. [PMID: 34821009 DOI: 10.1002/1878-0261.13142] [Reference Citation Analysis]
326 Krishnamurthy A, Behuria SS. Demographic Trends in Carcinoma Esophagus from India along with a Brief Comparative Review of the Global Trends. South Asian J Cancer 2020;9:163-7. [PMID: 33937139 DOI: 10.1055/s-0041-1723103] [Reference Citation Analysis]
327 Dey B, Raphael V, Khonglah Y, GiriLynrah K. Expression of Cyclin D1 and P16 in Esophageal Squamous Cell Carcinoma. Middle East J Dig Dis. 2015;7:220-225. [PMID: 26609350 DOI: 10.1016/s0022-0248(00)00190-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
328 Ali T, Choyke PL, Kobayashi H. Endoscopic molecular imaging of cancer. Future Oncol 2013;9:1501-13. [PMID: 24106901 DOI: 10.2217/fon.13.123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
329 Thumallapally N, Meshref A, Mousa M, Hendawi M, Lan M, Salem AI, Forte F. Survival benefit of neoadjuvant versus adjuvant radiotherapy in lymph node positive esophageal cancer: a population based analysis. J Gastrointest Oncol 2017;8:825-32. [PMID: 29184686 DOI: 10.21037/jgo.2017.06.19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
330 Yang X, Wang L, Du H, Lin B, Yi J, Wen X, Geng L, Du X. Prognostic impact of eosinophils in peripheral blood and tumor site in patients with esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy. Medicine (Baltimore) 2021;100:e24328. [PMID: 33546064 DOI: 10.1097/MD.0000000000024328] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
331 Wu X, Zhang J, Zhen R, Lv J, Zheng L, Su X, Zhu G, Gavine PR, Xu S, Lu S. Trastuzumab anti-tumor efficacy in patient-derived esophageal squamous cell carcinoma xenograft (PDECX) mouse models. J Transl Med. 2012;10:180. [PMID: 22935382 DOI: 10.1186/1479-5876-10-180] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
332 Suzuki T, Ishibashi Y, Tsujimoto H, Nomura S, Kouzu K, Itazaki Y, Sugihara T, Harada M, Ito N, Sugasawa H, Kishi Y, Ueno H. A Novel Systemic Inflammatory Score Combined With Immunoinflammatory Markers Accurately Reflects Prognosis in Patients With Esophageal Cancer. In Vivo 2020;34:3705-11. [PMID: 33144487 DOI: 10.21873/invivo.12218] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
333 Brown AM, Pucci MJ, Berger AC, Tatarian T, Evans NR 3rd, Rosato EL, Palazzo F. A standardized comparison of peri-operative complications after minimally invasive esophagectomy: Ivor Lewis versus McKeown. Surg Endosc 2018;32:204-11. [PMID: 28643075 DOI: 10.1007/s00464-017-5660-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
334 Chen XY, He QY, Guo MZ. XAF1 is frequently methylated in human esophageal cancer. World J Gastroenterol 2012; 18(22): 2844-2849 [PMID: 22719195 DOI: 10.3748/wjg.v18.i22.2844] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
335 Ismail T, Calcabrini C, Diaz AR, Fimognari C, Turrini E, Catanzaro E, Akhtar S, Sestili P. Ellagitannins in Cancer Chemoprevention and Therapy. Toxins (Basel). 2016;8. [PMID: 27187472 DOI: 10.3390/toxins8050151] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 7.8] [Reference Citation Analysis]
336 Sun LL, Wu JY, Wu ZY, Shen JH, Xu XE, Chen B, Wang SH, Li EM, Xu LY. A three-gene signature and clinical outcome in esophageal squamous cell carcinoma. Int J Cancer. 2015;136:E569-E577. [PMID: 25220908 DOI: 10.1002/ijc.29211] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
337 Yoon HH, Catalano P, Gibson MK, Skaar TC, Philips S, Montgomery EA, Hafez MJ, Powell M, Liu G, Forastiere AA, Benson AB, Kleinberg LR, Murphy KM. Genetic variation in radiation and platinum pathways predicts severe acute radiation toxicity in patients with esophageal adenocarcinoma treated with cisplatin-based preoperative radiochemotherapy: results from the Eastern Cooperative Oncology Group. Cancer Chemother Pharmacol 2011;68:863-70. [PMID: 21286719 DOI: 10.1007/s00280-011-1556-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
338 Zhang Y, Li J, Wang L, Meng P, Zhao J, Han P, Xia J, Xu J, Wang L, Shen F, Zheng A, Zhou F, Fan R. Clinical significance of detecting circulating tumor cells in patients with esophageal squamous cell carcinoma by EpCAM‑independent enrichment and immunostaining‑fluorescence in situ hybridization. Mol Med Rep 2019;20:1551-60. [PMID: 31257510 DOI: 10.3892/mmr.2019.10420] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
339 Xu X, Wang J, Zhu SM, Yang M, Fang Y, Zhao A, Song Q, Mao W. Impact of alcohol dehydrogenase gene 4 polymorphisms on esophageal squamous cell carcinoma risk in a Chinese population. PLoS One 2015;10:e0127304. [PMID: 26039424 DOI: 10.1371/journal.pone.0127304] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
340 Guohong Z, Min S, Duenmei W, Songnian H, Min L, Jinsong L, Hongbin L, Feng Z, Dongping T, Heling Y, Zhicai L, Shiyong L, Quansheng G, Xiaoyun L, Yuxia G. Genetic heterogeneity of oesophageal cancer in high-incidence areas of southern and northern China. PLoS One 2010;5:e9668. [PMID: 20300624 DOI: 10.1371/journal.pone.0009668] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
341 Li J, Wang Z, Li Y. USP22 nuclear expression is significantly associated with progression and unfavorable clinical outcome in human esophageal squamous cell carcinoma. J Cancer Res Clin Oncol. 2012;138:1291-1297. [PMID: 22447106 DOI: 10.1007/s00432-012-1191-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
342 Burdall OC, Boddy AP, Fullick J, Blazeby J, Krysztopik R, Streets C, Hollowood A, Barham CP, Titcomb D. A comparative study of survival after minimally invasive and open oesophagectomy. Surg Endosc. 2015;29:431-437. [PMID: 25125095 DOI: 10.1007/s00464-014-3694-4] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
343 Cho JH, Shin CM, Han KD, Yoon H, Park YS, Kim N, Lee DH. Abdominal obesity increases risk for esophageal cancer: a nationwide population-based cohort study of South Korea. J Gastroenterol 2020;55:307-16. [PMID: 31792601 DOI: 10.1007/s00535-019-01648-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
344 Choy B, Bandla S, Xia Y, Tan D, Pennathur A, Luketich JD, Godfrey TE, Peters JH, Sun J, Zhou Z. Clinicopathologic characteristics of high expression of Bmi-1 in esophageal adenocarcinoma and squamous cell carcinoma. BMC Gastroenterol. 2012;12:146. [PMID: 23078618 DOI: 10.1186/1471-230x-12-146] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
345 Jin Z, Feng W, Ji Y, Jin L. Resveratrol mediates cell cycle arrest and cell death in human esophageal squamous cell carcinoma by directly targeting the EGFR signaling pathway. Oncol Lett 2017;13:347-55. [PMID: 28123566 DOI: 10.3892/ol.2016.5391] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
346 Xu XL, Zheng WH, Fu ZX, Li ZP, Xie HX, Li XX, Jiang LH, Wang Y, Zhu SM, Mao WM. Topo2A as a prognostic biomarker for patients with resectable esophageal squamous cell carcinomas. Med Oncol 2015;32:396. [PMID: 25432700 DOI: 10.1007/s12032-014-0396-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
347 Bodelon C, Anderson GL, Rossing MA, Chlebowski RT, Ochs-Balcom HM, Vaughan TL. Hormonal factors and risks of esophageal squamous cell carcinoma and adenocarcinoma in postmenopausal women. Cancer Prev Res (Phila). 2011;4:840-850. [PMID: 21505180 DOI: 10.1158/1940-6207.capr-10-0389] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
348 Zhao Q, Miao C, Lu Q, Wu W, He Y, Wu S, Liu H, Lian C. Clinical Significance of Monitoring Circulating Free DNA and Plasma Heat Shock Protein 90alpha in Patients with Esophageal Squamous Cell Carcinoma. Cancer Manag Res 2021;13:2223-34. [PMID: 33707971 DOI: 10.2147/CMAR.S295927] [Reference Citation Analysis]
349 Zheng X, Xing S, Liu XM, Liu W, Liu D, Chi PD, Chen H, Dai SQ, Zhong Q, Zeng MS. Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma. BMC Cancer. 2014;14:490. [PMID: 25001061 DOI: 10.1186/1471-2407-14-490] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
350 Chen CC, Hsu YC, Lee CT, Hsu CC, Tai CM, Wang WL, Tseng CH, Hsu CT, Lin JT, Chang CY. Central Obesity and H. pylori Infection Influence Risk of Barrett's Esophagus in an Asian Population. PLoS One 2016;11:e0167815. [PMID: 27936223 DOI: 10.1371/journal.pone.0167815] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
351 Li H, Zheng D, Zhang B, Liu L, Ou J, Chen W, Xiong S, Gu Y, Yang J. Mir-208 promotes cell proliferation by repressing SOX6 expression in human esophageal squamous cell carcinoma. J Transl Med. 2014;12:196. [PMID: 25023649 DOI: 10.1186/1479-5876-12-196] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 7.0] [Reference Citation Analysis]
352 Zhou H, Yang L, Xu X, Lu M, Guo R, Li D, Huang Q, Liu Y, Deng G, Xu Y. miR-34a inhibits esophageal squamous cell carcinoma progression via regulation of FOXM1. Oncol Lett 2019;17:706-12. [PMID: 30655820 DOI: 10.3892/ol.2018.9593] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
353 Xiong JX, Wang YS, Sheng J, Xiang D, Huang TX, Tan BB, Zeng CM, Li HH, Yang J, Meltzer SJ, Mori Y, Qin YR, Guan XY, Fu L. Epigenetic alterations of a novel antioxidant gene SLC22A3 predispose susceptible individuals to increased risk of esophageal cancer. Int J Biol Sci 2018;14:1658-68. [PMID: 30416380 DOI: 10.7150/ijbs.28482] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
354 Saeed N, Shridhar R, Almhanna K, Hoffe S, Chuong M, Meredith K. CT-based assessment of visceral adiposity and outcomes for esophageal adenocarcinoma. J Gastrointest Oncol 2017;8:833-41. [PMID: 29184687 DOI: 10.21037/jgo.2017.07.03] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
355 Li B, Hong P, Zheng CC, Dai W, Chen WY, Yang QS, Han L, Tsao SW, Chan KT, Lee NPY, Law S, Xu LY, Li EM, Chan KW, Qin YR, Guan XY, Lung ML, He QY, Xu WW, Cheung AL. Identification of miR-29c and its Target FBXO31 as a Key Regulatory Mechanism in Esophageal Cancer Chemoresistance: Functional Validation and Clinical Significance. Theranostics. 2019;9:1599-1613. [PMID: 31037126 DOI: 10.7150/thno.30372] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
356 Yao C, Liu HN, Wu H, Chen YJ, Li Y, Fang Y, Shen XZ, Liu TT. Diagnostic and Prognostic Value of Circulating MicroRNAs for Esophageal Squamous Cell Carcinoma: a Systematic Review and Meta-analysis. J Cancer. 2018;9:2876-2884. [PMID: 30123356 DOI: 10.7150/jca.25351] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
357 Attendu X, Bourget MH, de Sivry-Houle MP, Boudoux C. Coregistered optical coherence tomography and frequency-encoded multispectral imaging for spectrally sparse color imaging. J Biomed Opt 2019;25:1-12. [PMID: 31755250 DOI: 10.1117/1.JBO.25.3.032008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
358 Hirashima K, Baba Y, Watanabe M, Karashima RI, Sato N, Imamura Y, Nagai Y, Hayashi N, Iyama KI, Baba H. Aberrant activation of the mTOR pathway and anti-tumour effect of everolimus on oesophageal squamous cell carcinoma. Br J Cancer. 2012;106:876-882. [PMID: 22333597 DOI: 10.1038/bjc.2012.36] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
359 Michel P, Adenis A, Di Fiore F, Boucher E, Galais MP, Dahan L, Mirabel X, Hamidou H, Raoul JL, Jacob JH. Induction cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial. Br J Cancer. 2006;95:705-709. [PMID: 16967056 DOI: 10.1038/sj.bjc.6603328] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
360 Xu YW, Peng YH, Ran LQ, Zhai TT, Guo HP, Qiu SQ, Chen HL, Wu ZY, Li EM, Xie JJ. Circulating levels of autoantibodies against L1-cell adhesion molecule as a potential diagnostic biomarker in esophageal squamous cell carcinoma. Clin Transl Oncol. 2017;19:898-906. [PMID: 28181176 DOI: 10.1007/s12094-017-1623-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
361 Yang C, Ning S, Li Z, Qin X, Xu W. miR-22 is down-regulated in esophageal squamous cell carcinoma and inhibits cell migration and invasion. Cancer Cell Int 2014;14:138. [PMID: 25516722 DOI: 10.1186/s12935-014-0138-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
362 Zhao JS, Li WJ, Ge D, Zhang PJ, Li JJ, Lu CL, Ji XD, Guan DX, Gao H, Xu LY. Tumor initiating cells in esophageal squamous cell carcinomas express high levels of CD44. PLoS One. 2011;6:e21419. [PMID: 21731740 DOI: 10.1371/journal.pone.0021419] [Cited by in Crossref: 74] [Cited by in F6Publishing: 72] [Article Influence: 6.7] [Reference Citation Analysis]
363 Fassan M, Volinia S, Palatini J, Pizzi M, Baffa R, De Bernard M, Battaglia G, Parente P, Croce CM, Zaninotto G, Ancona E, Rugge M. MicroRNA expression profiling in human Barrett's carcinogenesis. Int J Cancer. 2011;129:1661-1670. [PMID: 21128279 DOI: 10.1002/ijc.25823] [Cited by in Crossref: 79] [Cited by in F6Publishing: 80] [Article Influence: 7.2] [Reference Citation Analysis]
364 Cui G, Cui M, Li Y, Liang Y, Li W, Guo H, Zhao S. Galectin-3 knockdown increases gefitinib sensitivity to the inhibition of EGFR endocytosis in gefitinib-insensitive esophageal squamous cancer cells. Med Oncol 2015;32:124. [PMID: 25788032 DOI: 10.1007/s12032-015-0570-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
365 Jiang YX, Zhang DW, Chen Y, Sun HH, Xu SC, Gao HJ. The characteristics of oesophageal squamous cell carcinoma: an analysis of 1317 cases in southeastern China. Contemp Oncol (Pozn) 2015;19:137-41. [PMID: 26034392 DOI: 10.5114/wo.2015.51419] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
366 Xu Y, Wang J, Qiu M, Xu L, Li M, Jiang F, Yin R, Xu L. Upregulation of the long noncoding RNA TUG1 promotes proliferation and migration of esophageal squamous cell carcinoma. Tumour Biol 2015;36:1643-51. [PMID: 25366138 DOI: 10.1007/s13277-014-2763-6] [Cited by in Crossref: 109] [Cited by in F6Publishing: 111] [Article Influence: 13.6] [Reference Citation Analysis]
367 Huang J, Li Y, Lu Z, Che Y, Sun S, Mao S, Lei Y, Zang R, Li N, Sun N, He J. Long non-coding RNA GAS5 is induced by interferons and plays an antitumor role in esophageal squamous cell carcinoma. Cancer Med 2018. [PMID: 29745062 DOI: 10.1002/cam4.1524] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
368 Ren LH, Chen WX, Li S, He XY, Zhang ZM, Li M, Cao RS, Hao B, Zhang HJ, Qiu HQ. MicroRNA-183 promotes proliferation and invasion in oesophageal squamous cell carcinoma by targeting programmed cell death 4. Br J Cancer. 2014;111:2003-2013. [PMID: 25211657 DOI: 10.1038/bjc.2014.485] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 4.8] [Reference Citation Analysis]
369 Zhang H, Xu L, Xiao D, Xie J, Zeng H, Cai W, Niu Y, Yang Z, Shen Z, Li E. Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma. J Clin Pathol 2006;59:958-64. [PMID: 16524962 DOI: 10.1136/jcp.2005.032730] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 3.3] [Reference Citation Analysis]
370 Fortuny J, Johnson CC, Bohlke K, Chow WH, Hart G, Kucera G, Mujumdar U, Ownby D, Wells K, Yood MU, Engel LS. Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancers. Clin Gastroenterol Hepatol 2007;5:1154-1159.e3. [PMID: 17644046 DOI: 10.1016/j.cgh.2007.05.022] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
371 Nguyen GH, Schetter AJ, Chou DB, Bowman ED, Zhao R, Hawkes JE, Mathé EA, Kumamoto K, Zhao Y, Budhu A, Hagiwara N, Wang XW, Miyashita M, Casson AG, Harris CC. Inflammatory and microRNA gene expression as prognostic classifier of Barrett's-associated esophageal adenocarcinoma. Clin Cancer Res 2010;16:5824-34. [PMID: 20947516 DOI: 10.1158/1078-0432.CCR-10-1110] [Cited by in Crossref: 46] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
372 Huang JX, Shen SL, Lin M, Xiao W, Chen WC, Lin MS, Yu H, Chen P, Qian RY. Cyclin A overexpression is associated with chemosensitivity to paclitaxel-based chemotherapy in patients with esophageal squamous cell carcinoma. Oncol Lett 2012;4:607-11. [PMID: 23205070 DOI: 10.3892/ol.2012.814] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
373 Chen L, Liu X, Gao L, Wang R, Gao D, Bai D. The clinicopathological features and prognosis of signet ring cell carcinoma of the esophagus: A 10-year retrospective study in China. PLoS One 2017;12:e0176637. [PMID: 28486494 DOI: 10.1371/journal.pone.0176637] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
374 Wu YS, Chen YL, Yin SG, Wang HH. Role of transcription factors in regulation of gene expression in esophageal squamous cell carcinoma. Shijie Huaren Xiaohua Zazhi 2013; 21(16): 1533-1538 [DOI: 10.11569/wcjd.v21.i16.1533] [Reference Citation Analysis]
375 Sun L, Zhang H, Wu K. Esophageal Cancer: Current Options for Therapeutic Management. Gastrointest Tumors 2014;1:105-13. [PMID: 26674591 DOI: 10.1159/000362907] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
376 Liu F, Wu Q, Han W, Laster K, Hu Y, Ma F, Chen H, Tian X, Qiao Y, Liu H, Kim DJ, Dong Z, Liu K. Targeting integrin αvβ3 with indomethacin inhibits patient-derived xenograft tumour growth and recurrence in oesophageal squamous cell carcinoma. Clin Transl Med 2021;11:e548. [PMID: 34709754 DOI: 10.1002/ctm2.548] [Reference Citation Analysis]
377 Waterhouse DJ, Bano S, Januszewicz W, Stoyanov D, Fitzgerald RC, di Pietro M, Bohndiek SE. First-in-human pilot study of snapshot multispectral endoscopy for early detection of Barrett's-related neoplasia. J Biomed Opt 2021;26. [PMID: 34628734 DOI: 10.1117/1.JBO.26.10.106002] [Reference Citation Analysis]
378 Pennathur A, Zhang J, Chen H, Luketich JD. The “best operation” for esophageal cancer? Ann Thorac Surg. 2010;89:S2163-S2167. [PMID: 20494003 DOI: 10.1016/j.athoracsur.2010.03.068] [Cited by in Crossref: 59] [Cited by in F6Publishing: 44] [Article Influence: 4.9] [Reference Citation Analysis]
379 Hussain Z, Diamantopoulos A, Krokidis M, Katsanos K. Double-layered covered stent for the treatment of malignant oesophageal obstructions: Systematic review and meta-analysis. World J Gastroenterol 2016; 22(34): 7841-7850 [PMID: 27678367 DOI: 10.3748/wjg.v22.i34.7841] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
380 Zhang SS, Lei YY, Cai XL, Yang H, Xia X, Luo KJ, Su CH, Zou JY, Zeng B, Hu Y. Preoperative serum fibrinogen is an independent prognostic factor in operable esophageal cancer. Oncotarget. 2016;7:25461-25469. [PMID: 27009857 DOI: 10.18632/oncotarget.8171] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
381 Hibino S, Kawazoe T, Kasahara H, Itoh S, Ishimoto T, Sakata-Yanagimoto M, Taniguchi K. Inflammation-Induced Tumorigenesis and Metastasis. Int J Mol Sci 2021;22:5421. [PMID: 34063828 DOI: 10.3390/ijms22115421] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
382 Chua S, Dickson J, Groves AM. PET imaging for prediction of response to therapy and outcome in oesophageal carcinoma. Eur J Nucl Med Mol Imaging 2011;38:1591-4. [PMID: 21681555 DOI: 10.1007/s00259-011-1858-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
383 Zhang S, Guo J, Zhang H, Li H, Hassan MOO, Zhang L. Metastasis pattern and prognosis in men with esophageal cancer patients: A SEER-based study. Medicine (Baltimore) 2021;100:e26496. [PMID: 34160464 DOI: 10.1097/MD.0000000000026496] [Reference Citation Analysis]
384 Orosey M, Amin M, Cappell MS. A 14-Year Study of 398 Esophageal Adenocarcinomas Diagnosed Among 156,256 EGDs Performed at Two Large Hospitals: An Inlet Patch Is Proposed as a Significant Risk Factor for Proximal Esophageal Adenocarcinoma. Dig Dis Sci. 2018;63:452-465. [PMID: 29249048 DOI: 10.1007/s10620-017-4878-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
385 Zhu M, Xu Y, Mao X, Gao Y, Shao L, Yan F. Overexpression of metastasis-associated in colon cancer-1 associated with poor prognosis in patients with esophageal cancer. Pathol Oncol Res. 2013;19:749-753. [PMID: 23737034 DOI: 10.1007/s12253-013-9638-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
386 Reddy D, Wainberg ZA. Targeted therapies for metastatic esophagogastric cancer. Curr Treat Options Oncol 2011;12:46-60. [PMID: 21298375 DOI: 10.1007/s11864-011-0138-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
387 Yu J, Zhu M, Lv M, Wu X, Zhang X, Zhang Y, Li J, Zhang Q. Characterization of a five-microRNA signature as a prognostic biomarker for esophageal squamous cell carcinoma. Sci Rep 2019;9:19847. [PMID: 31882677 DOI: 10.1038/s41598-019-56367-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
388 Backemar L, Lagergren P, Djärv T, Johar A, Wikman A, Lagergren J. Comorbidities and Risk of Complications After Surgery for Esophageal Cancer: A Nationwide Cohort Study in Sweden. World J Surg 2015;39:2282-8. [PMID: 25952691 DOI: 10.1007/s00268-015-3093-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
389 Singhi AD, Foxwell TJ, Nason K, Cressman KL, McGrath KM, Sun W, Bahary N, Zeh HJ, Levy RM, Luketich JD, Davison JM. Smad4 loss in esophageal adenocarcinoma is associated with an increased propensity for disease recurrence and poor survival. Am J Surg Pathol 2015;39:487-95. [PMID: 25634752 DOI: 10.1097/PAS.0000000000000356] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 2.9] [Reference Citation Analysis]
390 Lindblad M, García Rodríguez LA, Chandanos E, Lagergren J. Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas. Br J Cancer 2006;94:136-41. [PMID: 16404367 DOI: 10.1038/sj.bjc.6602906] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 3.9] [Reference Citation Analysis]
391 Pourhoseingholi MA, Fazeli Z, Moghimi-Dehkordi B, Vahedi M, Pourhoseingholi A, Safaee A, Ashtari S, Zali MR. Increased oesophageal cancer mortality rate in Iran. Arab J Gastroenterol 2012;13:82-4. [PMID: 22980597 DOI: 10.1016/j.ajg.2012.06.008] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
392 Fan Z, Chang Y, Cui C, Sun L, Wang DH, Pan Z, Zhang M. Near infrared fluorescent peptide nanoparticles for enhancing esophageal cancer therapeutic efficacy. Nat Commun 2018;9:2605. [PMID: 29973582 DOI: 10.1038/s41467-018-04763-y] [Cited by in Crossref: 65] [Cited by in F6Publishing: 55] [Article Influence: 16.3] [Reference Citation Analysis]
393 Kersebaum J, Möller T, Becker T, Egberts J. Robotic resection for esophageal cancer. Eur Surg 2021;53:133-41. [DOI: 10.1007/s10353-020-00675-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
394 Sawada G, Niida A, Hirata H, Komatsu H, Uchi R, Shimamura T, Takahashi Y, Kurashige J, Matsumura T, Ueo H, Takano Y, Ueda M, Sakimura S, Shinden Y, Eguchi H, Sudo T, Sugimachi K, Yamasaki M, Tanaka F, Tachimori Y, Kajiyama Y, Natsugoe S, Fujita H, Tanaka Y, Calin G, Miyano S, Doki Y, Mori M, Mimori K. An Integrative Analysis to Identify Driver Genes in Esophageal Squamous Cell Carcinoma. PLoS One 2015;10:e0139808. [PMID: 26465158 DOI: 10.1371/journal.pone.0139808] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
395 Guo W, Zou YB, Ma Z, Niu HJ, Jiang YG, Zhao YP, Gong TQ, Wang RW. One surgeon’s learning curve for video-assisted thoracoscopic esophagectomy for esophageal cancer with the patient in lateral position: how many cases are needed to reach competence? Surg Endosc. 2013;27:1346-1352. [PMID: 23093242 DOI: 10.1007/s00464-012-2614-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
396 Dong SW, Zhang P, Liu YM, Cui YT, Wang S, Liang SJ, He Z, Sun P, Wang YG. Study on RIZ1 gene promoter methylation status in human esophageal squamous cell carcinoma. World J Gastroenterol 2012; 18(6): 576-582 [PMID: 22363126 DOI: 10.3748/wjg.v18.i6.576] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
397 Janmaat VT, Steyerberg EW, van der Gaast A, Mathijssen RH, Bruno MJ, Peppelenbosch MP, Kuipers EJ, Spaander MC. Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer. Cochrane Database Syst Rev. 2017;11:CD004063. [PMID: 29182797 DOI: 10.1002/14651858.cd004063.pub4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
398 Kuo IY, Huang YL, Lin CY, Lin CH, Chang WL, Lai WW, Wang YC. SOX17 overexpression sensitizes chemoradiation response in esophageal cancer by transcriptional down-regulation of DNA repair and damage response genes. J Biomed Sci 2019;26:20. [PMID: 30777052 DOI: 10.1186/s12929-019-0510-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
399 Nagami Y, Ominami M, Sakai T, Maruyama H, Fukunaga S, Otani K, Hosomi S, Tanaka F, Kamata N, Taira K, Tanigawa T, Shiba M, Watanabe T, Fujiwara Y. Predictive factors for difficult endoscopic submucosal dissection for esophageal neoplasia including failure of en bloc resection or perforation. Surg Endosc 2021;35:3361-9. [PMID: 32638121 DOI: 10.1007/s00464-020-07777-0] [Reference Citation Analysis]
400 Konda VJ, Dalal K. Optimal management of Barrett's esophagus: pharmacologic, endoscopic, and surgical interventions. Ther Clin Risk Manag 2011;7:447-58. [PMID: 22162921 DOI: 10.2147/TCRM.S23425] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
401 Gao SG, Yang JQ, Ma ZK, Yuan X, Zhao C, Wang GC, Wei H, Feng XS, Qi YJ. Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma. BMC Cancer. 2018;18:17. [PMID: 29298684 DOI: 10.1186/s12885-017-3905-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
402 Lemke J, Scheele J, Kapapa T, von Karstedt S, Wirtz CR, Henne-Bruns D, Kornmann M. Brain metastases in gastrointestinal cancers: is there a role for surgery? Int J Mol Sci 2014;15:16816-30. [PMID: 25247579 DOI: 10.3390/ijms150916816] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
403 Ohashi S, Natsuizaka M, Naganuma S, Kagawa S, Kimura S, Itoh H, Kalman RA, Nakagawa M, Darling DS, Basu D, Gimotty PA, Klein-Szanto AJ, Diehl JA, Herlyn M, Nakagawa H. A NOTCH3-mediated squamous cell differentiation program limits expansion of EMT-competent cells that express the ZEB transcription factors. Cancer Res 2011;71:6836-47. [PMID: 21890822 DOI: 10.1158/0008-5472.CAN-11-0846] [Cited by in Crossref: 80] [Cited by in F6Publishing: 60] [Article Influence: 7.3] [Reference Citation Analysis]
404 Wang Bx, Yin BL, He B, Chen C, Zhao M, Zhang Wx, Xia ZK, Pan Yz, Tang Jq, Zhou Xm, Yin N. Overexpression of DNA damage-induced 45 α gene contributes to esophageal squamous cell cancer by promoter hypomethylation. J Exp Clin Cancer Res 2012;31:11. [PMID: 22313682 DOI: 10.1186/1756-9966-31-11] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
405 Liu Y, Xiong Z, Beasley A, D'Amico T, Chen XL. Personalized and targeted therapy of esophageal squamous cell carcinoma: an update. Ann N Y Acad Sci 2016;1381:66-73. [PMID: 27399176 DOI: 10.1111/nyas.13144] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
406 Kong J, Wang W. A Systemic Review on the Regulatory Roles of miR-34a in Gastrointestinal Cancer. Onco Targets Ther 2020;13:2855-72. [PMID: 32308419 DOI: 10.2147/OTT.S234549] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
407 Song Y, Wang X, Wang F, Peng X, Li P, Liu S, Zhang D. Identification of four genes and biological characteristics of esophageal squamous cell carcinoma by integrated bioinformatics analysis. Cancer Cell Int 2021;21:123. [PMID: 33602210 DOI: 10.1186/s12935-021-01814-1] [Reference Citation Analysis]
408 Chen X, Wang L, Wang W, Zhao L, Shan B. B7-H4 facilitates proliferation of esophageal squamous cell carcinoma cells through promoting interleukin-6/signal transducer and activator of transcription 3 pathway activation. Cancer Sci 2016;107:944-54. [PMID: 27088889 DOI: 10.1111/cas.12949] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
409 Giorgetti A, Pallabazzer G, Ripoli A, Solito B, Genovesi D, Lencioni M, Fabrini MG, D'Imporzano S, Pieraccini L, Marzullo P, Santi S. Prognostic Significance of 2-Deoxy-2-[18F]-Fluoro-D-Glucose PET/CT in Patients With Locally Advanced Esophageal Cancer Undergoing Neoadjuvant Chemoradiotherapy Before Surgery: A Nonparametric Approach. Medicine (Baltimore) 2016;95:e3151. [PMID: 27043676 DOI: 10.1097/MD.0000000000003151] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
410 Gao P, Yang X, Suo C, Yuan Z, Cheng H, Zhang Y, Jin L, Lu M, Chen X, Ye W. Socioeconomic status is inversely associated with esophageal squamous cell carcinoma risk: results from a population-based case-control study in China. Oncotarget 2018;9:6911-23. [PMID: 29467939 DOI: 10.18632/oncotarget.24003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
411 Jin ZY, Wallar G, Zhou JY, Yang J, Han RQ, Wang PH, Liu AM, Gu XP, Zhang XF, Wang XS, Su M, Hu X, Sun Z, Li G, Mu LN, Lu QY, Liu X, Li LM, He N, Wu M, Zhao JK, Zhang ZF. Consumption of garlic and its interactions with tobacco smoking and alcohol drinking on esophageal cancer in a Chinese population. Eur J Cancer Prev 2019;28:278-86. [PMID: 30001285 DOI: 10.1097/CEJ.0000000000000456] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
412 Wang F, Ding X, Wang T, Shan Z, Wang J, Wu S, Chi Y, Zhang Y, Lv Z, Wang L, Fan Q. Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin. PLoS One 2017;12:e0174276. [PMID: 28406985 DOI: 10.1371/journal.pone.0174276] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
413 Becskeházi E, Korsós MM, Erőss B, Hegyi P, Venglovecz V. OEsophageal Ion Transport Mechanisms and Significance Under Pathological Conditions. Front Physiol 2020;11:855. [PMID: 32765303 DOI: 10.3389/fphys.2020.00855] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
414 Tinusz B, Szapáry LB, Paládi B, Papp A, Bogner B, Hegedűs I, Bellyei S, Vincze Á, Solt J, Micsik T, Dunás-Varga V, Pályu E, Vass T, Schnabel T, Farkas N, Hegyi P, Thrift AP, Erőss B. The Esophageal Adenocarcinoma Epidemic Has Reached Hungary: A Multicenter, Cross-Sectional Study. Front Oncol 2020;10:541794. [PMID: 33425714 DOI: 10.3389/fonc.2020.541794] [Reference Citation Analysis]
415 Zhou ZQ, Cao WH, Xie JJ, Lin J, Shen ZY, Zhang QY, Shen JH, Xu LY, Li EM. Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma. BMC Cancer. 2009;9:291. [PMID: 19698122 DOI: 10.1186/1471-2407-9-291] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 4.5] [Reference Citation Analysis]
416 Gines A, Cassivi SD, Martenson JA Jr, Schleck C, Deschamps C, Sinicrope FA, Alberts SR, Murray JA, Zinsmeister AR, Vazquez-Sequeiros E, Nichols FC 3rd, Miller RC, Quevedo JF, Allen MS, Alexander JA, Zais T, Haddock MG, Romero Y. Impact of endoscopic ultrasonography and physician specialty on the management of patients with esophagus cancer. Dis Esophagus 2008;21:241-50. [PMID: 18430106 DOI: 10.1111/j.1442-2050.2007.00766.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
417 Yang PW, Hsieh MS, Chang YH, Huang PM, Lee JM. Genetic polymorphisms of ATG5 predict survival and recurrence in patients with early-stage esophageal squamous cell carcinoma. Oncotarget 2017;8:91494-504. [PMID: 29207660 DOI: 10.18632/oncotarget.20793] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
418 Fakhrjou A, Niroumand-Oscoei SM, Somi MH, Ghojazadeh M, Naghashi S, Samankan S. Prognostic value of tumor-infiltrating mast cells in outcome of patients with esophagus squamous cell carcinoma. J Gastrointest Cancer 2014;45:48-53. [PMID: 24091743 DOI: 10.1007/s12029-013-9550-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
419 Kikuchi H, Endo H, Yamamoto H, Ozawa S, Miyata H, Kakeji Y, Matsubara H, Doki Y, Kitagawa Y, Takeuchi H. Impact of Reconstruction Route on Postoperative Morbidity After Esophagectomy: Analysis of Esophagectomies in the Japanese National Clinical Database. Ann Gastroenterol Surg. [DOI: 10.1002/ags3.12501] [Reference Citation Analysis]
420 Lin MY, Chen MC, Wu IC, Wu DC, Cheng YJ, Wu CC, Chai CY, Lee JM, Wu MT. Areca users in combination with tobacco and alcohol use are associated with younger age of diagnosed esophageal cancer in Taiwanese men. PLoS One 2011;6:e25347. [PMID: 22039411 DOI: 10.1371/journal.pone.0025347] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
421 Yin MP, Xie PF, Zhao Y, He W, Ma YZ, Li CX, Li Z, Zeng YW, Wu G. Clinical Evaluation of Transarterial Infusion Chemotherapy for Advanced Esophageal Cancer. J Cancer 2021;12:1493-8. [PMID: 33531994 DOI: 10.7150/jca.46877] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
422 Fu Y, Deng M, Zhou X, Lin Q, Du B, Tian X, Xu Y, Wang J, Lu Y, Gong Y. Dosimetric effect of beam arrangement for intensity-modulated radiation therapy in the treatment of upper thoracic esophageal carcinoma. Med Dosim 2017;42:47-52. [PMID: 28126472 DOI: 10.1016/j.meddos.2016.11.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
423 Talreja JP, Eloubeidi MA, Sauer BG, Al-Awabdy BS, Lopes T, Kahaleh M, Shami VM. Fully covered removable nitinol self-expandable metal stents (SEMS) in malignant strictures of the esophagus: a multicenter analysis. Surg Endosc. 2012;26:1664-1669. [PMID: 22179474 DOI: 10.1007/s00464-011-2089-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
424 Arnold M, Colquhoun A, Cook MB, Ferlay J, Forman D, Soerjomataram I. Obesity and the Incidence of Upper Gastrointestinal Cancers: An Ecological Approach to Examine Differences across Age and Sex. Cancer Epidemiol Biomarkers Prev 2016;25:90-7. [PMID: 26494763 DOI: 10.1158/1055-9965.EPI-15-0753] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
425 Katano A, Yamashita H, Okuma K, Nakagawa K. Complete response to abdominal bulky lymph node recurrence in an esophageal cancer patient treated with S-1 monotherapy: A case report. Oncol Lett 2016;11:3901-3. [PMID: 27313714 DOI: 10.3892/ol.2016.4462] [Reference Citation Analysis]
426 Dong J, Zeng BH, Xu LH, Wang JY, Li MZ, Zeng MS, Liu WL. Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma. J Transl Med. 2010;8:81. [PMID: 20813067 DOI: 10.1186/1479-5876-8-81] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
427 Tang YL, Zhang XM, Yang ZG, Huang YC, Chen TW, Chen YL, Chen F, Zeng NL, Li R, Hu J. The Blood Oxygenation T2* Values of Resectable Esophageal Squamous Cell Carcinomas as Measured by 3T Magnetic Resonance Imaging: Association with Tumor Stage. Korean J Radiol 2017;18:674-81. [PMID: 28670162 DOI: 10.3348/kjr.2017.18.4.674] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
428 Dragovich T, Campen C. Anti-EGFR-Targeted Therapy for Esophageal and Gastric Cancers: An Evolving Concept. J Oncol. 2009;2009:804108. [PMID: 19636422 DOI: 10.1155/2009/804108] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
429 Gao X, Xie Z, Wang Z, Cheng K, Liang K, Song Z. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma. Yonsei Med J 2017;58:1101-10. [PMID: 29047233 DOI: 10.3349/ymj.2017.58.6.1101] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
430 Wang W, Shen L, Sun Y, Dong B, Chen K. Role of E2F-1 and its involving pathway in esophageal squamous cell carcinoma. Thorac Cancer 2014;5:139-48. [PMID: 26766991 DOI: 10.1111/1759-7714.12061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
431 Nautiyal J, Kanwar SS, Majumdar AP. EGFR(s) in aging and carcinogenesis of the gastrointestinal tract. Curr Protein Pept Sci 2010;11:436-50. [PMID: 20491625 DOI: 10.2174/138920310791824110] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
432 Asanuma K, Iijima K, Shimosegawa T. Gender difference in gastro-esophageal reflux diseases. World J Gastroenterol 2016; 22(5): 1800-1810 [PMID: 26855539 DOI: 10.3748/wjg.v22.i5.1800] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
433 de Nucci G, Petrone MC, Imperatore N, Asti E, Rossi G, Manes G, Vecchi M, Pastorelli L, Bonavina L, Arcidiacono PG. Staging esophageal cancer: low EUS accuracy in t2n0 patients. Endosc Int Open 2021;9:E313-8. [PMID: 33655027 DOI: 10.1055/a-1336-2505] [Reference Citation Analysis]
434 Gao S, Liu Y, Duan X, Liu K, Mohammed M, Gu Z, Ren J, Yakoumatos L, Yuan X, Lu L, Liang S, Li J, Scott DA, Lamont RJ, Zhou F, Wang H. Porphyromonas gingivalis infection exacerbates oesophageal cancer and promotes resistance to neoadjuvant chemotherapy. Br J Cancer 2021;125:433-44. [PMID: 33981017 DOI: 10.1038/s41416-021-01419-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
435 Pan F, Mao H, Bu F, Tong X, Li J, Zhang S, Liu X, Wang L, Wu L, Chen R, Wei H, Li B, Li C, Yang Y, Steer CJ, Zhao J, Guo Y. Sp1-mediated transcriptional activation of miR-205 promotes radioresistance in esophageal squamous cell carcinoma. Oncotarget 2017;8:5735-52. [PMID: 27974696 DOI: 10.18632/oncotarget.13902] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 8.5] [Reference Citation Analysis]
436 Basu S. Personalized versus evidence-based medicine with PET-based imaging. Nat Rev Clin Oncol 2010;7:665-8. [PMID: 20700107 DOI: 10.1038/nrclinonc.2010.121] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
437 Harada K, Baba Y, Ishimoto T, Shigaki H, Kosumi K, Yoshida N, Watanabe M, Baba H. The role of microRNA in esophageal squamous cell carcinoma. J Gastroenterol. 2016;51:520-530. [PMID: 26794004 DOI: 10.1007/s00535-016-1161-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 5.8] [Reference Citation Analysis]
438 Butt J, Kandel G. Barrett esophagus: when to endoscope. Clin Endosc 2014;47:40-6. [PMID: 24570882 DOI: 10.5946/ce.2014.47.1.40] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
439 Yu T, Geng J, Song W, Jiang Z. Diagnostic Accuracy of Magnifying Endoscopy with Narrow Band Imaging and Its Diagnostic Value for Invasion Depth Staging in Esophageal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. Biomed Res Int 2018;2018:8591387. [PMID: 29888281 DOI: 10.1155/2018/8591387] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
440 Feng H, Song G, Ma S, Ma Q, Li X, Wei W, Abnet C, Qiao Y, Wang G. The optimal starting age of endoscopic screening for esophageal squamous cell cancer in high prevalence areas in China. J Gastroenterol Hepatol 2020;35:1761-8. [PMID: 32367575 DOI: 10.1111/jgh.15090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
441 Liu Q, Zhou YX, Hui-Wang, Li QX, Wu M, Ma YQ. The Silencing of SFRP2 Expression in ESCC Is Due to Methylation of the Gene Promoter. Technol Cancer Res Treat 2019;18:1533033819877977. [PMID: 31578133 DOI: 10.1177/1533033819877977] [Reference Citation Analysis]
442 Cash JC, Zehetner J, Hedayati B, Bildzukewicz NA, Katkhouda N, Mason RJ, Lipham JC. Outcomes following laparoscopic transhiatal esophagectomy for esophageal cancer. Surg Endosc. 2014;28:492-499. [PMID: 24100862 DOI: 10.1007/s00464-013-3230-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
443 Kersting S, Konopke R, Dittert D, Distler M, Rückert F, Gastmeier J, Baretton GB, Saeger HD. Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma? J Gastroenterol Hepatol 2009;24:886-95. [PMID: 19655439 DOI: 10.1111/j.1440-1746.2008.05732.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
444 Erhunmwunsee L, Englum BR, Onaitis MW, D'Amico TA, Berry MF. Impact of pretreatment imaging on survival of esophagectomy after induction therapy for esophageal cancer: who should be given the benefit of the doubt?: esophagectomy outcomes of patients with suspicious metastatic lesions. Ann Surg Oncol. 2015;22:1020-1025. [PMID: 25234017 DOI: 10.1245/s10434-014-4079-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
445 Shang L, Wang M. Molecular alterations and clinical relevance in esophageal squamous cell carcinoma. Front Med. 2013;7:401-410. [PMID: 24002746 DOI: 10.1007/s11684-013-0286-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
446 Scarpa M, Cavallin F, Noaro G, Pinto E, Alfieri R, Cagol M, Castoro C. Impact of jejunostomy during esophagectomy for cancer on health related quality of life. Chin J Cancer Res 2014;26:678-84. [PMID: 25561765 DOI: 10.3978/j.issn.1000-9604.2014.12.16] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
447 Shen Y, Wang Q, Tian Y. Reversal effect of ouabain on multidrug resistance in esophageal carcinoma EC109/CDDP cells by inhibiting the translocation of Wnt/β-catenin into the nucleus. Tumour Biol 2016. [PMID: 27709549 DOI: 10.1007/s13277-016-5437-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
448 Allaix ME, Herbella FA, Patti MG. Hybrid trans-thoracic esophagectomy with side-to-side stapled intra-thoracic esophagogastric anastomosis for esophageal cancer. J Gastrointest Surg 2013;17:1972-9. [PMID: 23835733 DOI: 10.1007/s11605-013-2281-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
449 Hsu PK, Chien LI, Huang CS, Hsieh CC, Wu YC, Hsu WH, Chou TY. Comparison of survival among neoadjuvant chemoradiation responders, non-responders and patients receiving primary resection for locally advanced oesophageal squamous cell carcinoma: does neoadjuvant chemoradiation benefit all? Interact Cardiovasc Thorac Surg. 2013;17:460-466. [PMID: 23728085 DOI: 10.1093/icvts/ivt216] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
450 Ahmadi N, Crnic A, Seely AJ, Sundaresan SR, Villeneuve PJ, Maziak DE, Shamji FM, Gilbert S. Impact of surgical approach on perioperative and long-term outcomes following esophagectomy for esophageal cancer. Surg Endosc 2018;32:1892-900. [PMID: 29067584 DOI: 10.1007/s00464-017-5881-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
451 Wang W, Chen Y, Zhang X, Xi K, Feng X, Zhang L. A Model Shows Utility in Predicting Postoperative Recurrence and Distant Metastasis in Curatively Resected Esophageal Squamous Cell Cancer. Cancer Control 2019;26:1073274819852965. [PMID: 31146546 DOI: 10.1177/1073274819852965] [Reference Citation Analysis]
452 Wu N, Song Y, Pang L, Chen Z. CRCT1 regulated by microRNA-520 g inhibits proliferation and induces apoptosis in esophageal squamous cell cancer. Tumour Biol 2016;37:8271-9. [PMID: 26718216 DOI: 10.1007/s13277-015-4730-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
453 Aziz M, Fatima R. Future of diagnosing neoplasia in Barrett's esophagus: volumetric laser endomicroscopy. Clin J Gastroenterol 2018;11:179-83. [PMID: 29680981 DOI: 10.1007/s12328-018-0863-3] [Reference Citation Analysis]
454 Reisinger KW, Bosmans JW, Uittenbogaart M, Alsoumali A, Poeze M, Sosef MN, Derikx JP. Loss of Skeletal Muscle Mass During Neoadjuvant Chemoradiotherapy Predicts Postoperative Mortality in Esophageal Cancer Surgery. Ann Surg Oncol 2015;22:4445-52. [PMID: 25893413 DOI: 10.1245/s10434-015-4558-4] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 11.1] [Reference Citation Analysis]
455 Liu T, Liu Q, Zheng S, Gao X, Lu M, Yang C, Dai F, Sheyhidin I, Lu X. MicroRNA-21 promotes cell growth and migration by targeting programmed cell death 4 gene in Kazakh's esophageal squamous cell carcinoma. Dis Markers. 2014;2014:232837. [PMID: 25400316 DOI: 10.1155/2014/232837] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
456 Marabotto E, Pellegatta G, Sheijani AD, Ziola S, Zentilin P, De Marzo MG, Giannini EG, Ghisa M, Barberio B, Scarpa M, Angriman I, Fassan M, Savarino V, Savarino E. Prevention Strategies for Esophageal Cancer-An Expert Review. Cancers (Basel) 2021;13:2183. [PMID: 34062788 DOI: 10.3390/cancers13092183] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
457 Yu T, Cao R, Li S, Fu M, Ren L, Chen W, Zhu H, Zhan Q, Shi R. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells. BMC Cancer. 2015;15:29. [PMID: 25637514 DOI: 10.1186/s12885-015-1031-5] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 8.1] [Reference Citation Analysis]
458 Li CQ, Huang GW, Wu ZY, Xu YJ, Li XC, Xue YJ, Zhu Y, Zhao JM, Li M, Zhang J, Wu JY, Lei F, Wang QY, Li S, Zheng CP, Ai B, Tang ZD, Feng CC, Liao LD, Wang SH, Shen JH, Liu YJ, Bai XF, He JZ, Cao HH, Wu BL, Wang MR, Lin DC, Koeffler HP, Wang LD, Li X, Li EM, Xu LY. Integrative analyses of transcriptome sequencing identify novel functional lncRNAs in esophageal squamous cell carcinoma. Oncogenesis 2017;6:e297. [PMID: 28194033 DOI: 10.1038/oncsis.2017.1] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 9.4] [Reference Citation Analysis]
459 Wang S, Li Y, Liu XD, Zhao CX, Yang KQ. Polymorphism of A118G in μ-opioid receptor gene is associated with risk of esophageal squamous cell carcinoma in a Chinese population. Int J Clin Oncol 2013;18:666-9. [PMID: 22752309 DOI: 10.1007/s10147-012-0441-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
460 Moelans CB, van Diest PJ, Milne AN, Offerhaus GJ. Her-2/neu testing and therapy in gastroesophageal adenocarcinoma. Patholog Res Int 2010;2011:674182. [PMID: 21188213 DOI: 10.4061/2011/674182] [Cited by in Crossref: 8] [Cited by in F6Publishing: 25] [Article Influence: 0.7] [Reference Citation Analysis]
461 Tsujimoto H, Ichikura T, Aiko S, Yaguchi Y, Kumano I, Takahata R, Matsumoto Y, Yoshida K, Ono S, Yamamoto J, Hase K. Multidetector-computed tomography attenuation values between the tumor and aortic wall in response to induction therapy for esophageal cancer and its predictive value for aortic invasion. Exp Ther Med 2012;3:243-8. [PMID: 22969876 DOI: 10.3892/etm.2011.386] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
462 Liu YP, Zheng CC, Huang YN, He ML, Xu WW, Li B. Molecular mechanisms of chemo- and radiotherapy resistance and the potential implications for cancer treatment. MedComm (2020) 2021;2:315-40. [PMID: 34766149 DOI: 10.1002/mco2.55] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
463 Arnold M, Laversanne M, Brown LM, Devesa SS, Bray F. Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030. Am J Gastroenterol. 2017;112:1247-1255. [PMID: 28585555 DOI: 10.1038/ajg.2017.155] [Cited by in Crossref: 141] [Cited by in F6Publishing: 118] [Article Influence: 28.2] [Reference Citation Analysis]
464 Kagawa S, Natsuizaka M, Whelan KA, Facompre N, Naganuma S, Ohashi S, Kinugasa H, Egloff AM, Basu D, Gimotty PA, Klein-Szanto AJ, Bass AJ, Wong KK, Diehl JA, Rustgi AK, Nakagawa H. Cellular senescence checkpoint function determines differential Notch1-dependent oncogenic and tumor-suppressor activities. Oncogene 2015;34:2347-59. [PMID: 24931169 DOI: 10.1038/onc.2014.169] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 5.3] [Reference Citation Analysis]
465 Yu X, Wen Y, Lin Y, Zhang X, Chen Y, Wang W, Wang G, Zhang L. The value of preoperative Glasgow Prognostic Score and the C-Reactive Protein to Albumin Ratio as prognostic factors for long-term survival in pathological T1N0 esophageal squamous cell carcinoma. J Cancer 2018;9:807-15. [PMID: 29581759 DOI: 10.7150/jca.22755] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
466 van Rossum PS, van Hillegersberg R, Lever FM, Lips IM, van Lier AL, Meijer GJ, van Leeuwen MS, van Vulpen M, Ruurda JP. Imaging strategies in the management of oesophageal cancer: what's the role of MRI? Eur Radiol. 2013;23:1753-1765. [PMID: 23404138 DOI: 10.1007/s00330-013-2773-6] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 5.4] [Reference Citation Analysis]
467 Du F, Dong D, Zhang X, Jia J. MXD1 is a Potential Prognostic Biomarker and Correlated With Specific Molecular Change and Tumor Microenvironment Feature in Esophageal Squamous Cell Carcinoma. Technol Cancer Res Treat 2021;20:15330338211052142. [PMID: 34761715 DOI: 10.1177/15330338211052142] [Reference Citation Analysis]
468 Walter F, Böckle D, Schmidt-Hegemann NS, Köpple R, Gerum S, Boeck S, Angele M, Belka C, Roeder F. Clinical outcome of elderly patients (≥ 70 years) with esophageal cancer undergoing definitive or neoadjuvant radio(chemo)therapy: a retrospective single center analysis. Radiat Oncol 2018;13:93. [PMID: 29769143 DOI: 10.1186/s13014-018-1044-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
469 Wang L, Han H, Wang Z, Shi L, Yang M, Qin Y. Targeting the Microenvironment in Esophageal Cancer. Front Cell Dev Biol 2021;9:684966. [PMID: 34513829 DOI: 10.3389/fcell.2021.684966] [Reference Citation Analysis]
470 Xu H, Yao Y, Meng F, Qian X, Jiang X, Li X, Gao Z, Gao L. Predictive Value of Serum miR-10b, miR-29c, and miR-205 as Promising Biomarkers in Esophageal Squamous Cell Carcinoma Screening. Medicine (Baltimore) 2015;94:e1558. [PMID: 26554762 DOI: 10.1097/MD.0000000000001558] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
471 Saeed NA, Mellon EA, Meredith KL, Hoffe SE, Shridhar R, Frakes J, Fontaine JP, Pimiento JM, Kothari N, Almhanna K. Adjuvant chemotherapy and outcomes in esophageal carcinoma. J Gastrointest Oncol 2017;8:816-24. [PMID: 29184685 DOI: 10.21037/jgo.2017.07.10] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
472 Liu X, Wang Z, Zhang G, Zhu Q, Zeng H, Wang T, Gao F, Qi Z, Zhang J, Wang R. High TRAF6 Expression Is Associated With Esophageal Carcinoma Recurrence and Prompts Cancer Cell Invasion. Oncol Res 2017;25:485-93. [PMID: 27697099 DOI: 10.3727/096504016X14749340314441] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
473 Villaflor VM, Allaix ME, Minsky B, Herbella FA, Patti MG. Multidisciplinary approach for patients with esophageal cancer. World J Gastroenterol 2012; 18(46): 6737-6746 [PMID: 23239911 DOI: 10.3748/wjg.v18.i46.6737] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
474 Wong GS, Lee JS, Park YY, Klein-Szanto AJ, Waldron TJ, Cukierman E, Herlyn M, Gimotty P, Nakagawa H, Rustgi AK. Periostin cooperates with mutant p53 to mediate invasion through the induction of STAT1 signaling in the esophageal tumor microenvironment. Oncogenesis 2013;2:e59. [PMID: 23917221 DOI: 10.1038/oncsis.2013.17] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
475 Wang G, Tang J, Zhan W, Zhang R, Zhang M, Liao D, Wang X, Wu Y, Kang T. CBX8 Suppresses Tumor Metastasis via Repressing Snail in Esophageal Squamous Cell Carcinoma. Theranostics 2017;7:3478-88. [PMID: 28912889 DOI: 10.7150/thno.20717] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
476 Wang ZQ, Chen LQ, Yuan Y, Wang WP, Niu ZX, Yang YS, Cai J. Effects of neutrophil elastase inhibitor in patients undergoing esophagectomy: A systematic review and meta-analysis. World J Gastroenterol 2015; 21(12): 3720-3730 [PMID: 25834341 DOI: 10.3748/wjg.v21.i12.3720] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
477 Baba Y, Watanabe M, Yoshida N, Baba H. Neoadjuvant treatment for esophageal squamous cell carcinoma. World J Gastrointest Oncol 2014; 6(5): 121-128 [PMID: 24834142 DOI: 10.4251/wjgo.v6.i5.121] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
478 Hassan MS, Awasthi N, Li J, Williams F, Schwarz MA, Schwarz RE, von Holzen U. Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal Adenocarcinoma. Transl Oncol 2018;11:426-35. [PMID: 29475139 DOI: 10.1016/j.tranon.2018.01.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
479 Xie Q, Ratnasinghe LD, Hong H, Perkins R, Tang ZZ, Hu N, Taylor PR, Tong W. Decision forest analysis of 61 single nucleotide polymorphisms in a case-control study of esophageal cancer; a novel method. BMC Bioinformatics 2005;6 Suppl 2:S4. [PMID: 16026601 DOI: 10.1186/1471-2105-6-S2-S4] [Cited by in Crossref: 40] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
480 Chen CH, Ferreira JC, Gross ER, Mochly-Rosen D. Targeting aldehyde dehydrogenase 2: new therapeutic opportunities. Physiol Rev. 2014;94:1-34. [PMID: 24382882 DOI: 10.1152/physrev.00017.2013] [Cited by in Crossref: 279] [Cited by in F6Publishing: 250] [Article Influence: 34.9] [Reference Citation Analysis]
481 Hassan MS, Williams F, Awasthi N, Schwarz MA, Schwarz RE, Li J, von Holzen U. Combination effect of lapatinib with foretinib in HER2 and MET co-activated experimental esophageal adenocarcinoma. Sci Rep 2019;9:17608. [PMID: 31772236 DOI: 10.1038/s41598-019-54129-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
482 Chu LY, Peng YH, Weng XF, Xie JJ, Xu YW. Blood-based biomarkers for early detection of esophageal squamous cell carcinoma. World J Gastroenterol 2020; 26(15): 1708-1725 [PMID: 32351288 DOI: 10.3748/wjg.v26.i15.1708] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
483 Theilen TM, Chou AJ, Klimstra DS, LaQuaglia MP. Esophageal Adenocarcinoma and Squamous Cell Carcinoma in Children and Adolescents: Report of 3 Cases and Comprehensive Literature Review. J Pediatr Surg Case Rep 2016;5:23-9. [PMID: 27057484 DOI: 10.1016/j.epsc.2015.12.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
484 Chen X, Niu YW, Wang GH, Yan GY. MKRMDA: multiple kernel learning-based Kronecker regularized least squares for MiRNA-disease association prediction. J Transl Med 2017;15:251. [PMID: 29233191 DOI: 10.1186/s12967-017-1340-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
485 Zhen C, Huang J, Lu J. MicroRNA-652 inhibits the biological characteristics of esophageal squamous cell carcinoma by directly targeting fibroblast growth factor receptor 1. Exp Ther Med 2019;18:4473-80. [PMID: 31777550 DOI: 10.3892/etm.2019.8072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
486 Qi YJ, Wang M, Liu RM, Wei H, Chao WX, Zhang T, Lou Q, Li XM, Ma J, Zhu H, Yang ZH, Liu HQ, Ma YF. Downregulation of 14-3-3σ correlates with multistage carcinogenesis and poor prognosis of esophageal squamous cell carcinoma. PLoS One 2014;9:e95386. [PMID: 24743601 DOI: 10.1371/journal.pone.0095386] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
487 Lynam-Lennon N, Connaughton R, Carr E, Mongan AM, O'Farrell NJ, Porter RK, Brennan L, Pidgeon GP, Lysaght J, Reynolds JV, O'Sullivan J. Excess visceral adiposity induces alterations in mitochondrial function and energy metabolism in esophageal adenocarcinoma. BMC Cancer 2014;14:907. [PMID: 25471892 DOI: 10.1186/1471-2407-14-907] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
488 Shang X, Liu G, Zhang Y, Tang P, Zhang H, Jiang H, Yu Z. Downregulation of BIRC5 inhibits the migration and invasion of esophageal cancer cells by interacting with the PI3K/Akt signaling pathway. Oncol Lett 2018;16:3373-9. [PMID: 30127937 DOI: 10.3892/ol.2018.8986] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
489 Su C, Chen Z, Luo H, Su Y, Liu W, Cai L, Wang T, Lei Y, Zhong B. Different patterns of NF-κB and Notch1 signaling contribute to tumor-induced lymphangiogenesis of esophageal squamous cell carcinoma. J Exp Clin Cancer Res. 2011;30:85. [PMID: 21939555 DOI: 10.1186/1756-9966-30-85] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
490 Zhou K, Yan Y, Zhao S. Esophageal cancer-selective expression of TRAIL mediated by MREs of miR-143 and miR-122. Tumour Biol 2014;35:5787-95. [PMID: 24659424 DOI: 10.1007/s13277-014-1768-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
491 Adachi Y, Ohashi H, Imsumran A, Yamamoto H, Matsunaga Y, Taniguchi H, Nosho K, Suzuki H, Sasaki Y, Arimura Y. The effect of IGF-I receptor blockade for human esophageal squamous cell carcinoma and adenocarcinoma. Tumour Biol. 2014;35:973-985. [PMID: 24026884 DOI: 10.1007/s13277-013-1131-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
492 Yoon HH, Khan M, Shi Q, Cassivi SD, Wu TT, Quevedo JF, Burch PA, Sinicrope FA, Diasio RB. The prognostic value of clinical and pathologic factors in esophageal adenocarcinoma: a mayo cohort of 796 patients with extended follow-up after surgical resection. Mayo Clin Proc. 2010;85:1080-1089. [PMID: 21123634 DOI: 10.4065/mcp.2010.0421] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
493 Li K, Lin Y, Luo Y, Xiong X, Wang L, Durante K, Li J, Zhou F, Guo Y, Chen S, Chen Y, Zhang D, Yeung SJ, Zhang H. A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study. Mol Cancer 2022;21:21. [PMID: 35042519 DOI: 10.1186/s12943-022-01499-8] [Reference Citation Analysis]
494 Chen Z, Che D, Gu X, Lin J, Deng J, Jiang P, Xu K, Xu B, Zhang T. Upregulation of PEDF Predicts a Poor Prognosis and Promotes Esophageal Squamous Cell Carcinoma Progression by Modulating the MAPK/ERK Signaling Pathway. Front Oncol 2021;11:625612. [PMID: 33718190 DOI: 10.3389/fonc.2021.625612] [Reference Citation Analysis]
495 Melis M, Weber JM, McLoughlin JM, Siegel EM, Hoffe S, Shridhar R, Turaga KK, Dittrick G, Dean EM, Karl RC, Meredith KL. An elevated body mass index does not reduce survival after esophagectomy for cancer. Ann Surg Oncol 2011;18:824-31. [PMID: 20865331 DOI: 10.1245/s10434-010-1336-1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
496 Ren Z, Hou X, Xue Z, Zhang L, Wang B, Wen J, Chu X. The relationship between the number of circulating tumor cells and the prognosis in patients with esophageal squamous cell carcinoma. J Gastrointest Oncol 2021;12:1265-76. [PMID: 34532086 DOI: 10.21037/jgo-21-409] [Reference Citation Analysis]
497 Morikawa S, Suzuki A, Nakase K, Yasuda K. Palliation of malignant upper gastrointestinal obstruction with self-expandable metal stent. Korean J Radiol 2012;13 Suppl 1:S98-103. [PMID: 22563294 DOI: 10.3348/kjr.2012.13.S1.S98] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
498 Ling ZQ, Li P, Ge MH, Hu FJ, Fang XH, Dong ZM, Mao WM. Aberrant methylation of different DNA repair genes demonstrates distinct prognostic value for esophageal cancer. Dig Dis Sci. 2011;56:2992-3004. [PMID: 21674174 DOI: 10.1007/s10620-011-1774-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
499 Xu YJ, Cheng JC, Lee JM, Huang PM, Huang GH, Chen CC. A Walk-and-Eat Intervention Improves Outcomes for Patients With Esophageal Cancer Undergoing Neoadjuvant Chemoradiotherapy. Oncologist 2015;20:1216-22. [PMID: 26341759 DOI: 10.1634/theoncologist.2015-0178] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 4.7] [Reference Citation Analysis]
500 Agrawal N, Jiao Y, Bettegowda C, Hutfless SM, Wang Y, David S, Cheng Y, Twaddell WS, Latt NL, Shin EJ. Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma. Cancer Discov. 2012;2:899-905. [PMID: 22877736 DOI: 10.1158/2159-8290.cd-12-0189] [Cited by in Crossref: 245] [Cited by in F6Publishing: 166] [Article Influence: 24.5] [Reference Citation Analysis]
501 Scarpa M, Saadeh LM, Fasolo A, Alfieri R, Cagol M, Cavallin F, Pinto E, Zaninotto G, Ancona E, Castoro C. Health-related quality of life in patients with oesophageal cancer: analysis at different steps of the treatment pathway. J Gastrointest Surg 2013;17:421-33. [PMID: 23297025 DOI: 10.1007/s11605-012-2069-1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]
502 Kirkeleit J, Riise T, Bjørge T, Moen BE, Bråtveit M, Christiani DC. Increased risk of oesophageal adenocarcinoma among upstream petroleum workers. Occup Environ Med 2010;67:335-40. [PMID: 19858535 DOI: 10.1136/oem.2009.046953] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
503 Zhu C, Xia Q, Gu B, Cui M, Zhang X, Yan W, Meng D, Shen S, Xie S, Li X, Jin H, Wang S. Esophageal Cancer Associated Immune Genes as Biomarkers for Predicting Outcome in Upper Gastrointestinal Tumors. Front Genet 2021;12:707299. [PMID: 34349789 DOI: 10.3389/fgene.2021.707299] [Reference Citation Analysis]
504 López Sala P, Alberdi Aldasoro N, Fuertes Fernández I, Sáenz Bañuelos J. An updated review of the TNM classification system for cancer of the oesophagus and its complications. Radiologia (Engl Ed) 2021;63:445-55. [PMID: 34625200 DOI: 10.1016/j.rxeng.2020.09.004] [Reference Citation Analysis]
505 Tomochika S, Iizuka N, Watanabe Y, Tsutsui M, Takeda S, Yoshino S, Ichihara K, Oka M. Increased serum cell-free DNA levels in relation to inflammation are predictive of distant metastasis of esophageal squamous cell carcinoma. Exp Ther Med 2010;1:89-92. [PMID: 23136599 DOI: 10.3892/etm_00000016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
506 Ganesamoni S, Krishnamurthy A. Three-field transthoracic versus transhiatal esophagectomy in the management of carcinoma esophagus-a single--center experience with a review of literature. J Gastrointest Cancer 2014;45:66-73. [PMID: 24272910 DOI: 10.1007/s12029-013-9562-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
507 Essakly A, Loeser H, Kraemer M, Alakus H, Chon SH, Zander T, Buettner R, Hillmer AM, Bruns CJ, Schroeder W, Gebauer F, Quaas A. PIK3CA and KRAS Amplification in Esophageal Adenocarcinoma and their Impact on the Inflammatory Tumor Microenvironment and Prognosis. Transl Oncol 2020;13:157-64. [PMID: 31865178 DOI: 10.1016/j.tranon.2019.10.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
508 Kiu AK, Lord AN, Trochsler MI, Maddern GJ, Kanhere HA. Isolated non-hepatic metastasis from upper gastrointestinal adenocarcinoma: A case for surgical resection. Int J Surg Case Rep 2014;5:307-10. [PMID: 24794022 DOI: 10.1016/j.ijscr.2014.04.004] [Reference Citation Analysis]
509 Zhang Y. Epidemiology of esophageal cancer. World J Gastroenterol 2013; 19(34): 5598-5606 [PMID: 24039351 DOI: 10.3748/wjg.v19.i34.5598] [Cited by in CrossRef: 533] [Cited by in F6Publishing: 521] [Article Influence: 59.2] [Reference Citation Analysis]
510 Guan S, Liu B, Zhang C, Lee KH, Sun S, Wei J. Circulating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma. Clin Transl Oncol. 2013;15:825-829. [PMID: 23423807 DOI: 10.1007/s12094-013-1007-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
511 Zhang F, Qu J, Zhang H, Liu H, Qin J, Ding Z, Li Y, Ma J, Zhang Z, Wang Z, Zhang J, Zhang S, Dong Y, Grimm R, Kamel IR, Li H. Preoperative T Staging of Potentially Resectable Esophageal Cancer: A Comparison between Free-Breathing Radial VIBE and Breath-Hold Cartesian VIBE, with Histopathological Correlation. Transl Oncol 2017;10:324-31. [PMID: 28327459 DOI: 10.1016/j.tranon.2017.02.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
512 Stoecklein NH, Siegmund A, Scheunemann P, Luebke AM, Erbersdobler A, Verde PE, Eisenberger CF, Peiper M, Rehders A, Esch JS, Knoefel WT, Hosch SB. Ep-CAM expression in squamous cell carcinoma of the esophagus: a potential therapeutic target and prognostic marker. BMC Cancer 2006;6:165. [PMID: 16796747 DOI: 10.1186/1471-2407-6-165] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 4.2] [Reference Citation Analysis]
513 Zhang SS, Xie X, Wen J, Luo KJ, Liu QW, Yang H, Hu Y, Fu JH. TRPV6 plays a new role in predicting survival of patients with esophageal squamous cell carcinoma. Diagn Pathol 2016;11:14. [PMID: 26818094 DOI: 10.1186/s13000-016-0457-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
514 Mao Y, Li L, Liu J, Wang L, Zhou Y. MiR-495 inhibits esophageal squamous cell carcinoma progression by targeting Akt1. Oncotarget 2016;7:51223-36. [PMID: 27323412 DOI: 10.18632/oncotarget.9981] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
515 Qi J, Li H, Liu N, Xing Y, Zhou G, Wu Y, Liu Y, Chen W, Yue J, Han B, Kang S, Wu X. The implications and mechanisms of the extra-nuclear nucleolin in the esophageal squamous cell carcinomas. Med Oncol 2015;32:45. [PMID: 25631630 DOI: 10.1007/s12032-015-0484-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
516 Tan HZ, Wu ZY, Wu JY, Long L, Jiao JW, Peng YH, Xu YW, Li SS, Wang W, Zhang JJ, Li EM, Xu LY. Single nucleotide polymorphism rs13042395 in the SLC52A3 gene as a biomarker for regional lymph node metastasis and relapse-free survival of esophageal squamous cell carcinoma patients. BMC Cancer 2016;16:560. [PMID: 27472962 DOI: 10.1186/s12885-016-2588-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
517 Doucet-O'Hare TT, Sharma R, Rodić N, Anders RA, Burns KH, Kazazian HH Jr. Somatically Acquired LINE-1 Insertions in Normal Esophagus Undergo Clonal Expansion in Esophageal Squamous Cell Carcinoma. Hum Mutat 2016;37:942-54. [PMID: 27319353 DOI: 10.1002/humu.23027] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 5.7] [Reference Citation Analysis]
518 Sato S, Kunisaki C, Suematsu H, Tanaka Y, Miyamoto H, Kosaka T, Yukawa N, Tanaka K, Sato K, Akiyama H, Endo I. Impact of Sarcopenia in Patients with Unresectable Locally Advanced Esophageal Cancer Receiving Chemoradiotherapy. In Vivo 2018;32:603-10. [PMID: 29695567 DOI: 10.21873/invivo.11282] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
519 Oh TK, Kim K, Jheon SH, Do SH, Hwang JW, Jeon YT, Kim K, Song IA. Long-Term Oncologic Outcomes, Opioid Use, and Complications after Esophageal Cancer Surgery. J Clin Med 2018;7:E33. [PMID: 29463006 DOI: 10.3390/jcm7020033] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
520 Zamani SA, McClain KM, Graubard BI, Liao LM, Abnet CC, Cook MB, Petrick JL. Dietary Polyunsaturated Fat Intake in Relation to Head and Neck, Esophageal, and Gastric Cancer Incidence in the National Institutes of Health-AARP Diet and Health Study. Am J Epidemiol 2020;189:1096-113. [PMID: 32141493 DOI: 10.1093/aje/kwaa024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
521 Choi YJ, Lee DH, Han KD, Yoon H, Shin CM, Park YS, Kim N. Elevated serum gamma-glutamyltransferase is associated with an increased risk of oesophageal carcinoma in a cohort of 8,388,256 Korean subjects. PLoS One. 2017;12:e0177053. [PMID: 28475598 DOI: 10.1371/journal.pone.0177053] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
522 Kim SM, Park YY, Park ES, Cho JY, Izzo JG, Zhang D, Kim SB, Lee JH, Bhutani MS, Swisher SG, Wu X, Coombes KR, Maru D, Wang KK, Buttar NS, Ajani JA, Lee JS. Prognostic biomarkers for esophageal adenocarcinoma identified by analysis of tumor transcriptome. PLoS One. 2010;5:e15074. [PMID: 21152079 DOI: 10.1371/journal.pone.0015074] [Cited by in Crossref: 93] [Cited by in F6Publishing: 88] [Article Influence: 7.8] [Reference Citation Analysis]
523 Hsieh MS, Yang PW, Wong LF, Lee JM. The AXL receptor tyrosine kinase is associated with adverse prognosis and distant metastasis in esophageal squamous cell carcinoma. Oncotarget 2016;7:36956-70. [PMID: 27172793 DOI: 10.18632/oncotarget.9231] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 6.5] [Reference Citation Analysis]
524 Kim SH, Hong SJ. Current Status of Image-Enhanced Endoscopy for Early Identification of Esophageal Neoplasms. Clin Endosc 2021;54:464-76. [PMID: 34304482 DOI: 10.5946/ce.2021.186] [Reference Citation Analysis]
525 Zhang X, Yang Y, Sun Y, Ye B, Guo X, Mao T, Hua R, Li B, Gu H, Liu J, Li Z. Adjuvant therapy for pathological T3N0M0 esophageal squamous cell carcinoma. J Thorac Dis 2019;11:2512-22. [PMID: 31372288 DOI: 10.21037/jtd.2019.05.70] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
526 Guo JH, Chen MQ, Chen C, Lu HJ, Xu BH. Efficacy and toxicity of nimotuzumab combined with radiotherapy in elderly patients with esophageal squamous cell carcinoma. Mol Clin Oncol 2015;3:1135-8. [PMID: 26623065 DOI: 10.3892/mco.2015.606] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
527 Natsuizaka M, Ohashi S, Wong GS, Ahmadi A, Kalman RA, Budo D, Klein-Szanto AJ, Herlyn M, Diehl JA, Nakagawa H. Insulin-like growth factor-binding protein-3 promotes transforming growth factor-{beta}1-mediated epithelial-to-mesenchymal transition and motility in transformed human esophageal cells. Carcinogenesis 2010;31:1344-53. [PMID: 20513670 DOI: 10.1093/carcin/bgq108] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 4.1] [Reference Citation Analysis]
528 Khattak MA, Martin HL, Karapetis CS. Targeted therapy for esophagogastric cancers: a review. Onco Targets Ther 2012;5:91-102. [PMID: 22719211 DOI: 10.2147/OTT.S25117] [Reference Citation Analysis]
529 Liang J, E M, Wu G, Zhao L, Li X, Xiu X, Li N, Chen B, Hui Z, Lv J, Fang H, Tang Y, Bi N, Wang W, Zhai Y, Li T, Chen D, Zou S, Lu N, Perez-Rodríguez R, Zheng J, Wang L. Nimotuzumab combined with radiotherapy for esophageal cancer: preliminary study of a Phase II clinical trial. Onco Targets Ther 2013;6:1589-96. [PMID: 24235844 DOI: 10.2147/OTT.S50945] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
530 Niccolai E, Taddei A, Prisco D, Amedei A. Gastric cancer and the epoch of immunotherapy approaches. World J Gastroenterol 2015; 21(19): 5778-5793 [PMID: 26019442 DOI: 10.3748/wjg.v21.i19.5778] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 48] [Article Influence: 7.1] [Reference Citation Analysis]
531 Oezcelik A, Ayazi S, DeMeester SR, Zehetner J, Abate E, Dunn J, Grant KS, Lipham JC, Hagen JA, DeMeester TR. Adenocarcinoma of the esophagus in the young. J Gastrointest Surg. 2013;17:1032-1035. [PMID: 23564309 DOI: 10.1007/s11605-013-2177-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
532 Worni M, Castleberry AW, Gloor B, Pietrobon R, Haney JC, D'Amico TA, Akushevich I, Berry MF. Trends and outcomes in the use of surgery and radiation for the treatment of locally advanced esophageal cancer: a propensity score adjusted analysis of the surveillance, epidemiology, and end results registry from 1998 to 2008. Dis Esophagus 2014;27:662-9. [PMID: 23937253 DOI: 10.1111/dote.12123] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
533 Klingelhöfer D, Zhu Y, Braun M, Brüggmann D, Schöffel N, Groneberg DA. A world map of esophagus cancer research: a critical accounting. J Transl Med 2019;17:150. [PMID: 31077194 DOI: 10.1186/s12967-019-1902-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
534 Aoki Y, Toh Y, Taomoto J, Sakaguchi Y, Okamura T. Long-term survival following radical surgery after chemotherapy for esophagogastric adenocarcinoma with extensive lymph node metastases: report of a case. Surg Today 2011;41:1255-9. [PMID: 21874426 DOI: 10.1007/s00595-010-4463-1] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
535 Xu B, Chen L, Li J, Zheng X, Shi L, Wu C, Jiang J. Prognostic value of tumor infiltrating NK cells and macrophages in stage II+III esophageal cancer patients. Oncotarget. 2016;7:74904-74916. [PMID: 27736796 DOI: 10.18632/oncotarget.12484] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 9.3] [Reference Citation Analysis]
536 Wang N, Yu Y, Xu B, Zhang M, Li Q, Miao L. Pivotal prognostic and diagnostic role of the long non‑coding RNA colon cancer‑associated transcript 1 expression in human cancer (Review). Mol Med Rep 2019;19:771-82. [PMID: 30535444 DOI: 10.3892/mmr.2018.9721] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
537 Ni PZ, Yang YS, Hu WP, Wang WP, Yuan Y, Chen LQ. Primary adenosquamous carcinoma of the esophagus: an analysis of 39 cases. J Thorac Dis. 2016;8:2689-2696. [PMID: 27867543 DOI: 10.21037/jtd.2016.09.59] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
538 Tomizawa Y, Wang KK. Screening, surveillance, and prevention for esophageal cancer. Gastroenterol Clin North Am 2009;38:59-73, viii. [PMID: 19327567 DOI: 10.1016/j.gtc.2009.01.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
539 He J, Wei W, Yang Q, Wang Y. Phillygenin Exerts In Vitro and In Vivo Antitumor Effects in Drug-Resistant Human Esophageal Cancer Cells by Inducing Mitochondrial-Mediated Apoptosis, ROS Generation, and Inhibition of the Nuclear Factor kappa B NF-κB Signalling Pathway. Med Sci Monit 2019;25:739-45. [PMID: 30681987 DOI: 10.12659/MSM.913138] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
540 Cai X, Yang X, Jin C, Li L, Cui Q, Guo Y, Dong Y, Yang X, Guo L, Zhang M. Identification and verification of differentially expressed microRNAs and their target genes for the diagnosis of esophageal cancer. Oncol Lett 2018;16:3642-50. [PMID: 30127973 DOI: 10.3892/ol.2018.9066] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
541 Ohashi S, Natsuizaka M, Wong GS, Michaylira CZ, Grugan KD, Stairs DB, Kalabis J, Vega ME, Kalman RA, Nakagawa M, Klein-Szanto AJ, Herlyn M, Diehl JA, Rustgi AK, Nakagawa H. Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors. Cancer Res 2010;70:4174-84. [PMID: 20424117 DOI: 10.1158/0008-5472.CAN-09-4614] [Cited by in Crossref: 102] [Cited by in F6Publishing: 72] [Article Influence: 8.5] [Reference Citation Analysis]
542 Ishihara R, Yamamoto S, Iishi H, Nagai K, Matui F, Kawada N, Ohta T, Kanzaki H, Hanafusa M, Hanaoka N, Takeuchi Y, Higashino K, Uedo N, Sugimoto N, Kawaguchi Y, Nishiyama K, Motoori M, Yano M, Hosoki T. Predicting the effects of chemoradiotherapy for squamous cell carcinoma of the esophagus by induction chemotherapy response assessed by positron emission tomography: toward PET-response-guided selection of chemoradiotherapy or esophagectomy. Int J Clin Oncol 2012;17:225-32. [PMID: 21735356 DOI: 10.1007/s10147-011-0278-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
543 Wang YY, Yang YX, Zhao R, Pan ST, Zhe H, He ZX, Duan W, Zhang X, Yang T, Qiu JX, Zhou SF. Bardoxolone methyl induces apoptosis and autophagy and inhibits epithelial-to-mesenchymal transition and stemness in esophageal squamous cancer cells. Drug Des Devel Ther 2015;9:993-1026. [PMID: 25733817 DOI: 10.2147/DDDT.S73493] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
544 Tanabe K, Shinsato Y, Furukawa T, Kita Y, Hatanaka K, Minami K, Kawahara K, Yamamoto M, Baba K, Mori S, Uchikado Y, Maemura K, Tanimoto A, Natsugoe S. Filamin C promotes lymphatic invasion and lymphatic metastasis and increases cell motility by regulating Rho GTPase in esophageal squamous cell carcinoma. Oncotarget 2017;8:6353-63. [PMID: 28031525 DOI: 10.18632/oncotarget.14087] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
545 Bao Y, Wang Q, Guo Y, Chen Z, Li K, Yang Y, Zhang H, Dong H, Shen K, Yang W. PRSS8 methylation and its significance in esophageal squamous cell carcinoma. Oncotarget 2016;7:28540-55. [PMID: 27081034 DOI: 10.18632/oncotarget.8677] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
546 Xue Z, Wu X, Chen X, Luo Q. MT3-MMP down-regulation promotes tumorigenesis and correlates to poor prognosis in esophageal squamous cell carcinoma. Cancer Med 2016;5:2459-68. [PMID: 27292876 DOI: 10.1002/cam4.790] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
547 Fujita Y, Masuda K, Hamada J, Shoda K, Naruto T, Hamada S, Miyakami Y, Kohmoto T, Watanabe M, Takahashi R, Tange S, Saito M, Kudo Y, Fujiwara H, Ichikawa D, Tangoku A, Otsuji E, Imoto I. KH-type splicing regulatory protein is involved in esophageal squamous cell carcinoma progression. Oncotarget 2017;8:101130-45. [PMID: 29254151 DOI: 10.18632/oncotarget.20926] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
548 Ai D, Zhu H, Ren W, Chen Y, Liu Q, Deng J, Ye J, Fan J, Zhao K. Patterns of distant organ metastases in esophageal cancer: a population-based study. J Thorac Dis. 2017;9:3023-3030. [PMID: 29221275 DOI: 10.21037/jtd.2017.08.72] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 5.6] [Reference Citation Analysis]
549 Li Q, Liu BR. Application of artificial intelligence-assisted endoscopic detection of early esophageal cancer. Shijie Huaren Xiaohua Zazhi 2021; 29(24): 1389-1395 [DOI: 10.11569/wcjd.v29.i24.1389] [Reference Citation Analysis]
550 Jin Z, Wang L, Cao Z, Cheng Y, Gao Y, Feng X, Chen S, Yu H, Wu W, Zhao Z, Dong M, Zhang X, Liu J, Fan X, Mori Y, Meltzer SJ. Temporal evolution in caveolin 1 methylation levels during human esophageal carcinogenesis. BMC Cancer 2014;14:345. [PMID: 24885118 DOI: 10.1186/1471-2407-14-345] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
551 Wang JY, Zheng YZ, Yang J, Lin YH, Dai SQ, Zhang G, Liu WL. Elevated levels of serum amyloid A indicate poor prognosis in patients with esophageal squamous cell carcinoma. BMC Cancer 2012;12:365. [PMID: 22917173 DOI: 10.1186/1471-2407-12-365] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
552 Orlicka K, Maynard S, Bouin M. Unusual presentation of a metastatic esophageal carcinoma. Case Rep Gastroenterol 2012;6:273-8. [PMID: 22679417 DOI: 10.1159/000339211] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
553 Yang PW, Hsu IJ, Chang CW, Wang YC, Hsieh CY, Shih KH, Wong LF, Shih NY, Hsieh MS, Hou MT, Lee JM. Visible-absorption spectroscopy as a biomarker to predict treatment response and prognosis of surgically resected esophageal cancer. Sci Rep 2016;6:33414. [PMID: 27624872 DOI: 10.1038/srep33414] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
554 Xiong G, Guo H, Wang K, Hu H, Wang D, Xu X, Guan X, Yang K, Bai Y. Polymorphisms of decoy receptor 3 are associated with risk of esophageal squamous cell carcinoma in Chinese Han. Tumour Biol. 2010;31:443-449. [PMID: 20567955 DOI: 10.1007/s13277-010-0053-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
555 Chen Y, Bieerkehazhi S, Li X, Ma L, Yibulayin W, Ran J. Survivin Regulates Bad Gene Expression by Binding to Its Promoter and Modulates Cell Cycle and Apoptosis in Esophageal Carcinoma Cell. J Oncol 2021;2021:1384289. [PMID: 33488710 DOI: 10.1155/2021/1384289] [Reference Citation Analysis]
556 Wu SG, Zhang WW, He ZY, Sun JY, Chen YX, Guo L. Sites of metastasis and overall survival in esophageal cancer: a population-based study. Cancer Manag Res. 2017;9:781-788. [PMID: 29255373 DOI: 10.2147/cmar.s150350] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]
557 Brooke MA, Etheridge SL, Kaplan N, Simpson C, O'Toole EA, Ishida-Yamamoto A, Marches O, Getsios S, Kelsell DP. iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier function. Hum Mol Genet 2014;23:4064-76. [PMID: 24643277 DOI: 10.1093/hmg/ddu120] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 6.3] [Reference Citation Analysis]
558 Hollier JM, Hinojosa-Lindsey M, Sansgiry S, El-Serag HB, Naik AD. Clinical and psychosocial variables associated with behavioral intentions to undergo surveillance endoscopy. BMC Gastroenterol 2014;14:107. [PMID: 24916457 DOI: 10.1186/1471-230X-14-107] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
559 Chen MF, Chen PT, Chen WC, Lu MS, Lin PY, Lee KD. The role of PD-L1 in the radiation response and prognosis for esophageal squamous cell carcinoma related to IL-6 and T-cell immunosuppression. Oncotarget 2016;7:7913-24. [PMID: 26761210 DOI: 10.18632/oncotarget.6861] [Cited by in Crossref: 71] [Cited by in F6Publishing: 75] [Article Influence: 11.8] [Reference Citation Analysis]
560 Jung HA, Adenis A, Lee J, Park SH, Maeng CH, Park S, Ahn HK, Shim YM, Penel N, Im YH. Nomogram to predict treatment outcome of fluoropyrimidine/platinum-based chemotherapy in metastatic esophageal squamous cell carcinoma. Cancer Res Treat 2013;45:285-94. [PMID: 24454001 DOI: 10.4143/crt.2013.45.4.285] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
561 Huang RW, Chao YK, Wen YW, Chang HK, Tseng CK, Chan SC, Liu YH. Predictors of pathological complete response to neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma. World J Surg Oncol 2014;12:170. [PMID: 24885430 DOI: 10.1186/1477-7819-12-170] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
562 Murata A, Baba Y, Watanabe M, Shigaki H, Miyake K, Karashima R, Imamura Y, Ida S, Ishimoto T, Iwagami S. p53 immunohistochemical expression and patient prognosis in esophageal squamous cell carcinoma. Med Oncol. 2013;30:728. [PMID: 24026664 DOI: 10.1007/s12032-013-0728-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
563 Zhou Z, Huang F. Long Non-Coding RNA LINC00152 Regulates Cell Proliferation, Migration And Invasion In Esophageal Squamous Cell Carcinoma Via miR-107/Rab10 Axis. Onco Targets Ther 2019;12:8553-67. [PMID: 31802892 DOI: 10.2147/OTT.S221515] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
564 Reynolds JV, Preston SR, O'Neill B, Baeksgaard L, Griffin SM, Mariette C, Cuffe S, Cunningham M, Crosby T, Parker I, Hofland K, Hanna G, Svendsen LB, Donohoe CL, Muldoon C, O'Toole D, Johnson C, Ravi N, Jones G, Corkhill AK, Illsley M, Mellor J, Lee K, Dib M, Marchesin V, Cunnane M, Scott K, Lawner P, Warren S, O'Reilly S, O'Dowd G, Leonard G, Hennessy B, Dermott RM. ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS). BMC Cancer 2017;17:401. [PMID: 28578652 DOI: 10.1186/s12885-017-3386-2] [Cited by in Crossref: 77] [Cited by in F6Publishing: 69] [Article Influence: 15.4] [Reference Citation Analysis]
565 Wang Q, Bai J, Abliz A, Liu Y, Gong K, Li J, Shi W, Pan Y, Liu F, Lai S, Yang H, Lu C, Zhang L, Chen W, Xu R, Cai H, Ke Y, Zeng C. An Old Story Retold: Loss of G1 Control Defines A Distinct Genomic Subtype of Esophageal Squamous Cell Carcinoma. Genomics Proteomics Bioinformatics 2015;13:258-70. [PMID: 26386145 DOI: 10.1016/j.gpb.2015.06.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
566 Huang B, Chan EG, Pennathur A, Luketich JD, Zhang J. The ideal approach for treatment of cT1N+ and cT2Nany esophageal cancer.: a NCDB analysis. BMC Cancer 2021;21:1334. [PMID: 34911468 DOI: 10.1186/s12885-021-08896-0] [Reference Citation Analysis]
567 Sharkey AR, Sah BR, Withey SJ, Bhuva S, Neji R, Jeljeli S, Green A, Cook GJR, Goh V; Guy’s & St Thomas’ Oesophago-Gastric Research Group. Initial experience in staging primary oesophageal/gastro-oesophageal cancer with 18F-FDG PET/MRI. Eur J Hybrid Imaging 2021;5:23. [PMID: 34897589 DOI: 10.1186/s41824-021-00117-y] [Reference Citation Analysis]
568 McNair AGK, MacKichan F, Donovan JL, Brookes ST, Avery KNL, Griffin SM, Crosby T, Blazeby JM. What surgeons tell patients and what patients want to know before major cancer surgery: a qualitative study. BMC Cancer 2016;16:258. [PMID: 27036216 DOI: 10.1186/s12885-016-2292-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 5.5] [Reference Citation Analysis]
569 Zaidi AH, Kelly LA, Kreft RE, Barlek M, Omstead AN, Matsui D, Boyd NH, Gazarik KE, Heit MI, Nistico L, Kasi PM, Spirk TL, Byers B, Lloyd EJ, Landreneau RJ, Jobe BA. Associations of microbiota and toll-like receptor signaling pathway in esophageal adenocarcinoma. BMC Cancer. 2016;16:52. [PMID: 26841926 DOI: 10.1186/s12885-016-2093-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 6.7] [Reference Citation Analysis]
570 Dai MM, Wu SG, Zheng H, Chen SY, Li YM, Deng C, Zhou YF, Lin Q. Patterns of regional lymph node recurrence after radical esophagectomy for thoracic esophageal squamous cell carcinoma. Shijie Huaren Xiaohua Zazhi 2014; 22(28): 4237-4242 [DOI: 10.11569/wcjd.v22.i28.4237] [Reference Citation Analysis]
571 Wang Y, Zhou P, Qin S, Xu D, Liu Y, Fu W, Ruan B, Zhang L, Zhang Y, Wang X, Pan Y, Wang S, Yan H, Qin J, Wang X, Liu Q, Du Z, Liu Z, Wang Y. The Curcumin Analogs 2-Pyridyl Cyclohexanone Induce Apoptosis via Inhibition of the JAK2-STAT3 Pathway in Human Esophageal Squamous Cell Carcinoma Cells. Front Pharmacol 2018;9:820. [PMID: 30186159 DOI: 10.3389/fphar.2018.00820] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
572 Sonohara F, Gao F, Iwata N, Kanda M, Koike M, Takahashi N, Yamada Y, Kodera Y, Wang X, Goel A. Genome-wide Discovery of a Novel Gene-expression Signature for the Identification of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma. Ann Surg 2019;269:879-86. [PMID: 29240008 DOI: 10.1097/SLA.0000000000002622] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
573 Shao Y, Ning Z, Chen J, Geng Y, Gu W, Huang J, Pei H, Shen Y, Jiang J. Prognostic nomogram integrated systemic inflammation score for patients with esophageal squamous cell carcinoma undergoing radical esophagectomy. Sci Rep 2015;5:18811. [PMID: 26689680 DOI: 10.1038/srep18811] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
574 Chen YF, Xie JD, Jiang YC, Chen DT, Pan JH, Chen YH, Yuan YF, Wen ZS, Zeng WA. The Prognostic Value of Peripheral Benzodiazepine Receptor in Patients with Esophageal Squamous Cell Carcinoma. J Cancer 2017;8:3343-55. [PMID: 29158807 DOI: 10.7150/jca.20739] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
575 Lee F, Sarkaria IS, Luketich JD. Surgeon proficiency and outcomes in esophagectomy: a perspective and comment on an analysis of the Swedish Cancer Registry. J Thorac Dis 2017;9:E279-81. [PMID: 28449520 DOI: 10.21037/jtd.2017.02.92] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
576 van Rossum PSN, Xu C, Fried DV, Goense L, Court LE, Lin SH. The emerging field of radiomics in esophageal cancer: current evidence and future potential. Transl Cancer Res 2016;5:410-23. [PMID: 30687593 DOI: 10.21037/tcr.2016.06.19] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
577 Ye L, Guan S, Zhang C, Lee KH, Sun S, Wei J, Liu B. Circulating autoantibody to FOXP3 may be a potential biomarker for esophageal squamous cell carcinoma. Tumour Biol. 2013;34:1873-1877. [PMID: 23483489 DOI: 10.1007/s13277-013-0729-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
578 Espinel J, Pinedo E, Ojeda V, Rio MGD. Multiband mucosectomy for advanced dysplastic lesions in the upper digestive tract. World J Gastrointest Endosc 2015; 7(4): 370-380 [PMID: 25901216 DOI: 10.4253/wjge.v7.i4.370] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
579 Shigeoka M, Urakawa N, Nakamura T, Nishio M, Watajima T, Kuroda D, Komori T, Kakeji Y, Semba S, Yokozaki H. Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma. Cancer Sci 2013;104:1112-9. [PMID: 23648122 DOI: 10.1111/cas.12188] [Cited by in Crossref: 109] [Cited by in F6Publishing: 110] [Article Influence: 12.1] [Reference Citation Analysis]
580 Evans RPT, Mourad MM, Fisher SG, Bramhall SR. Evolving management of metaplasia and dysplasia in Barrett's epithelium. World J Gastroenterol 2016; 22(47): 10316-10324 [PMID: 28058012 DOI: 10.3748/wjg.v22.i47.10316] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
581 Zhang LQ, Du XJ, Zhou FY, Chen PN, Wang HL, Sun L, Li XL. Awareness for Endoscopic Screening Among Accompanying Children of Hospitalized Esophageal Cancer Patients in Henan. J Cancer Educ 2020. [PMID: 33137207 DOI: 10.1007/s13187-020-01911-1] [Reference Citation Analysis]
582 Ingravallo G, Dall’Olmo L, Segat D, Fassan M, Mescoli C, Dazzo E, Castoro C, Polimeno L, Rizzetto C, Baroni MD. CDX2 hox gene product in a rat model of esophageal cancer. J Exp Clin Cancer Res. 2009;28:108. [PMID: 19664209 DOI: 10.1186/1756-9966-28-108] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
583 Londono R, Jobe BA, Hoppo T, Badylak SF. Esophagus and regenerative medicine. World J Gastroenterol 2012; 18(47): 6894-6899 [PMID: 23322986 DOI: 10.3748/wjg.v18.i47.6894] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
584 Wang PL, Liu B, Xia Y, Pan CF, Ma T, Chen YJ. Long non-coding RNA-Low Expression in Tumor inhibits the invasion and metastasis of esophageal squamous cell carcinoma by regulating p53 expression. Mol Med Rep. 2016;13:3074-3082. [PMID: 26935396 DOI: 10.3892/mmr.2016.4913] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
585 Cui XB, Peng H, Li RR, Mu JQ, Yang L, Li N, Liu CX, Hu JM, Li SG, Wei Y, Laibo-Yin, Zhou H, Li F, Chen YZ. MicroRNA-34a functions as a tumor suppressor by directly targeting oncogenic PLCE1 in Kazakh esophageal squamous cell carcinoma. Oncotarget 2017;8:92454-69. [PMID: 29190930 DOI: 10.18632/oncotarget.21384] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
586 Yang L, Ji Y, Chen L, Li M, Wu F, Hu J, Jiang J, Cui X, Chen Y, Pang L, Wei Y, Li F. Genetic variability in LMP2 and LMP7 is associated with the risk of esophageal squamous cell carcinoma in the Kazakh population but is not associated with HPV infection. PLoS One 2017;12:e0186319. [PMID: 29073155 DOI: 10.1371/journal.pone.0186319] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
587 O'Doherty MG, Freedman ND, Hollenbeck AR, Schatzkin A, Murray LJ, Cantwell MM, Abnet CC. Association of dietary fat intakes with risk of esophageal and gastric cancer in the NIH-AARP diet and health study. Int J Cancer 2012;131:1376-87. [PMID: 22116732 DOI: 10.1002/ijc.27366] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
588 Humphreys LM, Meredith H, Morgan J, Norton S. Detection of asymptomatic adenocarcinoma at endoscopy prior to gastric banding justifies routine endoscopy. Obes Surg 2012;22:594-6. [PMID: 21887608 DOI: 10.1007/s11695-011-0506-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
589 Chen YF, Ma G, Cao X, Huang ZL, Zeng MS, Wen ZS. Downregulated expression of PTK6 is correlated with poor survival in esophageal squamous cell carcinoma. Med Oncol 2014;31:317. [PMID: 25377660 DOI: 10.1007/s12032-014-0317-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
590 Grotenhuis BA, Wijnhoven BP, Hötte GJ, van der Stok EP, Tilanus HW, van Lanschot JJ. Prognostic value of body mass index on short-term and long-term outcome after resection of esophageal cancer. World J Surg 2010;34:2621-7. [PMID: 20596708 DOI: 10.1007/s00268-010-0697-8] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 4.9] [Reference Citation Analysis]
591 Otterstatter MC, Brierley JD, De P, Ellison LF, Macintyre M, Marrett LD, Semenciw R, Weir HK. Esophageal cancer in Canada: trends according to morphology and anatomical location. Can J Gastroenterol 2012;26:723-7. [PMID: 23061066 DOI: 10.1155/2012/649108] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
592 Kikuchi H, Takeuchi H. Future Perspectives of Surgery for Esophageal Cancer. Ann Thorac Cardiovasc Surg 2018;24:219-22. [PMID: 29962387 DOI: 10.5761/atcs.ed.18-00126] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
593 Morrissey ME, Byrne R, Nulty C, McCabe NH, Lynam-Lennon N, Butler CT, Kennedy S, O'Toole D, Larkin J, McCormick P, Mehigan B, Cathcart MC, Lysaght J, Reynolds JV, Ryan EJ, Dunne MR, O'Sullivan J. The tumour microenvironment of the upper and lower gastrointestinal tract differentially influences dendritic cell maturation. BMC Cancer 2020;20:566. [PMID: 32552799 DOI: 10.1186/s12885-020-07012-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
594 Antunes LCM, Prolla JC, de Barros Lopes A, da Rocha MP, Fagundes RB. No evidence of HPV DNA in esophageal squamous cell carcinoma in a population of Southern Brazil. World J Gastroenterol 2013; 19(39): 6598-6603 [PMID: 24151387 DOI: 10.3748/wjg.v19.i39.6598] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
595 Zeng J, Liu JS. Quality of life after three kinds of esophagectomy for cancer. World J Gastroenterol 2012; 18(36): 5106-5113 [PMID: 23049222 DOI: 10.3748/wjg.v18.i36.5106] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
596 Otsubo T, Hagiwara T, Tamura-Nakano M, Sezaki T, Miyake O, Hinohara C, Shimizu T, Yamada K, Dohi T, Kawamura YI. Aberrant DNA hypermethylation reduces the expression of the desmosome-related molecule periplakin in esophageal squamous cell carcinoma. Cancer Med 2015;4:415-25. [PMID: 25583674 DOI: 10.1002/cam4.369] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
597 Krarup AL, Olesen SS, Funch-Jensen P, Gregersen H, Drewes AM. Proximal and distal esophageal sensitivity is decreased in patients with Barrett’s esophagus. World J Gastroenterol 2011; 17(4): 514-521 [PMID: 21274382 DOI: 10.3748/wjg.v17.i4.514] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
598 Peng X, Xue H, Lü L, Shi P, Wang J, Wang J. Accumulated promoter methylation as a potential biomarker for esophageal cancer. Oncotarget 2017;8:679-91. [PMID: 27893424 DOI: 10.18632/oncotarget.13510] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
599 Zhang F, Li J, Xiao H, Zou Y, Liu Y, Huang W. AFAP1-AS1: A novel oncogenic long non-coding RNA in human cancers. Cell Prolif 2018;51. [PMID: 29057544 DOI: 10.1111/cpr.12397] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
600 Mao A. Interventional Therapy of Esophageal Cancer. Gastrointest Tumors 2016;3:59-68. [PMID: 27904858 DOI: 10.1159/000447512] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
601 Chen YB, Jia WH. A comprehensive genomic characterization of esophageal squamous cell carcinoma: from prognostic analysis to in vivo assay. Chin J Cancer 2016;35:76. [PMID: 27515178 DOI: 10.1186/s40880-016-0142-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
602 Cheng WC, Shen MF, Wu BR, Chen CY, Chen WC, Liao WC, Chen CH, Tu CY. The prognostic predictors of patients with airway involvement due to advanced esophageal cancer after metallic airway stenting using flexible bronchoscopy. J Thorac Dis 2019;11:3929-40. [PMID: 31656667 DOI: 10.21037/jtd.2019.08.108] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
603 Ueda M, Iguchi T, Masuda T, Nakahara Y, Hirata H, Uchi R, Niida A, Momose K, Sakimura S, Chiba K, Eguchi H, Ito S, Sugimachi K, Yamasaki M, Suzuki Y, Miyano S, Doki Y, Mori M, Mimori K. Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence. Oncotarget. 2016;7:62280-62291. [PMID: 27556701 DOI: 10.18632/oncotarget.11409] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 9.8] [Reference Citation Analysis]
604 Cui Y, Hou R, Lv X, Wang F, Yu Z, Cui Y. Identification of Immune-Cell-Related Prognostic Biomarkers of Esophageal Squamous Cell Carcinoma Based on Tumor Microenvironment. Front Oncol 2021;11:771749. [PMID: 34760708 DOI: 10.3389/fonc.2021.771749] [Reference Citation Analysis]
605 Wu CC, Chang CM, Hsu TW, Lee CH, Chen JH, Huang CY, Lee CC. The effect of individual and neighborhood socioeconomic status on esophageal cancer survival in working-age patients in Taiwan. Medicine (Baltimore) 2016;95:e4140. [PMID: 27399129 DOI: 10.1097/MD.0000000000004140] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
606 Mathieu LN, Kanarek NF, Tsai HL, Rudin CM, Brock MV. Age and sex differences in the incidence of esophageal adenocarcinoma: results from the Surveillance, Epidemiology, and End Results (SEER) Registry (1973-2008). Dis Esophagus. 2014;27:757-763. [PMID: 24118313 DOI: 10.1111/dote.12147] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 5.2] [Reference Citation Analysis]
607 Huang YH, Chen KC, Lin SH, Huang PM, Yang PW, Lee JM. Robotic-assisted single-incision gastric mobilization for minimally invasive oesophagectomy for oesophageal cancer: preliminary results. Eur J Cardiothorac Surg 2020;58:i65-9. [PMID: 32617584 DOI: 10.1093/ejcts/ezaa212] [Reference Citation Analysis]
608 Zhou S, Cui Y, Yu D, Liang J, Zhang M, Ye W. MicroRNA-381 enhances radiosensitivity in esophageal squamous cell carcinoma by targeting X-linked inhibitor of apoptosis protein. Onco Targets Ther 2017;10:2527-38. [PMID: 28546757 DOI: 10.2147/OTT.S134551] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
609 Etemadi A, Dawsey SM, Abnet CC, Mwachiro MM. Predicting the risk of esophageal high-grade lesions in opportunistic screening. Gastrointest Endosc 2020;92:1136-7. [PMID: 33160493 DOI: 10.1016/j.gie.2020.05.051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
610 Ma Z, Dong Z, Yu D, Mu M, Feng W, Guo J, Cheng B, Guo J, Ma J. IL-32 Promotes the Radiosensitivity of Esophageal Squamous Cell Carcinoma Cell through STAT3 Pathway. Biomed Res Int 2021;2021:6653747. [PMID: 33681363 DOI: 10.1155/2021/6653747] [Reference Citation Analysis]
611 Fu L, Peng Q. A deep ensemble model to predict miRNA-disease association. Sci Rep 2017;7:14482. [PMID: 29101378 DOI: 10.1038/s41598-017-15235-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
612 Spohn L, Fichter C, Werner M, Lassmann S. Subcellular localization of EGFR in esophageal carcinoma cell lines. J Cell Commun Signal 2016;10:41-7. [PMID: 26582583 DOI: 10.1007/s12079-015-0308-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
613 Ma W, Ma L, Zhe H, Bao C, Wang N, Yang S, Wang K, Cao F, Cheng Y, Cheng Y. Detection of esophageal squamous cell carcinoma by cathepsin B activity in nude mice. PLoS One 2014;9:e92351. [PMID: 24618814 DOI: 10.1371/journal.pone.0092351] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
614 Chen J, Zhang N, Wakai T, Wei L, He Y, Kumagai N, Kitsu K, Wang S, Akazawa K. Effect of the interaction between the amount and duration of alcohol consumption and tobacco smoking on the risk of esophageal cancer: A case-control study. Exp Ther Med 2010;1:991-7. [PMID: 22993631 DOI: 10.3892/etm.2010.152] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
615 Palanivelu C, Prakash A, Parthasarathi R, Senthilkumar R, Senthilnathan PR, Rajapandian S. Laparoscopic esophagogastrectomy without thoracic or cervical access for adenocarcinoma of the gastroesophageal junction: an Indian experience from a tertiary center. Surg Endosc 2007;21:16-20. [PMID: 17031742 DOI: 10.1007/s00464-005-0418-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
616 Zhang J, Yang X, Wang Y, Shi H, Guan C, Yao L, Huang X, Ding Z, Huang Y, Wang H, Cheng C. Low expression of cyclinH and cyclin-dependent kinase 7 can decrease the proliferation of human esophageal squamous cell carcinoma. Dig Dis Sci 2013;58:2028-37. [PMID: 23456497 DOI: 10.1007/s10620-013-2597-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
617 Shi X, Chen Z, Hu X, Luo M, Sun Z, Li J, Shi S, Feng X, Zhou C, Li Z, Yang W, Li Y, Wang P, Zhou F, Gao Y, He J. AJUBA promotes the migration and invasion of esophageal squamous cell carcinoma cells through upregulation of MMP10 and MMP13 expression. Oncotarget 2016;7:36407-18. [PMID: 27172796 DOI: 10.18632/oncotarget.9239] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
618 Kosumi K, Baba Y, Ishimoto T, Harada K, Nakamura K, Ohuchi M, Kiyozumi Y, Izumi D, Tokunaga R, Taki K, Higashi T, Miyata T, Shigaki H, Kurashige J, Hiyoshi Y, Iwatsuki M, Iwagami S, Sakamoto Y, Miyamoto Y, Yoshida N, Oki E, Watanabe M, Baba H. APOBEC3B is an enzymatic source of molecular alterations in esophageal squamous cell carcinoma. Med Oncol 2016;33:26. [PMID: 26880326 DOI: 10.1007/s12032-016-0739-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
619 Tew WP, Radovich D, O'Reilly E, Schwartz G, Schrag D, Saltz LB, Kelsen DP, Kepler S, Ilson DH. Phase I trial of weekly cisplatin, irinotecan and paclitaxel in patients with advanced gastrointestinal cancer. Invest New Drugs 2009;27:366-73. [PMID: 18956138 DOI: 10.1007/s10637-008-9194-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
620 Zhao L, Yan X, Shi J, Ren F, Liu L, Sun S, Shan B. Ethanol extract of Forsythia suspensa root induces apoptosis of esophageal carcinoma cells via the mitochondrial apoptotic pathway. Mol Med Rep 2015;11:871-80. [PMID: 25373392 DOI: 10.3892/mmr.2014.2874] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
621 de Man FM, van Eerden RAG, Oomen-de Hoop E, Veraart JN, van Doorn N, van Doorn L, van der Gaast A, Mathijssen RHJ. Efficacy and Toxicity of Weekly Carboplatin and Paclitaxel as Induction or Palliative Treatment in Advanced Esophageal Cancer Patients. Cancers (Basel) 2019;11:E826. [PMID: 31200588 DOI: 10.3390/cancers11060826] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
622 Goto M, Liu M. Chemokines and their receptors as biomarkers in esophageal cancer. Esophagus 2020;17:113-21. [PMID: 31773415 DOI: 10.1007/s10388-019-00706-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
623 Zhao HY, Gu Y, Yi YX. NQO1 C609T polymorphism is associated with esophageal cancer risk among Chinese: a meta-analysis. Tumour Biol 2014;35:2199-203. [PMID: 24142529 DOI: 10.1007/s13277-013-1292-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
624 Ono S, Dobashi A, Furuhashi H, Koizumi A, Matsui H, Hara Y, Sumiyama K. Characteristics of superficial esophageal squamous cell carcinomas undetectable with narrow-band imaging endoscopy. Gastroenterol Rep (Oxf) 2021;9:402-7. [PMID: 34733525 DOI: 10.1093/gastro/goab028] [Reference Citation Analysis]
625 Zhao Q, Xie D, Liu H, Wang F, Yan GY, Chen X. SSCMDA: spy and super cluster strategy for MiRNA-disease association prediction. Oncotarget 2018;9:1826-42. [PMID: 29416734 DOI: 10.18632/oncotarget.22812] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
626 Imura Y, Yamamoto S, Wakamatsu T, Tanaka T, Tamiya H, Sugimura K, Miyata H, Ishihara R, Yano M, Naka N. Clinical features and prognostic factors in patients with esophageal cancer with bone metastasis. Oncol Lett 2020;19:717-24. [PMID: 31897187 DOI: 10.3892/ol.2019.11142] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
627 Hoffman A, Manner H, Rey JW, Kiesslich R. A guide to multimodal endoscopy imaging for gastrointestinal malignancy - an early indicator. Nat Rev Gastroenterol Hepatol 2017;14:421-34. [PMID: 28611477 DOI: 10.1038/nrgastro.2017.46] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
628 Wang J, Wu M, Zheng D, Zhang H, Lv Y, Zhang L, Tan HS, Zhou H, Lao YZ, Xu HX. Garcinol inhibits esophageal cancer metastasis by suppressing the p300 and TGF-β1 signaling pathways. Acta Pharmacol Sin 2020;41:82-92. [PMID: 31371781 DOI: 10.1038/s41401-019-0271-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
629 Choi J, Kim SG, Kim JS, Jung HC, Song IS. Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer. Surg Endosc. 2010;24:1380-1386. [PMID: 20033712 DOI: 10.1007/s00464-009-0783-x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 77] [Article Influence: 6.2] [Reference Citation Analysis]
630 Guo J, Zhang S, Li H, Hassan MOO, Lu T, Zhao J, Zhang L. Lung Metastases in Newly Diagnosed Esophageal Cancer: A Population-Based Study. Front Oncol 2021;11:603953. [PMID: 33718154 DOI: 10.3389/fonc.2021.603953] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
631 Ding Y, Liu W, Wang X, Zhang L, Zhao M, Deng H, Liu Y. Bufalin induces apoptosis in human esophageal carcinoma ECA109 cells by inhibiting the activation of the mTOR/p70S6K pathway. Oncol Lett 2018;15:9339-46. [PMID: 29805658 DOI: 10.3892/ol.2018.8526] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
632 Takeshita H, Ichikawa D, Komatsu S, Tsujiura M, Kosuga T, Deguchi K, Konishi H, Morimura R, Shiozaki A, Fujiwara H, Okamoto K, Otsuji E. Prediction of CCND1 amplification using plasma DNA as a prognostic marker in oesophageal squamous cell carcinoma. Br J Cancer 2010;102:1378-83. [PMID: 20389301 DOI: 10.1038/sj.bjc.6605657] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
633 Yuan J, Jiang Q, Gong T, Fan D, Zhang J, Chen F, Zhu X, Wang X, Qiao Y, Chen H, Liu Z, Su J. Loss of grand histone H3 lysine 27 trimethylation domains mediated transcriptional activation in esophageal squamous cell carcinoma. NPJ Genom Med 2021;6:65. [PMID: 34381055 DOI: 10.1038/s41525-021-00232-6] [Reference Citation Analysis]
634 Yang PW, Hsieh MS, Huang YC, Hsieh CY, Chiang TH, Lee JM. Genetic variants of EGF and VEGF predict prognosis of patients with advanced esophageal squamous cell carcinoma. PLoS One 2014;9:e100326. [PMID: 24945674 DOI: 10.1371/journal.pone.0100326] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
635 Meng MB, Jiang C, Tian LJ, Liu CL, Zhuang HQ, Chen ZJ, Song YC, Wang J, Pang QS, Zhao LJ, Yuan ZY, Wang P. Late course accelerated hyperfractionation radiotherapy for locally advanced esophageal squamous cell carcinoma. Thorac Cancer 2013;4:174-85. [PMID: 28920199 DOI: 10.1111/j.1759-7714.2012.00166.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
636 Li XH, Wang XP, Gu WS, Lin JH, Huang H, Kang T, Zhang L, Chen H, Zheng X. Clinical Significance of Preoperative Thrombin Time in Patients with Esophageal Squamous Cell Carcinoma following Surgical Resection. PLoS One 2015;10:e0140323. [PMID: 26469700 DOI: 10.1371/journal.pone.0140323] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
637 Kim HJ, Suh YG, Lee YC, Lee SK, Shin SK, Cho BC, Lee CG. Dose-Response Relationship between Radiation Dose and Loco-regional Control in Patients with Stage II-III Esophageal Cancer Treated with Definitive Chemoradiotherapy. Cancer Res Treat 2017;49:669-77. [PMID: 27737537 DOI: 10.4143/crt.2016.354] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
638 Okonogi N, Hashimoto T, Ishida M, Ohno T, Terunuma T, Okumura T, Sakae T, Sakurai H. Designed-seamless irradiation technique for extended whole mediastinal proton-beam irradiation for esophageal cancer. Radiat Oncol 2012;7:173. [PMID: 23078998 DOI: 10.1186/1748-717X-7-173] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
639 Mawhinney MR, Glasgow RE. Current treatment options for the management of esophageal cancer. Cancer Manag Res 2012;4:367-77. [PMID: 23152702 DOI: 10.2147/CMAR.S27593] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 0.4] [Reference Citation Analysis]
640 Yang Y, Jia J, Sun Z, Liu C, Xiao Y, Yu J, Du F, Zhang X. Association Between Multiple Lines of Active Therapy and Prognosis in Esophageal Squamous Cell Carcinoma. Cancer Manag Res 2020;12:2177-84. [PMID: 32273757 DOI: 10.2147/CMAR.S242780] [Reference Citation Analysis]
641 Zhou X, Huang GR, Hu P. Over-expression of Oct4 in human esophageal squamous cell carcinoma. Mol Cells. 2011;32:39-45. [PMID: 21547540 DOI: 10.1007/s10059-011-2315-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
642 Hjortland GO, Meza-Zepeda LA, Beiske K, Ree AH, Tveito S, Hoifodt H, Bohler PJ, Hole KH, Myklebost O, Fodstad O, Smeland S, Hovig E. Genome wide single cell analysis of chemotherapy resistant metastatic cells in a case of gastroesophageal adenocarcinoma. BMC Cancer 2011;11:455. [PMID: 22014070 DOI: 10.1186/1471-2407-11-455] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
643 Kajiwara T, Hiasa Y, Nishina T, Matsumoto T, Hori S, Nadano S, Iguchi H, Takeji S, Tsubouchi E, Ikeda Y, Onji M. Maximum standardized uptake value in 18F-fluoro-2-deoxyglucose positron emission tomography is associated with advanced tumor factors in esophageal cancer. Mol Clin Oncol 2014;2:313-21. [PMID: 24649354 DOI: 10.3892/mco.2014.238] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
644 Zhu H, Wang C, Wang J, Chen D, Deng J, Deng J, Fan J, Badakhshi H, Huang X, Zhang L, Cai J, Guo S, Qian W, Nie Y, Li Q, Zhao K. A subset of esophageal squamous cell carcinoma patient-derived xenografts respond to cetuximab, which is predicted by high EGFR expression and amplification. J Thorac Dis 2018;10:5328-38. [PMID: 30416780 DOI: 10.21037/jtd.2018.09.18] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
645 Zingg U, Divalentino D, McQuinn A, Mardzuki A, Thompson SK, Karapetis CS, Watson DI. Outcome for esophageal cancer following treatment with chemotherapy and radiotherapy but not esophagectomy: Nonsurgical treatment of esophageal cancer. Clin Exp Gastroenterol 2009;2:75-83. [PMID: 21694830 DOI: 10.2147/ceg.s6273] [Reference Citation Analysis]
646 Hull R, Mbele M, Makhafola T, Hicks C, Wang SM, Reis RM, Mehrotra R, Mkhize-Kwitshana Z, Hussain S, Kibiki G, Bates DO, Dlamini Z. A multinational review: Oesophageal cancer in low to middle-income countries. Oncol Lett 2020;20:42. [PMID: 32802164 DOI: 10.3892/ol.2020.11902] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
647 Liu WL, Guo XZ, Zhang LJ, Wang JY, Zhang G, Guan S, Chen YM, Kong QL, Xu LH, Li MZ, Song LB, Zeng MS. Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma. BMC Cancer. 2010;10:467. [PMID: 20809956 DOI: 10.1186/1471-2407-10-467] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
648 Chen MF, Lee KD, Lu MS, Chen CC, Hsieh MJ, Liu YH, Lin PY, Chen WC. The predictive role of E2-EPF ubiquitin carrier protein in esophageal squamous cell carcinoma. J Mol Med (Berl). 2009;87:307-320. [PMID: 19083192 DOI: 10.1007/s00109-008-0430-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
649 Chen YF, Ma G, Cao X, Luo RZ, He LR, He JH, Huang ZL, Zeng MS, Wen ZS. Overexpression of cystatin SN positively affects survival of patients with surgically resected esophageal squamous cell carcinoma. BMC Surg 2013;13:15. [PMID: 23711283 DOI: 10.1186/1471-2482-13-15] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
650 Dong SW, Li D, Xu C, Sun P, Wang YG, Zhang P. Alteration in gene expression profile and oncogenicity of esophageal squamous cell carcinoma by RIZ1 upregulation. World J Gastroenterol 2013; 19(37): 6170-6177 [PMID: 24115813 DOI: 10.3748/wjg.v19.i37.6170] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
651 Liu D, Yang Y, Liu Q, Wang J. Inhibition of autophagy by 3-MA potentiates cisplatin-induced apoptosis in esophageal squamous cell carcinoma cells. Med Oncol. 2011;28:105-111. [PMID: 20041317 DOI: 10.1007/s12032-009-9397-3] [Cited by in Crossref: 162] [Cited by in F6Publishing: 155] [Article Influence: 12.5] [Reference Citation Analysis]
652 Wu YS, Chen YL, Yin SG, Zhou FX. Identification of differentially expressed miRNAs and mRNAs in esophageal squamous cell cancer by gene microarray. Shijie Huaren Xiaohua Zazhi 2011; 19(36): 3687-3691 [DOI: 10.11569/wcjd.v19.i36.3687] [Reference Citation Analysis]
653 Qiao Y, Zhang C, Li A, Wang D, Luo Z, Ping Y, Zhou B, Liu S, Li H, Yue D, Zhang Z, Chen X, Shen Z, Lian J, Li Y, Wang S, Li F, Huang L, Wang L, Zhang B, Yu J, Qin Z, Zhang Y. IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma. Oncogene. 2018;37:873-883. [PMID: 29059160 DOI: 10.1038/onc.2017.387] [Cited by in Crossref: 68] [Cited by in F6Publishing: 68] [Article Influence: 13.6] [Reference Citation Analysis]
654 Nakamura K, Yoshida N, Baba Y, Kosumi K, Uchihara T, Kiyozumi Y, Ohuchi M, Ishimoto T, Iwatsuki M, Sakamoto Y, Watanabe M, Baba H. Elevated preoperative neutrophil-to-lymphocytes ratio predicts poor prognosis after esophagectomy in T1 esophageal cancer. Int J Clin Oncol 2017;22:469-75. [PMID: 28097441 DOI: 10.1007/s10147-017-1090-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
655 Ba-Ssalamah A, Matzek W, Baroud S, Bastati N, Zacherl J, Schoppmann SF, Hejna M, Wrba F, Weber M, Herold CJ. Accuracy of hydro-multidetector row CT in the local T staging of oesophageal cancer compared to postoperative histopathological results. Eur Radiol. 2011;21:2326-2335. [PMID: 21710266 DOI: 10.1007/s00330-011-2187-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
656 Zhang SW, Zhang N, Wang N. Role of COL3A1 and POSTN on Pathologic Stages of Esophageal Cancer. Technol Cancer Res Treat 2020;19:1533033820977489. [PMID: 33280513 DOI: 10.1177/1533033820977489] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
657 Zhou YW, Li R, Duan CJ, Gao Y, Cheng YD, He ZW, Zeng JX, Zhang CF. Expression and clinical significance of C14orf166 in esophageal squamous cell carcinoma. Mol Med Rep 2017;15:605-12. [PMID: 28000881 DOI: 10.3892/mmr.2016.6056] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
658 Zeng Z, Ma C, Chen K, Jiang M, Vasu R, Liu R, Zhao Y, Zhang H. Roles of G Protein-Coupled Receptors (GPCRs) in Gastrointestinal Cancers: Focus on Sphingosine 1-Shosphate Receptors, Angiotensin II Receptors, and Estrogen-Related GPCRs. Cells 2021;10:2988. [PMID: 34831211 DOI: 10.3390/cells10112988] [Reference Citation Analysis]
659 Chen HS, Wu SC, Hsu PK, Huang CS, Liu CC, Wu YC. The Prognostic Impact of Preoperative and Postoperative Chemoradiation in Clinical Stage II and III Esophageal Squamous Cell Carcinomas: A Population Based Study in Taiwan. Medicine (Baltimore) 2015;94:e1002. [PMID: 26107665 DOI: 10.1097/MD.0000000000001002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
660 Li RZ, Li YY, Qin H, Li SS. ACTL6A Promotes the Proliferation of Esophageal Squamous Cell Carcinoma Cells and Correlates with Poor Clinical Outcomes. Onco Targets Ther 2021;14:199-211. [PMID: 33469301 DOI: 10.2147/OTT.S288807] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
661 Thakur B, Li H, Devkota M. Results of management of esophageal and GE junction malignancies in Nepalese context. J Thorac Dis 2013;5:123-8. [PMID: 23585936 DOI: 10.3978/j.issn.2072-1439.2013.03.07] [Reference Citation Analysis]
662 Zheng ST, Zhang CS, Qin X, Gen YH, Liu T, Sheyhidin I, Lu XM. The status of phosphorylated p38 in esophageal squamous cell carcinoma. Mol Biol Rep 2012;39:5315-21. [PMID: 22167332 DOI: 10.1007/s11033-011-1330-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
663 Lin DC, Wang MR, Koeffler HP. Genomic and Epigenomic Aberrations in Esophageal Squamous Cell Carcinoma and Implications for Patients. Gastroenterology. 2018;154:374-389. [PMID: 28757263 DOI: 10.1053/j.gastro.2017.06.066] [Cited by in Crossref: 90] [Cited by in F6Publishing: 90] [Article Influence: 18.0] [Reference Citation Analysis]
664 Wolf MC, Zehentmayr F, Schmidt M, Hölzel D, Belka C. Treatment strategies for oesophageal cancer - time-trends and long term outcome data from a large tertiary referral centre. Radiat Oncol 2012;7:60. [PMID: 22501022 DOI: 10.1186/1748-717X-7-60] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
665 Kim SG. What Is the Next Step after Endoscopic Resection of Superficial Esophageal Squamous Cell Carcinoma? Gut Liver 2015;9:693-4. [PMID: 26503566 DOI: 10.5009/gnl15109] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
666 Chedgy FJ, Kandiah K, Thayalasekaran S, Subramaniam S, Bhandari P. Advances in the endoscopic diagnosis and treatment of Barrett's neoplasia. F1000Res 2016;5:F1000 Faculty Rev-113. [PMID: 26918175 DOI: 10.12688/f1000research.6996.1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
667 Namikawa K, Yoshio T, Yoshimizu S, Ishiyama A, Tsuchida T, Tokai Y, Horiuchi Y, Hirasawa T, Fujisaki J. Clinical outcomes of endoscopic resection of preoperatively diagnosed non-circumferential T1a-muscularis mucosae or T1b-submucosa 1 esophageal squamous cell carcinoma. Sci Rep 2021;11:6554. [PMID: 33753766 DOI: 10.1038/s41598-021-85572-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
668 Meng H, Guan X, Guo H, Xiong G, Yang K, Wang K, Bai Y. Association between SNPs in Serpin gene family and risk of esophageal squamous cell carcinoma. Tumour Biol. 2015;36:6231-6238. [PMID: 25775950 DOI: 10.1007/s13277-015-3308-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
669 Lai X, Gu Q, Zhou X, Feng W, Lin X, He Y, Cao J, Liu P, Zhang H, Zheng X. Decreased expression of CD63 tetraspanin protein predicts elevated malignant potential in human esophageal cancer. Oncol Lett 2017;13:4245-51. [PMID: 28599425 DOI: 10.3892/ol.2017.6023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
670 Hatogai K, Kitano S, Fujii S, Kojima T, Daiko H, Nomura S, Yoshino T, Ohtsu A, Takiguchi Y, Doi T, Ochiai A. Comprehensive immunohistochemical analysis of tumor microenvironment immune status in esophageal squamous cell carcinoma. Oncotarget 2016;7:47252-64. [PMID: 27322149 DOI: 10.18632/oncotarget.10055] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 13.8] [Reference Citation Analysis]
671 Fakhrian K, Ordu AD, Lordick F, Theisen J, Haller B, Omrčen T, Molls M, Nieder C, Geinitz H. Long-term outcomes of trimodality treatment for squamous cell carcinoma of the esophagus with cisplatin and/or 5-FU: more than 20 years' experience at a single institution. Strahlenther Onkol 2014;190:1133-40. [PMID: 25015426 DOI: 10.1007/s00066-014-0711-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
672 Schneider PM, Baldus SE, Metzger R, Kocher M, Bongartz R, Bollschweiler E, Schaefer H, Thiele J, Dienes HP, Mueller RP. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification. Ann Surg. 2005;242:684-692. [PMID: 16244542 DOI: 10.1097/01.sla.0000186170.38348.7b] [Cited by in Crossref: 256] [Cited by in F6Publishing: 242] [Article Influence: 15.1] [Reference Citation Analysis]
673 Tai SY, Wu IC, Wu DC, Su HJ, Huang JL, Tsai HJ, Lu CY, Lee JM, Wu MT. Cigarette smoking and alcohol drinking and esophageal cancer risk in Taiwanese women. World J Gastroenterol 2010; 16(12): 1518-1521 [PMID: 20333794 DOI: 10.3748/wjg.v16.i12.1518] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
674 Liu R, Peng Y, Li X, Wang Y, Pan E, Guo W, Pu Y, Yin L. Identification of plasma metabolomic profiling for diagnosis of esophageal squamous-cell carcinoma using an UPLC/TOF/MS platform. Int J Mol Sci. 2013;14:8899-8911. [PMID: 23615477 DOI: 10.3390/ijms14058899] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 4.2] [Reference Citation Analysis]
675 Liu H, Ren G, Zhu L, Liu X, He X. The upregulation of miRNA-146a inhibited biological behaviors of ESCC through inhibition of IRS2. Tumour Biol 2016;37:4641-7. [PMID: 26508028 DOI: 10.1007/s13277-015-4274-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
676 Onishi S, Tajika M, Tanaka T, Hirayama Y, Hara K, Mizuno N, Kuwahara T, Okuno N, Inaba Y, Kodaira T, Abe T, Muro K, Shimizu M, Niwa Y. Prognostic Significance of Sarcopenia in Patients with Unresectable Advanced Esophageal Cancer. J Clin Med 2019;8:E1647. [PMID: 31601040 DOI: 10.3390/jcm8101647] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
677 Ma K, Cao B, Guo M. The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma. Clin Epigenetics 2016;8:43. [PMID: 27110300 DOI: 10.1186/s13148-016-0210-9] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 7.0] [Reference Citation Analysis]
678 Xie Z, Chen G, Zhang X, Li D, Huang J, Yang C, Zhang P, Qin Y, Duan Y, Gong B, Li Z. Salivary microRNAs as promising biomarkers for detection of esophageal cancer. PLoS One 2013;8:e57502. [PMID: 23560033 DOI: 10.1371/journal.pone.0057502] [Cited by in Crossref: 90] [